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Summary 
Chromatin is a tightly controlled cellular environment and protein association with 
chromatin is often regulated by post-translational modifications (PTMs), including 
modification with SUMO and ubiquitin. In the last decades, both these modifications and 
their corresponding enzymatic machineries have emerged as pivotal regulators involved in 
nuclear quality control, DNA repair and transcriptional regulation. More recently, SUMO-
targeted ubiquitin ligases (STUbLs) were discovered to provide an important link between 
those pathways, as they recognize SUMOylated proteins and catalyze their ubiquitylation. 
However, many of the physiological functions of STUbLs and how exactly they recognize 
specific substrates, while SUMOylated proteins are highly prevalent on chromatin, 
remained elusive. 
In this study, my analysis of the genome-wide distribution of the yeast STUbL 
Slx5/Slx8 demonstrates a remarkably specific localization of Slx5/Slx8 to seven loci of 
strong ubiquitin accumulation, so-called “ubiquitin hotspots”. My data show that Slx5/Slx8 
is recruited to ubiquitin hotspots by the uncharacterized transcription factor-like protein 
Ymr111c/Euc1. Slx5/Slx8 recruitment relies on a bipartite interaction between 
Ymr111c/Euc1 and Slx5, which involves the Slx5 SUMO-interacting motifs and a novel, 
uncharacterized substrate recognition domain of Slx5 directly interacting with 
Ymr111c/Euc1. Importantly, the Euc1–ubiquitin hotspot pathway and Slx5/Slx8 are 
required for the cellular response to various stresses like temperature shifts, in particular 
when general gene expression control is impaired by mutation of members of the H2A.Z 
and Rpd3L pathways. 
Thus, my data suggest that the STUbL-dependent ubiquitin hotspots shape 
chromatin during stress adaptation, and the bipartite recruitment mechanism exemplifies 
how specificity can be generated in the STUbL pathway. These findings can guide future 
research elucidating how different substrate recognition domains control the diverse 
STUbL functions, which range from the response to DNA damage to early embryonic 
development. 
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1. Introduction 
1.1 Post-translational Modification by Ubiquitin and UBLs 
Post-translational modifications (PTMs) represent an essential way for all eukaryotic cells 
to modify protein function and virtually all cellular pathways can be regulated and fine-
tuned by PTMs. Many PTMs like phosphorylation, acetylation or methylation expand the 
chemical repertoire of the twenty regular amino acids by addition of a small chemical 
group to side chains or to protein N- or C-termini. In contrast, modifications by ubiquitin 
(referred to as ubiquitylation or ubiquitination) and ubiquitin-like proteins (UBLs, e. g. 
SUMO) are distinct, because they involve the covalent attachment of a small protein to the 
substrate protein (Varshavsky, 2012). The ubiquitin-family proteins of eukaryotic cells 
comprise nearly twenty proteins that share a typical β-grasp fold and that are highly 
diverse in their cellular functions (Van der Veen & Ploegh, 2012). The founding member 
ubiquitin is most well-known for its function in targeting proteins for degradation by the 
26S proteasome (Finley et al, 2012). However, already in the early days of ubiquitin 
research, it had been revealed that ubiquitin functions not only in protein degradation 
pathways, but also in DNA repair and cell cycle regulation (Jentsch et al, 1987; Goebl et 
al, 1988). Over the last three decades, it became clear that ubiquitin achieves these 
functions by both proteolytic and nonproteolytic means, and numerous additional pathways 
and signaling events in all eukaryotic cells have been described to be regulated by the 
ubiquitin system (Oh et al, 2018). Similarly, other UBLs are involved in a wide range of 
cellular processes, including proteolysis, nuclear transport, autophagy, antiviral defense, 
tRNA-modification or splicing (Van der Veen & Ploegh, 2012). The molecular 
mechanisms of UBLs range from covalent attachment to substrate proteins similar to 
ubiquitylation (e. g. SUMO, Urm1, Nedd8/Rub1, Atg12) over covalent modification of 
lipids with Atg8 in autophagy, to non-covalent functions of Hub1 in splicing, or 
extracellular signaling functions of soluble ISG15 (Van der Veen & Ploegh, 2012). These 
variegated molecular mechanisms vividly reflect the diversity of cellular UBL functions. 
Besides the ubiquitin proteasome system (UPS), the small ubiquitin-like modifier 
(SUMO) pathway is of specific relevance to this study. It has been shown to be particularly 
active within the nucleus and targets many DNA-associated proteins (Jentsch & Psakhye, 
2013; Flotho & Melchior, 2013). SUMO and ubiquitin together regulate many chromatin- 
associated processes like DNA repair, replication or transcription (Gareau & Lima, 2010; 
Geng et al, 2012; Dantuma & van Attikum, 2016; Schwertman et al, 2016; Rosonina et al, 
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2017), and both systems with their specific functions at chromatin will be discussed in the 
following sections in more detail, with particular focus on the model organism 
Saccharomyces cerevisiae.   
1.2 The Ubiquitin Pathway 
1.2.1 Covalent Modification of Substrate Proteins by Ubiquitin 
Ubiquitylation is achieved by the covalent attachment of the 8.5 kDa protein ubiquitin to 
substrate proteins, usually to ε-amino groups of lysine residues via its C-terminal di-
glycine motif that is exposed upon initial processing. The enzymatic cascade required for 
ubiquitylation (Fig. 1) is initiated by an E1 enzyme for ubiquitin activation (Uba1), which 
forms a high-energy thioester-bond between the ubiquitin C-terminal carboxyl group and a 
cysteine residue in an ATP-dependent manner. In a transesterification reaction, activated 
ubiquitin is then transferred to the cysteine residue of a ubiquitin-conjugating enzyme (E2, 
Ubc-enzymes). Finally, ubiquitin ligases (E3) catalyze the isopeptide bond formation 
between the ubiquitin C-terminus and the ε-amino group of lysine residues of substrate 
proteins (Varshavsky, 2012; Finley et al, 2012; Deshaies & Joazeiro, 2009). The enzymes 
are organized in a hierarchical manner, with a single E1 in yeast (up to two in other 
species), eleven E2s (>30 in mammalian cells), and 60–100 E3s (>600 in mammalian 
cells) (Finley et al, 2012; Oh et al, 2018). Because many E3s act in concert with E2s, 
several hundred E2–E3 complexes are possible in yeast, which is the basis for substrate 
specificity of ubiquitin ligases (Kerscher et al, 2006). Typically, specific recognition by 
ubiquitin ligases is conferred by linear or structural motifs on the surface of substrate 
proteins, which are called degrons if proteins are destined for degradation (Varshavsky, 
2012). The ubiquitin pathway repertoire is enriched by E4 enzymes, which are E3 ligases 
that specifically act on monoubiquitylated substrates to attach polyubiquitin chains (Koegl 
et al, 1999). 
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Figure 1. The ubiquitin pathway.  
Ubiquitin (Ub) is translated as a precursor that needs C-terminal processing and for ubiquitylation, an enzymatic cascade 
involving enzymes for activation (E1), conjugation (E2) and finally ligation (E3) to substrate lysines (K) is required 
(top). RING-type E3s catalyze transfer of ubiquitin from an E2 to substrates (Sub), while HECT-type ligases first transfer 
ubiquitin to an internal cysteine (C) residue (top right). Monoubiquitylated substrates can be further modified resulting in 
multi- or polyubiquitylation (center). Polyubiquitylation can result in different chain topologies and while mono- or K63-
linked chains often signal nonproteolytic functions (center, top branch), K11, K48 or mixed chain types often result in 
degradation via the 26S proteasome or the autophagy pathway (bottom left). Specific recognition of chain topologies is 
mediated by ubiquitin-binding proteins, or “readers” (shown in light brown). Finally, deubiquitylation enzymes (DUBs) 
can cleave ubiquitin to recycle free ubiquitin and unmodified substrates (center left). Numbers in brackets indicate 
number of enzyme family members in S. cerevisiae and in H. sapiens, respectively. 
Ubiquitin Ligases  
Within E3 ligases, three distinct families have been described to date: (1) RING (really 
interesting new gene), (2) HECT (homologous to E6AP C-terminus) and (3) RBR (RING-
between-RING) domain ligases (Morreale & Walden, 2016; Zheng & Shabek, 2017). 
RING domain ligases act in concert with E2s and catalyze ubiquitin transfer directly from 
the E2 to the substrate by positioning them in a conformation that allows efficient 
ubiquitylation (Fig. 1) (Deshaies & Joazeiro, 2009). Adding to the complexity of the 
ubiquitylation enzyme machinery, RING-ligases often form homo- and heterodimers as 
well as oligomeric structures (Deshaies & Joazeiro, 2009). On the other hand, HECT and 
RBR domain ligases, which are RING-HECT hybrid enzymes, contain a catalytic cysteine 
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residue that accepts ubiquitin from the E2 and subsequently transfer it to the substrate 
protein (Fig. 1) (Scheffner et al, 1995; Finley et al, 2012; Morreale & Walden, 2016). 
RING domain ligases constitute the majority of E3s in yeast, with only five HECT domain 
and two putative RBR ligases encoded in the yeast genome (Finley et al, 2012). 
Importantly, many ubiquitin ligases act in complex with regulatory or adaptor subunits, 
with the anaphase promoting complex or cyclosome (APC/C) representing probably the 
most complex ligase composed of 13 subunits (McLean et al, 2011). A large class of 
multi-subunit ligases is the Cullin-RING ligase (CRL) family, for which a wide range of 
substrate specificity is achieved by a modular architecture featuring at least four subunits 
(RING protein, cullin-scaffold, linker protein and substrate receptor). For full activity, 
CRLs require modification by the UBL Rub1 (NEDD8 in humnas) (Deshaies & Joazeiro, 
2009; Skaar et al, 2013; Liakopoulos et al, 1998). 
Functions of Polyubiquitylation 
Ubiquitin ligases differ not only in their substrate specificity, but also in the pattern of 
substrate ubiquitylation, because after initial monoubiquitylation all of the seven lysine 
residues within ubiquitin (K6, K11, K27, K29, K33, K48, K63) and its N-terminal amino 
group (M1) can be used for chain formation (polyubiquitylation) (Finley et al, 2012; 
Komander & Rape, 2012). In principle all chain types can lead to proteasomal degradation, 
although K11- and K48-linked chains appear to be the major degradation signals (Fig. 1). 
M1- and K63-chains often serve as signaling platforms in DNA repair, NFκB-signaling or 
protein synthesis, and K6-chains are important in mitophagy (Oh et al, 2018; Komander & 
Rape, 2012). Specific functions of the less abundant K27-, K29- and K33-chains are 
largely unexplored. Recently, new research has also shed light on specific functions of 
mixed and branched chain types. For example, K11/K48-branched chains have been 
demonstrated to act as a priority signal for proteasomal degradation of conjugated 
substrates (Meyer & Rape, 2014; Yau et al, 2017), further expanding the “ubiquitin code” 
(Komander & Rape, 2012).  
Besides canonical conjugation to amino groups of lysine residues or the ubiquitin 
N-terminus, ubiquitin can also be attached to thiol or hydroxyl groups in cysteine, serine or 
threonine residues (Pao et al, 2018; Cadwell & Coscoy, 2005; Shimizu et al, 2010; Wang 
et al, 2012). Recent findings also demonstrated the ability of bacterial effector proteins to 
transfer ubiquitin to substrate serines in a phosphoribosylation-dependent manner, 
bypassing the eukaryotic E1-E2-E3 cascade (Qiu et al, 2016; Bhogaraju et al, 2016). 
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Taken together, the immense complexity of the enzymatic machinery catalyzing 
ubiquitylation allows specific recognition of a wide range of substrates and generates a 
variegated pattern of substrate ubiquitylation. Consequently, to mediate proper 
downstream recognition or processing of substrates, an equally diversified set of “readers” 
of this code is required. 
1.2.2 Consequences of Protein Ubiquitylation 
Once a protein is covalently modified with ubiquitin, the mark can be recognized to 
mediate a plethora of biological functions, which can be conceptually separated into 
substrate processing and signaling events. Major substrate processing events triggered by 
ubiquitin are further modifications with other PTMs, proteasomal or autophagic 
degradation (discussed in more detail below) or deubiquitylation by specific proteases 
(deubiquitylating enzymes, DUBs) to balance ubiquitylation (Fig. 1) (Dikic, 2017; 
Mevissen & Komander, 2017; Pickles et al, 2018). Signaling by ubiquitin is highly diverse 
and ranges from endolysosomal receptor sorting over the establishment of signaling 
platforms in immune reactions or in DNA repair, to the recruitment of other modifying 
enzymes to establish epigenetic marks on chromatin (Höhfeld & Hoppe, 2018; Oh et al, 
2018). 
Ubiquitin Binding Domains 
Both processing and signaling functions are mediated by proteins harboring specific 
ubiquitin binding domains (UBDs) (Dikic et al, 2009; Husnjak & Dikic, 2012). Not 
surprisingly, there is a wide range of UBDs, most of which recognize a hydrophobic patch 
around isoleucine 44 on the surface of ubiquitin. Around twenty distinct UBDs can be 
grouped according to structural features: (1) α-helical (e.g. ubiquitin-interacting motif 
(UIM), ubiquitin-associated (UBA)), (2) zinc finger (ZnF, e.g. ubiquitin-binding zinc 
finger (UBZ)), (3) plekstrin homology (PH) domain, (4) ubiquitin-conjugating (Ubc)-like 
domain, and (5) other structures (Dikic et al, 2009; Husnjak & Dikic, 2012). The basis for 
specific recognition of certain chain-types by UBDs is the distinct structural topology that 
arises due to linkage via different lysine residues. For example, UBDs can act as rulers to 
measure the distance between ubiquitin moieties in a chain: Two tandem UIMs in RAP80 
separated by a seven-residue helix recognize the extended conformation of K63-linked 
chains, but not compact K48-linked chains (Sato et al, 2009; Sims & Cohen, 2009). On the 
other hand, two closely spaced UIMs in Ataxin-3 separated by only two residues mediate 
preference for the compact K48 chains. In this case, swapping the linkers is sufficient to 
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change the preference for K48- versus K63-linked chains (Sims & Cohen, 2009). A 
different mode of binding is applied by the UBA domain of the proteasome shuttling factor 
RAD23A (Rad23 in yeast) to recognize K48 chains. Here, the UBA domain is sandwiched 
by two closely spaced K48-linked ubiquitin moieties and has contacts with both molecules 
and the linkage, which gives it selectivity over monoubiquitin (Varadan et al, 2005).  
Combination of different UBDs could also allow the specific recognition of 
branched chains or chains with different linkage types. For the case of K11/K48 branched 
chains, however, the increased local ubiquitin concentration was suggested to support more 
efficient binding by the proteasome and the ubiquitin-specific segregase p97/VCP (Cdc48 
in yeast, see below) (Yau et al, 2017). 
Deubiquitylation 
UBDs are also essential for the specificity of DUBs (~20 in yeast, ~100 in humans), which 
counteract ubiquitylation by cleaving off individual ubiquitin moieties, partial or complete 
chains (Mevissen & Komander, 2017; Harrigan et al, 2018). So far, six families of DUBs 
can be distinguished based on structural features of their catalytic domain: (1) USP 
(ubiquitin specific protease), (2) OTU (ovarian tumor protease), (3) UCH (ubiquitin 
C-terminal hydrolase), (4) Josephin, (5) MINDY (motif interacting with ubiquitin DUB 
family), and (6) JAMM-type (JAB1/MPN/MOV34). The first five DUB families are all 
cysteine proteases, while JAMM-type DUBs are Zn-dependent metalloproteases. Related 
to DUBs are also ubiquitin-like proteases (ULPs) that cleave UBLs like SUMO (see 
below) or NEDD8 (Mevissen & Komander, 2017; Harrigan et al, 2018). 
1.2.3 Proteasomal Protein Degradation 
The 26S proteasome is the endpoint of the ubiquitin-proteasome system because it 
degrades ubiquitylated substrates and achieves recycling of their amino acid components 
(Bard et al, 2018). Depending on the nature of the substrate and the ubiquitin chain type, 
substrates can also be degraded by autophagy-mediated delivery to the lysosome (vacuole 
in yeast) (Dikic, 2017; Lu et al, 2014; 2017). However, the fact that autophagy is 
dispensable in yeast under normal growth conditions, while proteasome function is 
essential, underscores the importance of the proteasome for cellular physiology. This is 
especially true for nuclear proteins that are largely inaccessible to autophagy. 
The proteasome is a large 2.5 MDa complex composed of a barrel-shaped 20S core 
particle (CP) and one or two 19S regulatory particles (RP) attached to either side that 
regulate entry to the central pore (Finley et al, 2012; Bard et al, 2018). Altogether, 33 
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proteins constitute the largest and most complex ATP-dependent protease in eukaryotes. 
The protease activity is mediated by three subunits of the two CP central β-rings (β1, β2 
and β5), which are shielded by adjacent α-rings that regulate substrate entry and serve as 
docking sites for RPs on either side (Finley et al, 2012; Bard et al, 2018). The RP is 
essential for substrate selection and delivery to the proteolytic cavity and is composed of a 
9-subunit base and a 9-subunit lid subcomplex, linked by an additional factor (Rpn10). As 
part of the base, the heterohexameric Rpt1–Rpt6 AAA+-type motor (ATPases associated 
with various cellular activities) provides the energy to unfold and thread substrates into the 
catalytic center.  
Substrate recognition is achieved by intrinsic or extrinsic ubiquitin receptors (Bard 
et al, 2018). At least three intrinsic receptors (Rpn1, Rpn10 and Rpn13) are part of the RP 
(Schreiner et al, 2008; Husnjak et al, 2008; van Nocker et al, 1996; Deveraux et al, 1994; 
Elsasser et al, 2002), while extrinsic receptors, also called shuttling factors (Rad23, Dsk2 
and Ddi1 in yeast, more paralogs in humans), dynamically associate with the proteasome 
(Hofmann & Bucher, 1996; Schauber et al, 1998; Kaplun et al, 2005; Elsasser et al, 2002; 
Funakoshi et al, 2002). This is achieved by a domain organization featuring a UBA 
domain for ubiquitin binding and a ubiquitin-like (UBL) domain that is in turn bound by 
the intrinsic proteasome receptors Rpn1 or Rpn13. Together, these receptors allow 
recognition of ubiquitylated substrates, especially K11-, K48-, K29-, but also K63-linked 
chains (Lu et al, 2017). Interestingly, the in vivo preference of the proteasome for 
substrates modified with K48-linked ubiquitin chains might be largely due to the linkage 
type specificity of upstream processing by the AAA+ enzyme Cdc48 and associated 
factors (Richly et al, 2005; Tsuchiya et al, 2017). 
Preceding degradation, substrates are usually deubiquitylated by proteasome-
associated DUBs to allow recycling of ubiquitin. Of those, the JAMM-type 
metalloprotease Rpn11 of the lid subcomplex is essential and it cleaves off ubiquitin chains 
between substrates and the first ubiquitin moiety en bloc (Bard et al, 2018; Maytal-Kivity 
et al, 2002; Verma et al, 2002). Additionally, the non-essential DUBs Ubp6 and Uch37 (no 
homolog in S. cerevisiae) act at the proteasome (Bard et al, 2018; Verma et al, 2000; 
Leggett et al, 2002).  
1.2.4 The Ubiquitin-targeted Segregase Cdc48 
A key component of the UPS involved in both proteolytic and nonproteolytic functions is 
the AAA+-type ATPase Cdc48 (p97 or valosin-containing protein/VCP in humans). The 
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main function of Cdc48 is the physical dissociation of ubiquitylated substrates from their 
local subcellular environment, like large protein complexes, membranes or chromatin, 
often leading to proteasomal degradation of substrates (Jentsch & Rumpf, 2007; Meyer et 
al, 2012; van den Boom & Meyer, 2017). Like other AAA+-type ATPases (e.g. the Rpt1–
Rpt6 complex of the RP), Cdc48 utilizes the chemical energy of ATP to create physical 
movement of its subunits, ultimately resulting in a pulling force on substrates. Each 
subunit of the homohexameric ring-shaped structure consists of a lateral, N-terminal 
N-domain and two ATPase subunits (D1 and D2) stacked on top of each other and 
surrounding the central pore (DeLaBarre & Brunger, 2003; Buchberger et al, 2015; 
Banerjee et al, 2016). 
For long, it had been thought that substrates cannot enter the narrow central pore of 
Cdc48 and are only remodeled due to structural rearrangements on the outer surface of 
Cdc48. However, recently it has been demonstrated that model substrates are unfolded and 
even threaded through the pore, shedding new light on how Cdc48 could provide a 
continuous pulling force, which is required e.g. for its function in the translocation of 
proteins over membranes (Bodnar & Rapoport, 2017; Blythe et al, 2017). So far, this 
threading mechanism has only been demonstrated in vitro, and whether and to what extent 
this also applies to substrates in vivo still needs further investigation (Bodnar & Rapoport, 
2017). 
Regulation of Cdc48 Functions by Cofactors 
The molecular segregase function of Cdc48 is applicable to a wide range of substrates, due 
to its association with a number accessory proteins or cofactors (around 40 in mammals) 
(Buchberger et al, 2015). Conceptually, Cdc48 cofactors can be separated into two major 
groups: substrate recruiting cofactors and substrate processing cofactors (Jentsch & 
Rumpf, 2007; Buchberger et al, 2015). Most cofactors bind to the N-domain via distinct 
Cdc48-binding domains or motifs, including the UBX (ubiquitin regulatory X) or UBXL 
(UBX-like) domains or the short linear binding motifs VIM (VCP-interacting motif), VBM 
(VCP-binding motif) and SHP box (suppressor of high-copy PP1). In contrast, PUB 
(PNGase/UBA or UBX containing proteins) and PUL (PLAP, Ufd3, and Lub1) domains 
mediate binding to the Cdc48 C-terminus (Buchberger et al, 2015). 
Three basic Cdc48 complexes can be distinguished based on association with 
substrate-recruitment cofactors: (1) Most functions in protein segregation upstream of 
proteasomal degradation are mediated by the Cdc48Ufd1-Npl4 complex; (2) Cdc48Shp1 (p97p47 
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in mammals) regulates homotypic membrane fusion events; (3) with UBXD1, which is 
only found in mammalian cells, p97UBXD1 is involved in sorting of ubiquitylated cargo in 
the endocytic pathway (Buchberger et al, 2015; Ritz et al, 2011; Hetzer et al, 2001). 
Additional cofactors can associate with these basic complexes to better control substrate 
specificity or cellular localization of Cdc48/p97.  
Substrate processing cofactors can modify the ubiquitylation status of substrates, 
exemplified for Spt23 ubiquitylation by the antagonistic action of the Ufd2 ubiquitin ligase 
and the Otu1 DUB, which fine-tune Spt23 degradation kinetics (Richly et al, 2005; Rumpf 
& Jentsch, 2006; Jentsch & Rumpf, 2007). Other processing activities include the PNGase 
function (peptide N-glycanase) for deglycosylation of misfolded glycoproteins in 
mammalian cells (Li et al, 2006) and the recently described protease function of Wss1 
acting on DNA–protein crosslinks, although the exact function of Cdc48 in this pathway is 
still elusive (Stingele et al, 2014; Stingele & Jentsch, 2015). The latest addition to this 
group of diverse enzymatic functions is the peptidyl-tRNA hydrolase or tRNA-cleavage 
activity of Vms1 that facilitates release of aberrant tRNA-linked peptides from stalled 
ribosomes (Verma et al, 2018; Rendón et al, 2018; Kuroha et al, 2018). 
In addition to substrate recruitment and processing cofactors, a third distinct group 
comprising regulatory cofactors that modulate Cdc48 activity has been suggested recently, 
which includes TUG (also known as ASPL or UBXD9, Ubx4 in yeast), UBXD4 and SVIP 
in mammalian cells (Hänzelmann & Schindelin, 2017). 
Cellular Functions of Cdc48 
The wide range of cofactors and their distinct activities imply diverse biological functions 
of Cdc48. Indeed, Cdc48 is involved in cell cycle progression, homotypic membrane 
fusion, endoplasmic reticulum-associated degradation (ERAD), mitochondria-associated 
degradation, autophagy, ribosome-associated quality control, transcription factor (TF) 
processing and various chromatin-associated functions (the latter will be discussed in more 
detail as part of the next section) (van den Boom & Meyer, 2017; Franz et al, 2016). As an 
example for TF processing, the activation mechanism of the transcription factor Spt23 of 
the oleic acid pathway in yeast has greatly contributed to a mechanistic understanding of 
Cdc48: Spt23 is synthesized as an inactive precursor (p120) and has a transmembrane 
domain that tethers it to the ER. Upon activation it is ubiquitylated and cleaved by the 
proteasome, but stays attached to its uncleaved homodimer binding partner. Separation of 
this complex to allow translocation of the active p90 fragment into the nucleus requires the 
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activity of Cdc48Ufd1-Npl4. This has led to the proposition of Cdc48 as a molecular 
segregase (Rape et al, 2001; Jentsch & Rumpf, 2007).  
Another well-studied example of Cdc48-function is its role in ERAD. Here, 
Cdc48Ufd1-Npl4 is required to translocate misfolded proteins across the ER membrane, which 
is assisted by the transmembrane cofactor Ubx2 and Ubx4. ERAD substrates first get 
ubiquitylated on the cytoplasmic surface of the ER membrane and then Cdc48 is required 
to fully translocate them across the membrane to allow proteasomal degradation (Berner et 
al, 2018). Like for many proteolytic functions of Cdc48, the shuttling factors Rad23 and 
Dsk2 facilitate substrate handover to the proteasome (Berner et al, 2018; Richly et al, 
2005). 
1.2.5 Chromatin-related Functions of Ubiquitin and Cdc48/p97 
Nuclear functions of ubiquitin can be separated in quality control (QC) functions similar to 
cytoplasmic QC pathways, and functions related to DNA metabolism and chromatin, 
which will be discussed in more detail due to their relevance to this study (Finley et al, 
2012; Ulrich & Walden, 2010; Shibata & Morimoto, 2014; Gallagher et al, 2013). 
Historically, the ubiquitin system is tightly linked to DNA transactions: histone H2A was 
the first identified ubiquitin substrate (Goldknopf et al, 1977); the first cloned E2 enzymes 
Rad6 and Cdc34 play pivotal roles in DNA repair and cell cycle regulation, respectively 
(Jentsch et al, 1987; Goebl et al, 1988); and the first physiological substrate for ubiquitin 
dependent proteasomal degradation was the transcription factor Matα2 (Hochstrasser & 
Varshavsky, 1990; Hochstrasser et al, 1991). Over the last three decades, both proteolytic 
and nonproteolytic functions of ubiquitin have been demonstrated in a wide range of 
chromatin-related processes. These include (1) regulation of replication by controlling 
crucial factors in initiation, origin licensing, replication fork protection, replication 
termination and chromosome segregation (Finley et al, 2012; Abbas & Dutta, 2017; Dewar 
& Walter, 2017); (2) various DNA repair pathways, like postreplicative DNA repair, 
global genome repair or transcription coupled repair (Bergink & Jentsch, 2009; Ulrich & 
Walden, 2010); and (3) the regulation of chromatin structure and epigenetic marks, 
transcription, mRNA processing and export (Tutucci & Stutz, 2011; Geng et al, 2012; 
Hammond-Martel et al, 2012; Yao & Ndoja, 2012; Braun & Madhani, 2012). 
Importantly, Cdc48/p97 has emerged as a crucial downstream processing factor 
thanks to its ability to remove ubiquitylated proteins that are tightly associated with 
chromatin (Franz et al, 2016; Dantuma & Hoppe, 2012). The first examples for chromatin 
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targets of Cdc48/p97 include the Aurora B kinase that is extracted from chromatin by p97 
at the end of mitosis to allow reformation of the nucleus (Ramadan et al, 2007), and the 
replication licensing factor CDT1 (and CDT-1 in C. elegans) that needs to be removed 
from chromatin to ensure a single round of replication origin firing per cell cycle (Raman 
et al, 2011; Franz et al, 2011). More recently, it has been discovered that also replication 
termination involves Cdc48/p97: After DNA replication is finished, the Mcm7 subunit of 
the CMG helicase (Cdc45, minichromosome maintenance [MCM] subunits 2–7, GINS 
complex) is marked with K48-linked ubiquitin chains (by the E3 ligase complexes SCFDIA2 
in yeast and CRL2LRR1 in vertebrates) and disassembled from DNA by Cdc48/p97 (Maric 
et al, 2014; Moreno et al, 2014; Maculins et al, 2015; Dewar et al, 2017). Cdc48 not only 
acts on DNA replication components, but is also critically involved in transcription by 
targeting TFs (Wilcox & Laney, 2009; Ndoja et al, 2014) or subunits of stalled/defective 
RNA polymerases II and III (Verma et al, 2011; Wang et al, 2018). Cdc48 plays another 
important role in the response to various sources of DNA damage (reviewed in (Franz et 
al, 2016)), where it has been shown to also act in non-conventional ways by targeting not 
only ubiquitylated, but also SUMOylated proteins (Nie et al, 2012; Bergink et al, 2013). 
 
Taken together, it is now well accepted that the UPS and in particular Cdc48 play 
crucial roles in the control and maintenance of chromatin composition throughout the cell 
cycle and in interphase cells. Importantly, ubiquitin-mediated functions can interfere and 
crosstalk with other PTMs at chromatin to ensure accurate regulation and responses to 
changing cellular conditions. One of these is modification with the related SUMO, which 
is known to be particularly active in the nucleus and has been shown to be involved in 
numerous protein–DNA transactions.  
1.3 The SUMO pathway 
1.3.1 Protein Modification with SUMO 
At first glance, the SUMO and ubiquitin pathways share striking similarities: The 
chemistry of covalent attachment of SUMO to substrates (SUMOylation) is analogous to 
that of ubiquitin, relying on initial processing to expose a C-terminal di-glycine motif, 
activation by an E1-enzyme (the heterodimeric Aos1/Uba2 in S. cerevisiae), transfer to a 
cysteine residue of an E2 conjugating enzyme and transfer to substrates aided by E3 
ligases (Fig. 2) (Gareau & Lima, 2010). Like ubiquitylation, SUMOylation can lead to 
formation of SUMO chains (polySUMOylation), but can also be reversed 
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(deSUMOylation) by the activity of specific proteases of the Ulp or SENP-family 
(ubiquitin-like specific protease or sentrin specific protease), and deSUMOylating 
Isopeptidase-1 (Fig. 2) (Mevissen & Komander, 2017; Kunz et al, 2018). SUMO is 
essential in most eukaryotes, and while a single gene encodes SUMO in S. cerevisiae 
(SMT3), there are at least three distinct isoforms in higher eukaryotes (SUMO1–3) (Flotho 
& Melchior, 2013). 
 
 
Figure 2. The SUMO pathway. 
As for ubiquitin, the SUMO (S) is translated as a precursor and needs C-terminal processing and an enzymatic cascade 
for activation (E1), conjugation (E2) and ligation (E3) to lysines within substrate (Sub) proteins (top). Lysines within 
SUMOylation consensus sites (ΨKx(D/E), Ψ is a large hydrophobic residue)  can also be modified by the E2 enzyme 
without the need of E3s (top right). Center: SUMOylation often provides additional protein–protein interaction sites for 
binding partners with SUMO-interacting motifs (SIMs, SUMO binding proteins shown in light brown). Multi-SIM 
proteins have increased specificity for multi/polySUMOylated proteins, like some SUMO-targeted ubiquitin ligases 
(STUbLs), which transfer SUMO-substrates to the ubiquitin pathway (bottom left). Alternatively, deSUMOylation by 
ubiquitin-like specific proteases (Ulp) leads to recycling of free SUMO and substrates (center left). Numbers in brackets 
indicate number of enzyme family members in S. cerevisiae and in H. sapiens, respectively. 
Despite these parallels, the enzymatic outfit of the SUMO pathway reveals an 
obvious difference to the ubiquitin pathway: While multiple E2 and myriads of E3 
enzymes and DUBs promote substrate specificity in the ubiquitin pathway (see above), 
Ubc9 is the sole E2 in both yeast and mammalian cells, only very few E3 enzymes exist 
(Siz1, Siz2, Mms21, and Zip3 in yeast, around ten are described in mammalian cells), and 
only two specific proteases are present in yeast (7 in mammalian cells) (Jentsch & 
Psakhye, 2013; Kunz et al, 2018; Mevissen & Komander, 2017). Interestingly, many 
proteins with the consensus SUMOylation site ΨKx(D/E), where ψ is a large hydrophobic 
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residue, can be modified by Ubc9 alone, bypassing the need for E3s altogether (Gareau & 
Lima, 2010). Therefore, for many target proteins it currently remains enigmatic if and how 
the limited number of enzymes allow specific targeting by the SUMO pathway. 
The apparent lack of high substrate specificity, together with the observation that in 
many cases multiple proteins of a macromolecular complex or functional pathway are 
simultaneously SUMOylated led to the proposition of the concept of “protein group 
SUMOylation” (Psakhye & Jentsch, 2012; Jentsch & Psakhye, 2013). First demonstrated 
for the homologous recombination (HR) DNA repair pathway (Psakhye & Jentsch, 2012), 
according to this idea, SUMOylation happens in waves upon specific triggers or confined 
to subcellular localizations, and targets multiple members of a protein complex with low 
specificity, e.g. HR repair proteins that assemble on DNA double strand breaks (Jentsch & 
Psakhye, 2013). SUMO-mediated protein–protein interactions can then help to both 
propagate the SUMOylation wave and act as a molecular glue to stabilize complexes. 
Other examples of protein groups targeted by SUMOylation include yeast septin proteins 
that assemble at the bud neck, telomeres, ribosome biogenesis factors, or promyelocytic 
leukemia (PML) bodies in mammalian cells (Johnson & Blobel, 1999; Potts & Yu, 2007; 
Panse et al, 2006; Shen et al, 2006). Although for protein group SUMOylation individual 
modified sites often seem dispensable or redundant, SUMOylation can also target highly 
specific lysine residues to achieve distinct outcomes. 
1.3.2 Consequences of SUMOylation 
On a molecular level, protein modification with SUMO can have three main consequences 
for target proteins (Jentsch & Psakhye, 2013): First, SUMOylation can compete with other 
PTMs that target lysine residues, like ubiquitylation, which can lead to protein stabilization 
(e.g. for of IκBα (Desterro et al, 1998)), or acetylation, which in the case of MEF2A 
affects its activity as transcription factor (Shalizi et al, 2006). Second, addition of the 11 
kDa SUMO moiety to a protein can block interactions with other proteins, as demonstrated 
for proliferating cell nuclear antigen (PCNA) K127 SUMOylation that prevents the 
interaction with Eco1 (Moldovan et al, 2006). Third, SUMOylation can enhance protein–
protein interactions, which seems to be the most prevalent function (Gareau & Lima, 
2010). This mechanism is usually brought about by a moderate-affinity interaction 
between SUMO and SUMO-interacting motifs (SIMs), which consist of a short stretch of 
hydrophobic residues (often (V/I)x(V/I)(V/I)), sometimes flanked by acidic residues (Song 
et al, 2004). This interaction can stabilize weak interactions or achieve specificity for 
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SUMO-modified binding partners, as exemplified by the preferential binding of the Srs2 
helicase to K164-SUMOylated PCNA during S-phase (Pfander et al, 2005; Papouli et al, 
2005; Armstrong et al, 2012). Crucially, SUMO–SIM interactions also contribute to the 
proposed glue-like function and protein group SUMOylation, because most SUMO E3s 
harbor SIMs and are therefore attracted to SUMOylated proteins or complexes. An 
additional SUMO–SIM mediated function can be intramolecular contacts that change 
protein conformation, as for thymine DNA glycosylase (Steinacher & Schär, 2005). 
Like for ubiquitin chains, polySUMO chains can also be recognized by proteins 
that harbor multiple SIMs, although there seems to be little specificity towards linkage 
types, and increased avidity is the basis for recognition of multi- or polySUMOylated 
proteins by multi-SIM proteins (Cappadocia & Lima, 2018). A prominent example of 
multi-SIM proteins are SUMO-targeted ubiquitin ligases (STUbLs) that recognize 
SUMOylated proteins and catalyze their ubiquitylation, which can ultimately lead to their 
degradation (Fig. 2, see also below) (Sriramachandran & Dohmen, 2014). Mixed chains 
can also be recognized by reader proteins that feature both SUMO- and ubiquitin-binding 
domains, as exemplified by RAP80 being recruited to DNA damage sites by STUbL-
generated mixed chains (Guzzo et al, 2012). 
Taken together, like all PTMs, SUMOylation expands and fine-tunes the functions 
of modified proteins, however, alteration of protein–protein interactions plays a central 
role for SUMO-mediated functions. 
1.3.3 Cellular Functions of SUMO 
In contrast to ubiquitin, SUMO signals primarily nonproteolytic functions. Consistent with 
the relatively low specificity of the enzymatic machinery, many proteins can be modified 
with SUMO, evidenced by estimates of ~10% of the yeast proteome being targeted by 
SUMOylation under different conditions (Jentsch & Psakhye, 2013); a similar fraction was 
reported for the human proteome (>3600 proteins) (Hendriks & Vertegaal, 2016). Notably, 
dramatic responses of global SUMOylation patterns can be induced by certain cellular 
stress conditions, including heat shock (where SUMOylation increases in most organisms), 
oxidative stress, or hypoxia (Tempé et al, 2008). Importantly, SUMOylation is essential 
for cellular survival under some of these stress conditions, but the molecular basis is 
largely unclear (Flotho & Melchior, 2013). Although examples for dedicated SUMO 
functions in the cytoplasm have been described (e.g. the above-mentioned septins), SUMO 
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primarily acts in the nucleus and most SUMOylation enzymes localize to the nucleus 
(Jentsch & Psakhye, 2013).  
Consistently, SUMO substrates are enriched for nuclear and DNA-binding proteins 
(Wohlschlegel et al, 2004; Hannich et al, 2005; Lewicki et al, 2014). Several nuclear 
substructures are regulated or maintained by SUMOylation, including DNA repair foci, 
telomeres, nucleoli, centromeres and kinetochores, polycomb group bodies and PML-
bodies as well as processes like DNA repair, cell cycle progression, transcription, pre-
mRNA splicing, nucleo-cytoplasmatic transport and ribosome biogenesis (Cubeñas-Potts 
& Matunis, 2013; Zhao, 2018). Historically, early on after the discovery of SUMO in the 
mid-1990s (Matunis et al, 1996; Mahajan et al, 1997), SUMO pathway mutants were 
linked to nuclear anomalies and chromosome segregation defects (Biggins et al, 2001; Hari 
et al, 2001). Since then, SUMO emerged as a central player in several DNA-repair 
pathways, including homolgous recombination (HR), non-homologous end joining 
(NHEJ), base excision repair (BER), and nucleotide excision repair (NER), orchestrating 
repair proteins often in concert with other PTMs like ubiquitylation (Bergink & Jentsch, 
2009; Ulrich & Walden, 2010). Also in the context of DNA repair, SUMOylation is 
required for chromosome movements and the relocation of certain types of DNA lesions to 
the nuclear pore complex or nuclear envelope (Nagai et al, 2008; Horigome et al, 2016; 
Kalocsay et al, 2009). 
SUMO in Transcriptional Regulation 
Additionally, proteins linked to transcription are amongst the most prominent SUMO 
substrates (Fig. 3) (Wohlschlegel et al, 2004; Hannich et al, 2005; Lewicki et al, 2014). In 
most cases, SUMOylation was shown to have a negative effect on transcription, although 
examples for SUMO-mediated activation are emerging (Chymkowitch et al, 2015a). 
Global regulators of transcription, including DNA methyltransferases or histone 
deacetylases (HDACs), which mediate mostly repressive effects, have been shown to be 
regulated by SUMO. For example, SUMOylated histones or TFs can recruit HDAC1 and 
HP1 (heterochromatin protein 1) (Shiio & Eisenman, 2003), and SUMOylation of HDAC1 
and HDAC4 is required for full transcriptional repression of target promoters  (David et al, 
2002; Kirsh et al, 2002; Cheng et al, 2004). 
For gene-specific TFs, SUMOylation can modulate their effect on transcription in 
numerous ways (Rosonina et al, 2017). Conceptually, SUMOylation can on the one hand 
directly affect TF activity on DNA by interfering with other regulatory PTMs like 
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acetylation and phosphorylation, or by mediating recruitment of corepressors (like 
HDACs) or coactivators (Fig. 3A–C). On the other hand, in many cases SUMOylation 
influences TF association with DNA, e.g. by regulating shuttling of TFs into the nucleus, 
regulating DNA-binding, promoting TF clearance from DNA, or by triggering STUbL-
mediated TF degradation (Fig. 3D–H) (Rosonina et al, 2017; Sri Theivakadadcham et al, 
2019). 
 
 
Figure 3. SUMO in transcriptional regulation. 
(A-C) SUMOylation can modulate transcription factor (TF) activity, e.g. by (A) blocking other modifications like 
acetylation (Ac) or phosphorylation (P), or by mediating histone deacetylase (HDAC, (B)) or histone acetyl transferase 
(HAT, (C)) recruitment. 
(D-H) SUMOylation can regulate the association of TFs with DNA. SUMOylation can promote or block nuclear 
transport of TFs (D) or their binding to promoter sequences (E). (F) SUMOylation can signal removal of TFs from DNA. 
SUMOylation can compete with ubiquitylation and thus stabilize TFs (G) or lead to STUbL-mediated ubiquitylation and 
degradation of TFs (H). Note that effects on transcription rates (red cross: down, green arrow: up) are based on the 
scenario of an activating TF. For transcriptional repressors, the reverse outcome is expected. ORF: open reading frame.  
Figure inspired by (Rosonina et al, 2017). 
Well-studied examples for transcriptional regulation in S. cerevisiae include Gcn4, 
a TF induced by amino acid starvation. Specifically, SUMOylation is required to promote 
eviction of Gcn4 to shut down transcription of e.g. ARG1 upon re-availability of amino 
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acids (Rosonina et al, 2010; 2012). Additionally, SUMOylation of the Tup1 corepressor 
also contributes to ARG1 deactivation (Ng et al, 2015). Conversely, Tup1 in complex with 
the coactivator Ssn6 maintains the galactose inducible gene GAL1 in a repressed state. 
Upon induction, the NPC-associated SUMO protease Ulp1 deSUMOylates Ssn6 to allow 
full GAL1 transcription (Texari et al, 2013). Another study found many pro-growth genes 
like ribosomal protein genes (RPGs) and RNA Pol III-transcribed genes positively 
regulated by SUMO (Chymkowitch et al, 2015b). For RPGs, this effect relied on enhanced 
SUMOylation of the TF Rap1, which leads to recruitment of TFIID and consequently 
RNA Pol II. 
 
Besides the multiple effects of SUMOylation on transcriptional regulation, ever 
more novel SUMO-mediated regulatory mechanisms continue to be discovered for the 
thousands of cellular SUMO substrates. What is understudied in many cases, however, is 
the fate of SUMOylated proteins. Besides deSUMOylation by SUMO-specific 
isopeptidases to recycle unmodified proteins, another major pathway is STUbL-mediated 
ubiquitylation. 
1.4 SUMO-targeted Ubiquitin Ligases (STUbLs) 
1.4.1 Proteolytic Control of SUMOylated Proteins 
STUbLs modify SUMOylated proteins with ubiquitin and thereby transfer substrates from 
the SUMO to the ubiquitin pathway, often leading to proteasomal degradation (Fig. 2, 
bottom left, Fig. 3H). STUbLs orchestrate multiple functions in DNA repair, quality 
control, transcriptional regulation and beyond (Sriramachandran & Dohmen, 2014). To 
achieve this, STUbLs combine binding to SUMOylated proteins via SUMO-interacting 
motifs (SIMs) with ubiquitin ligase activity, STUbL mutants accumulate high molecular 
weight (HMW) SUMOylated proteins, and are hypersensitive to DNA damage and 
replication stress (Uzunova et al, 2007; Prudden et al, 2007; Sun et al, 2007; Xie et al, 
2007). Among eukaryotes, the STUbL family is highly diversified, although the basic 
enzymatic activity is conserved from yeast to mammalian cells, evidenced by the ability of 
the mammalian STUbLs RNF4 or Arkadia (RNF111) to complement the replication stress 
phenotypes of yeast STUbL mutants (schemes Fig. 4) (Uzunova et al, 2007; Sun et al, 
2007; Prudden et al, 2007). 
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S. Cerevisiae STUbLs 
Slx5/Slx8. The main STUbL enzyme in yeast is formed by the heterodimeric Slx5/Slx8, of 
which both subunits harbor C-terminal RING-domains, which are essential for 
ubiquitylation in vitro, and for in vivo functions (Fig. 4) (Ii et al, 2007; Xie et al, 2007). 
Slx5 harbors 5 SIMs, 4 of which cluster in the N-terminal part and are most important for 
recruitment of the Slx5/Slx8 complex to polySUMOylated proteins (Xie et al, 2010). Slx8 
contains one putative SIM and its N-terminal part exhibits non-specifc DNA-binding 
activity (Yang et al, 2006). 
Consistent with DNA-binding activity and the predominant role of SUMO inside 
the nucleus, Slx5/Slx8 primarily localizes to the nucleus and to nuclear pore complexes 
(Nagai et al, 2008; Cook et al, 2009), and most of the substrates are nuclear proteins. 
Initially, the Slx5/Slx8 complex has been identified for its role in genome stability, which 
manifests in a synthetic lethal phenotype with the DNA helicase Sgs1 (hence the name 
Synthetic lethal of unknown [X] function (Mullen et al, 2001)), and hypersensitivity to 
replication stress (Xie et al, 2007). Slx5/Slx8 is also involved in the repositioning of 
different types of DNA lesions to nuclear pore complexes (Nagai et al, 2008; Horigome et 
al, 2016; Churikov et al, 2016; Su et al, 2015), and has recently been demonstrated to 
contribute to the cell cycle regulation of the Yen1 nuclease, which acts on HR 
intermediates (Talhaoui et al, 2018). Several DNA-associated proteins have been shown to 
be Slx5/Slx8 substrates, including the centromeric histone variant Cse4 (Ohkuni et al, 
2016; 2018), the chromosomal passenger complex proteins Bir1 and Sli15 (Thu et al, 
2016), the kinetochore-protein Kar9 (Schweiggert et al, 2016), the rDNA silencing protein 
Tof2 (Liang et al, 2017) and RNA polymerase III (Wang et al, 2018). Furthermore, 
transcription factors such as a mutant variant of Mot1 and the mating type regulator Matα2 
are substrates for Slx5/Slx8 (Wang & Prelich, 2009; Xie et al, 2010). Interestingly, in the 
latter case, Matα2-SUMOylation is dispensable for Slx5/Slx8 targeting, however, the SIMs 
of Slx5 and Matα2 DNA-binding are required (Xie et al, 2010; Hickey et al, 2018). 
Ubiquitylation is not only important for targeting Matα2 for proteasomal degradation, but 
also signals recruitment of the Cdc48 complex for extraction (Wilcox & Laney, 2009). 
Noteworthy, Cdc48 can be recruited not only to ubiquitylated, but also to SUMOylated 
proteins (Bergink et al, 2013). 
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Figure 4. SUMO-targeted ubiquitin ligases (STUbLs). 
Schematic representation of selected STUbLs. SUMO-interacting motifs (SIMs) are marked by green bars. Functional 
features and interaction sites to recognize specific substrates or binding partners are highlighted. For RNF4, aminoacid 
(aa) positions are given for the H. sapiens protein, for Arkadia for the M. musculus variant. For Uls1, the N-terminal part 
is not drawn to scale. UBZ: ubiquitin-binding zinc finger; SAP: SAF-A/B, Acinus, PIAS-domain (DNA-binding); ARM: 
arginine rich motif; (P): phosphorylation; PRC1: polycomb repressive complex 1; His: histidine; MN/C: middle-domain 
N-/C-terminal. 
Uls1. Uls1 (also known as Ris1/Dis1/Tid4) is a complex 1619 aa protein with 4 SIMs in 
the N-terminal part and a RING domain sandwiched between a Swi2/Snf2-like 
(switch/sucrose non-fermentable) translocase/helicase ATP-binding motif and the C-
terminal helicase domain (Fig. 4). Uls1, like Slx5/Slx8, contributes to the clearance of 
HMW SUMO conjugates (Uzunova et al, 2007), however, a direct biochemical proof of 
STUbL activity is still elusive. The Swi2/Snf2-like translocase function, which mediates 
ATP-dependent repositioning or removal of proteins from DNA, is essential for most Uls1 
functions. A major function is partially overlapping with other Swi2/Snf2-like translocases 
(Rad54, Rdh54) for the removal of Rad51 from undamaged DNA (Shah et al, 2010). Uls1 
also prevents detrimental NHEJ of telomeres by curbing the accumulation of 
polySUMOylated Rap1 at telomeric DNA. Both the Swi2/Snf2-like translocase and RING 
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domains contribute to this function (Lescasse et al, 2013). Similarily, NHEJ of Rap1-
bound double-strand breaks (DSBs) is prevented by Uls1, likely by a similar mechanism 
(Marcomini et al, 2018). 
Interestingly, Rrp2, the S. pombe homolog of Uls1, has been termed a “SUMO 
targeted DNA translocase” for its activity on SUMOylated Top2 that is trapped by Top2 
poisons. Notably, the translocase function, but not the RING domain, is essential for this 
function (Wei et al, 2017). In fact, the authors propose that Rrp2 safeguards SUMOylated 
Top2 from ubiquitylation by the S. pombe STUbL formed by Slx8 and Rfp1 or Rfp2, and 
show similar behavior in S. cerevisiae. Indeed, several studies reported physical or genetic 
interactions between Uls1 and Slx5/Slx8 and proposed antagonistic functions, suggesting a 
complex interplay between the two STUbLs (Cal-Bąkowska et al, 2011; Tan et al, 2013; 
Kramarz et al, 2014).  
Although the requirement for intact SIMs, Swi1/Snf2-like translocase and RING 
domain has not been deteremined for all Uls1 functions, it seems likely that Uls1 acts as a 
multi-purpose protein that is recruited to SUMOylated proteins on DNA to translocate 
and/or ubiquitylate them. 
 
Rad18. Rad18 (Fig. 4) has been suggested to have STUbL-like activity for its substrate 
PCNA, however, in this case the interaction of a single SIM with monoSUMOylated 
PCNA only enhances Rad18 activity, but is not strictly required (Parker & Ulrich, 2012). 
Also, the mechanism does not seem to be conserved, since the SIM is absent from human 
Rad18. 
Mammalian STUbL Enzymes 
RNF4. With 190 aa, RNF4 is the smallest STUbL described to date (Fig. 4). It forms a 
homodimeric ligase and is the best-studied family member so far. The first physiological 
substrate described for RNF4 was the PML protein, which gets polySUMOylated upon 
exposure to arsenic and RNF4-mediated ubiquitylation subsequently leads to its 
degradation (Tatham et al, 2008). Although it is unclear whether RNF4 a is direct homolog 
of yeast STUbLs (S. pombe Rfp1/Rfp2 or S.pombe/S. cerevisiae Slx8 have been suggested 
as distant homologs (Prudden et al, 2007; Sriramachandran & Dohmen, 2014)), RNF4 and 
its yeast counterparts act in similar biological pathways. 
RNF4 has crucial functions in DNA repair and both proteolytic and nonproteolytic 
functions are relevant in this case, as well as generation of SUMO/ubiquitin hybrid chains 
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(Galanty et al, 2012; Yin et al, 2012; Luo et al, 2012; Guzzo et al, 2012). Other substrates 
include the kinetochore protein CENP-I (Mukhopadhyay et al, 2010), misfolded and 
quality control substrates (Ahner et al, 2013; Guo et al, 2014), transcriptional regulators 
and oncogenes (Guo & Sharrocks, 2009; van Hagen et al, 2010; Kuo et al, 2014; Thomas 
et al, 2016; Costanzo et al, 2018), and even SUMOylation enzymes (Kumar et al, 2017). 
The wide range of RNF4 functions is also underscored by the ability to cooperate with 
multiple E2s to catalyze mono-ubiquitylation as well as K11-, K33-, K48- and K63-linked 
ubiquitin chains (Plechanovová et al, 2011; Branigan et al, 2015; Thomas et al, 2016). 
 
Arkadia (RNF111). Arkadia has functions in the repair of UV-induced DNA lesions by 
targeting polySUMOylated XPC (Xeroderma pigmentosum C), a central damage 
recognition factor in NER (Poulsen et al, 2013). Furthermore, Arkadia has overlapping 
functions with RNF4 in PML degradation (Erker et al, 2013). However, its best-studied 
and possibly major function lies in transcriptional control of the TGFβ (transforming 
growth factor β) pathway, where it promotes TGFβ signaling through degradation of 
negative regulators (Smad7, c-Ski, SnoN) (Inoue & Imamura, 2008). Binding and 
degradation of c-Ski and SnoN seem to be independent of SIMs (Erker et al, 2013), but 
SUMO-binding has been shown to contribute to localization to Polycomb bodies and 
thereby transcriptional regulation of the TGFβ pathway (Fig. 4) (Sun & Hunter, 2012; Sun 
et al, 2014). 
Other STUbL Enzymes 
Degringolade/Dgrn is an RNF4 homolog in Drosophila melanogaster and has been shown 
to mediate transcriptional repression in early embryonic development or transcriptional 
activation in the innate immune response (Abed et al, 2011a; Koltun et al, 2017). 
Furthermore, like S. cerevisiae Slx5/Slx8, it contributes to relocalization of DNA breaks to 
the nuclear periphery and their repair (Ryu et al, 2015). 
Besides the eukaryotic members, two viral STUbLs have been identified: ICP0 of 
Herpes simplex virus 1 and the related ORF61p of Varicella zoster virus, which target 
SUMOylated host proteins for degradation to promote viral infectivity (Everett et al, 
2013). 
1.4.2 Specificity in the STUbL Pathway 
The initial characterization of STUbL enzymes showed an accumulation of HMW SUMO 
conjugates, and that multiple SIMs were necessary for STUbL-mediated clearance and to 
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alleviate replication stress hypersensitivity (Uzunova et al, 2007; Xie et al, 2007; Tatham 
et al, 2008). Multiple SUMO–SIM interactions have been demonstrated to provide 
increased avidity and therefore preference for polySUMOylated over monoSUMOylated 
substrates (Xu et al, 2014; Keusekotten et al, 2014), and many substrates accumulate in a 
polySUMOylated form in the absence of STUbLs (Tatham et al, 2011; Lescasse et al, 
2013; Ohkuni et al, 2016). Consistent with a shared role in keeping substrate 
SUMOylation in check, STUbLs also compete or cooperate with deSUMOylation enzymes 
for certain substrates (Kosoy et al, 2007; Xie et al, 2007; Uzunova et al, 2007). 
Additionally, polySUMO chains have been shown to activate STUbLs and contribute to 
homodimerization of RNF4 (Rojas-Fernandez et al, 2014), which is required for catalysis 
(Plechanovová et al, 2012). Therefore, the prevailing view is that STUbLs are ligases with 
specificity for polySUMOylated proteins. 
However, how STUbLs select their proper substrates amongst myriads of 
SUMOylated proteins is still largely unclear. Enzyme localization likely contributes to 
specificity, e.g. RNF4 is recruited to PML bodies (in a SUMO-dependent manner 
(Geoffroy et al, 2010)) and Slx5/Slx8 is targeted to the nuclear pore complex (Nagai et al, 
2008). More recently, it has been reported that STUbLs also use SUMO-independent 
substrate interactions (highlighted in Fig. 4): RNF4 interacts with nucleosomes via a basic 
patch and can target non-SUMOylated, but phosphorylated proteins via an arginine-rich 
motif (ARM) (Groocock et al, 2014; Thomas et al, 2016; Kuo et al, 2014). Similarily, 
substrate-specific interactions have been described for Arkadia and Degringolade (Sun et 
al, 2014; Abed et al, 2011a). In contrast, for the prototypical S. cerevisiae STUbL 
Slx5/Slx8, substrate specificity is rather unexplored. As mentioned, for Matα2 turnover, 
SUMOylation is dispensable, but Slx5-SIMs are still required and it has been suggested 
that SUMO-like features of Matα2 and its DNA binding contribute to recognition by 
Slx5/Slx8 (Xie et al, 2010; Hickey et al, 2018). Also, it was demonstrated, that Slx5/Slx8 
can target binding partners of SUMOylated proteins in trans, suggesting that 
SUMOylation of the substrate is not a prerequirement for ubiquitylation.  
 
Taken together, since their discovery in 2007, STUbLs have emerged as critical 
effectors at the crossroads of the SUMO and ubiquitin pathways that are involved in a 
plethora of cellular, predominantly nuclear functions, reflecting the versatility of the 
SUMO pathway. However, a clear mechanistic understanding of how substrate specificity 
is achieved in the STUbL pathway is still elusive. 
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2 Aims of this Study 
2.1 Rationale 
Extensive evidence suggests that STUbLs play pivotal roles in controlling the functions of 
proteins on chromatin. Many SUMOylated proteins associate with chromatin and, by using 
chromatin immuno-precipitation (ChIP), it has recently been demonstrated that SUMO 
associates with hundreds of regions in S. cerevisiae cells, and thousands of regions in 
human cells (Chymkowitch et al, 2015b; Neyret-Kahn et al, 2013; Seifert et al, 2015; 
Niskanen et al, 2015). However, what remains completely unexplored is whether STUbLs 
play a global role in turnover of SUMOylated proteins on chromatin. In this context, a 
crucial question is whether STUbLs are recruited to all SUMOylated proteins on 
chromatin, or if additional features define and select bona fide substrates. Therefore, a 
detailed study on the role of STUbLs on chromatin is expected to not only further our 
understanding of SUMO metabolism on chromatin, but is also likely to give insights into 
mechanisms of STUbL recruitment and potentially novel biological functions. 
2.2 Preliminary Data 
In a previous PhD project in the Jentsch laboratory, a novel approach to study protein 
turnover on chromatin on a genome-wide scale in S. cerevisiae has been developed by 
Maximilan J. Kern (Kern, 2013). To this end, ChIP with ubiquitin-specific antibodies was 
paired with genome-wide tiling arrays (ChIP-chip). Critically, nine genomic sites with high 
enrichment of ubiquitylated proteins (“ubiquitin hotspots”) stood out because of a marked 
increase of ubiquitin signal in mutants of the Cdc48Ufd1-Npl4 complex and its cofactors 
Ubx4 and Ubx5. Seven of those intergenic ubiquitin hotspots share a common mechanism, 
involving a DNA sequence motif (ub-HS-motif) bound by the transcription factor-like 
protein Ymr111c, now named Euc1: Enriches ubiquitin on chromatin 1 (Fig. 5). Euc1 gets 
SUMOylated and then recruits the STUbL Slx5/Slx8 to mediate ubiquitylation at ubiquitin 
hotspots. Although SUMOylation-deficient Ymr111c/Euc1 exhibited transactivation 
function when artificially targeted to reporter genes, it did not seem to regulate genes 
adjacent to ubiquitin hotspots. Hence, the biological function of ubiquitin hotspots 
remained elusive (Kern, 2013). 
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Figure 5. Seven “ubiquitin hotspots” across the yeast genome. 
(A) Schematic representation of the S. cerevisiae genome with positions of seven related “ubiquitin hotspots” indicated 
by red triangles. (B) The ubiquitin hotspots (ub-HS) contain a shared sequence motif that was used in a yeast one-hybrid 
screen, which identified Ymr111c/Euc1 as a specific interactor (Kern, 2013). (C) Working model for the ubiquitin 
hotspot pathway: (1) Euc1 binds to the DNA sequence motif (2) and gets SUMOylated by Ubc9 together with Siz1 or 
Siz2; (3) SUMOylation recruits the yeast STUbL Slx5/Slx8 to (4) catalyze modification of Euc1 itself or associated 
proteins with K48-linked ubiquitin chains; (5) the ubiquitin-specific segregase Cdc48 in complex with Ufd1-Npl4 and the 
cofactors Ubx4 and Ubx5 are required to remove ubiquitylated proteins from ubiquitin hotspots. Figure adapted from 
(Kern, 2013). 
2.3 Aims of this Study 
Several questions remained open after the initial characterization of ubiquitin hotspots: 
First, what is the biological function of ubiquitin hotspots? A sophisticated mechanism 
seemed to be at work to establish ubiquitin hotspots and control protein turnover at these 
sites, suggesting that they have evolved to serve an important physiological function. 
However, strains deleted for EUC1 did not exhibit any obvious growth phenotypes. 
Additionally, the identity of the ubiquitylated proteins remained elusive. Second, what is 
the global function and distribution of Slx5/Slx8 across the yeast genome? It was 
demonstrated that Slx8 is highly enriched at ubiquitin hotspots, but the genome-wide 
distribution was unexplored. Third, how can Slx5/Slx8 be specifically recruited by Euc1, 
while SUMOylation is highly prevalent on chromatin? Euc1 seemed to be predominantly 
monoSUMOylated, so recruitment of Slx5/Slx8 might involve other, polySUMOylation 
independent mechanisms. Since the apparent lack of substrate specificity in both the 
SUMO and STUbL pathways is a major unresolved question, gaining insight into 
Slx5/Slx8 recruitment is expected to contribute to our understanding of both pathways. 
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3 Results 
3.1 Euc1 and Slx8 Bind to Ubiquitin Hotspots with High 
Specificity 
Ubiquitin hotspots (ub-hotspots, ub-HS in figures) have previously been shown to be the 
major sites of Cdc48-mediated extraction of ubiquitylated proteins from chromatin within 
the S. cerevisiae genome (Kern, 2013). Furthermore, for selected ub-hotspot sites it has 
been demonstrated that both Slx8 and the ub-hotspot factor Euc1 are enriched by 
performing chromatin immunoprecipitation combined with quantitative real-time PCR 
(ChIP-qPCR). However, the genome-wide distribution of Euc1 and Slx8 remained 
unexplored. Therefore, and to gain further insight into the biological functions of 
Slx5/Slx8 and Euc1, I performed ChIP experiments combined with genome-wide tiling 
arrays (ChIP-chip, Fig. 6A–D). 
Using a chain-type specific antibody (ub-K48, clone Apu2), I could confirm the 
specific enrichment of K48-linked ubiquitin chains at ub-hotspots, that ub-hotspots are 
enhanced in cdc48 mutants (cdc48-3), and lost in the absence of Euc1 (Fig. 6B, cdc48-3 
euc1∆). Consistent with a crucial function at ub-hotspots, Euc1 was detected at all ub-
hotspots in wild-type (WT) cells, but not in euc1∆ cells (Fig. 6C). ChIP-chip data for 
tagged Slx8 (Slx8-9myc) revealed a marked enrichment at most ub-hotspots, that was 
mildly enhanced in cdc48-3 cells, reduced in cells with impaired SUMOylation (ubc9-1), 
and lost in the absence of Euc1 (euc1∆, Fig. 6D). Notably, with few exceptions as 
described below, the localization not only of Euc1, but also of Slx8 was confined to ub-
hotspots, arguing that these are prominent sites of STUbL activity within the yeast 
genome. All ub-hotspots are situated in intergenic regions, do not seem to be linked with 
any annotated features within the yeast genome, and are spread across the sixteen yeast 
chromosomes (Fig. 5A) in an apparently random way. No common genetic pathway or 
function could be identified for ub-hotspot adjacent genes, and no physical association was 
apparent in publicly available chromosome conformation capture datasets (Duan et al, 
2010). 
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Figure 6. Ubiquitin hotspots are the main binding sites for Euc1 and Slx8 in the S. cerevisiae genome. 
(A) Schematic representation of the strategy used to probe proteins bound at ubiquitin hotspots (ub-hotspots, ub-HS) 
using chromatin immuno-precipitation combined with NimbleGen genome-wide tiling arrays (ChIP-chip).  
(B) Ub-hotspots depend on Euc1. 16-kb windows of the indicated regions centered around the seven ub-hotspots of 
ChIP-chip tracks for ub-K48 directed ChIP-experiments. Significantly enriched regions are marked by bars above the 
respective ChIP-chip tracks, DNA from non-specific IgG-ChIP experiments served as background control (not shown). 
Genotypes of the used strains are indicated on the right. Data represent means from two independent replicates. All 
experiments, including those using cdc48-3 and ubc9-1 temperature-sensitive (ts) alleles, were performed at 30°C 
(semipermissive temperature for ts-alleles) unless stated otherwise. 
(C) Euc1 binds to ub-hotspots. Genome-wide binding profiles of Euc1 were obtained in ChIP-chip experiments as 
described in (B). Euc1 ChIP experiments were performed with a polyclonal antibody raised against Euc1 aa 292–462. 
The wider peaks of Euc1 compared to ubiquitin peaks are likely due to very strong enrichments of Euc1 over background 
signals and the limited resolution of the tiling arrays. Data represent means from two independent replicates. 
(D) Slx8 is specifically recruited to ub-hotspots. Genome-wide binding profiles of Slx8-9myc probed with a Myc-tag 
specific antibody. ChIP-chip was performed as described in (B). Data represent means from two independent replicates. 
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Besides ub-hotspots, I could detect only three additional sites of major Euc1 
enrichment, two of which also contained a ub-HS-motif and coincided with Slx8 binding 
sites (Euc1-sites1–3, Fig. 7). However, these sites did not show any accumulation of 
ubiquitylated proteins (Fig. 7). Conversely, two of the nine originally identified Cdc48-
controlled ub-hotspots did not show Euc1 or Slx8 localization, arguing for a different 
pathway acting at those positions (ub-only-sites1–2, Fig. 7). 
 
 
Figure 7. Major non-ub-hotspot binding sites of ubiquitin, Slx8 and Euc1. 
ChIP-chip data for sites with major Euc1 enrichment without ubiquitin enrichment, two of which also show Slx8-
accumulation (Euc1-sites, left panels) and sites with major ubiquitin enrichment in cdc48 mutants (cdc48-3) without Slx8 
and Euc1 enrichment (ub-only-sites, right panels). ChIP-chip experiments were performed as described in Fig. 6.  
Of note, in agreement with a previous study (van de Pasch et al, 2013), I did not observe any binding of Slx8-9myc to 
centromeres in ChIP-chip or ChIP-qPCR. In contrast to that study, however, I also did not detect any Slx5 enrichments at 
centromeres when probed by qPCR for 3HA-Slx5 or endogenous Slx5 (not shown). The discrepancies might be due to a 
non-functional SLX5 allele that had been used by van de Pasch et al (2013), as stated in their methods section. 
I confirmed the binding of Slx8 to selected ub-hotspots using ChIP-qPCR, which 
also highlighted a strong variability in the relative amount of bound Slx8 at the different 
loci (Slx8-9myc, Fig. 8A). Importantly, Slx5 (3HA-Slx5) also associated with ub-hotspots 
in a similar pattern (Fig. 8B), suggesting that both STUbL subunits are recruited together. 
Data from ChIP experiments using antibodies raised against endogenous Slx5 or Slx8 were 
in good agreement with the results for epitope-tagged proteins (Fig. 8C). 
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Figure 8. Slx5 and Slx8 localize to ub-hotspots in similar patterns. 
(A–C) ChIP followed by quantitative real-time PCR (ChIP-qPCR) with primers specific for the indicated ub-hotspot sites 
or at centromeres (CEN1, CEN11). ChIP was performed using antibodies for epitope-tagged Slx8-9myc (A) and 3HA-
Slx5 (B), or endogenous Slx5 or Slx8 using specific antibodies (C). In contrast to a previous study (van de Pasch et al, 
2013), no signals for Slx5 were detected at centromeres. Data were normalized to an unrelated control region (contr.) on 
ChrII (TOS1 promoter region, see Materials and Methods), i.e. background levels are defined as 1. The control region is 
omitted from plots of normalized ChIP-qPCR experiments for clarity hereafter. 
(D) Spotting assay to compare relative growth and survival rates of the indicated strains. Cells were diluted to OD600 = 
0.5 and 5-fold serial dilutions were spotted on YPD plates, supplemented with 100 mM hydroxyurea (HU) as indicated. 
Plates were incubated at 30°C or 22°C for 3 days. Note that tagged Slx8 and Slx5 allels do not show the typical 
slx5∆/slx8∆ phenotypes upon cold stress or replication stress (HU). 
A previous study investigating genome-wide binding of Slx5 and Slx8 reported 
specific localization of Slx5 to centromeres, and no specific enrichment sites for Slx8 (van 
de Pasch et al, 2013). I tested enrichment of Slx5 and Slx8 at centromeres (CEN1, 
CEN11), however, did not detect any specific signal for either subunit (Fig. 8A–C). The 
discrepancies might be due to technical reasons, or due to the fact that van de Pasch et al 
(2013) used a non-functional variant of Slx5 (Slx5-GFP), as stated in their methods 
section. Possibly, accumulation of kinetochore-bound Slx5/Slx8 substrates could have led 
to trapping of non-functional Slx5 at centromeres (Schweiggert et al, 2016). Manual 
inspection of the data revealed signals for both Slx5-GFP and Slx8-GFP at some of the ub-
hotspots, however, these might not have fulfilled the bioinformatics criteria for peak 
definition (van de Pasch et al, 2013). Importantly, all tagged WT Slx5 and Slx8 variants 
used in this study did not show any growth defects or STUbL-specific phenotypes, like 
sensitivity to cold or replication stress induced by hydroxyurea (HU, Fig. 8D). 
Taken together, my ChIP-chip data indicate that Euc1 localizes to ub-hotspots in a 
highly specifc manner, which is required for recruitment of Slx8. Site-specific enrichment 
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of Slx8 on a genome-wide level seems to be confined to ub-hotspots, and Slx5 appears to 
be recruited together with Slx8. 
3.2 SUMOylated Euc1 Recruits Slx5/Slx8 to Ub-hotspots  
Besides Euc1, which is likely binding to the ub-HS-motif directly, a Y1H screen also 
identified SUMO to associate with ub-hotspots in an Euc1-dependent manner (Kern, 
2013). Large-scale proteomic studies have previously reported Ymr111c/Euc1 as a 
candidate SUMOylation substrate (Zhou et al, 2004; Denison et al, 2005; Hannich et al, 
2005) and Euc1 immunoprecipitation (IP) suggested that Euc1 is SUMOylated in a highly 
specific manner on lysine 231 (K231, see scheme Fig. 9A). Replacement of this residue 
with arginine (K231R mutant, euc1-KR hereafter) seemed to abolish Euc1 SUMOylation 
(Kern, 2013). Therefore, SUMOylation might be a crucial regulator of the ub-hotspots. 
 
 
Figure 9. Euc1 SUMOylation is required for ub-hotspot formation. 
(A) Schematic representation of the Euc1/Ymr111c domain structure. A coiled-coil domain (CC, green) and a GCR1 
domain with predicted DNA-binding activity (orange) are indicated. A single lysine residue has been identified as the 
major SUMOylation site (K231, (Kern, 2013) and (B)). 
(B) Euc1 is predominantly monoSUMOylated on lysine 231. Denaturing NiNTA-pulldowns (NiNTA-PD) with strains 
expressing 7-histidine-tagged SUMO (HisSUMO) as indicated and 3FLAGEuc1 constructs under the control of an ADH 
promoter. Covalently SUMO-modified proteins were enriched and eluates probed with a FLAG antibody to visualize 
SUMOylated Euc1. Eluates were probed for SUMO to control for equal pull-down efficiency; to control for equal input 
levels, input samples were probed with FLAG and Pgk1 antibodies (top to bottom). Euc1-KR denotes the K231R 
mutation here and hereafter. 
(C) Left: Euc1 and its SUMOylation are required for ub-hotspot formation. Ub-K48 ChIP followed by qPCR for the 
indicated sites and strains. Right: Euc1 binding to ub-HSs drops in euc1-KR cells. In parallel to ub-K48 ChIP, ChIP 
against Euc1 was performed and quantified by qPCR. Data represent means ± SD (n = 2). 
To corroborate these initial findings and demonstrate a direct, covalent 
modification of Euc1 with SUMO, I performed NiNTA pull-downs (NiNTA-PDs) of His-
tagged SUMO (HisSUMO) in cells expressing 3FLAG-tagged Euc1 (3FLAGEuc1). Using 
denaturing conditions, only covalently SUMO-modified proteins are enriched and 
associated proteins are washed off. The NiNTA-PD experiments followed by western blot 
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(WB) revealed an up-shifted Euc1 band corresponding to monoSUMOylated Euc1 and a 
weaker band further up-shifted, likely representing diSUMOylation (Fig. 9B). 
SUMOylation was strongly reduced in cells expressing Euc1-KR, confirming that K231 is 
the major SUMOylation site of Euc1 (Fig. 9B). 
Importantly, Euc1-K231 SUMOylation is required for ub-hotspot formation (Fig. 
9C, left panel, (Kern, 2013)). Curiously, Euc1 binding at ub-hotspots itself was also 
reduced by up to ten-fold in euc1-KR cells for several selected sites (Fig. 9C, right panel). 
Hence, SUMOylation seems to regulate ub-hotspot formation through modulating Euc1 
binding and/or Slx5/Slx8 recruitment.  
To address the possibility that Euc1 is an Slx5/Slx8 substrate, I established 
denaturing NiNTA-PDs to probe for covalently His-ubiquitin-modified proteins (HisUbi, 
Fig. 10A). A WB against 3FLAGEuc1 revealed an up-shifted smear likely representing 
polyubiquitylated Euc1, which was reduced for Euc1-KR and entirely lost in cells 
expressing a catalytically dead Slx8 RING domain variant (slx8-CD, Fig. 10A), and in 
slx5∆ cells (Fig. 10B). 
 
 
Figure 10. Euc1 is ubiquitylated in an Slx5/Slx8-dependent manner. 
(A) Euc1 ubiquitylation depends on Slx8 and partly on Euc1 SUMOylation. Denaturing NiNTA-PDs as described for 
Fig. 9B, but with strains expressing 6-histidine-tagged ubiquitin (HisUbi) and 3FLAGEuc1 constructs under the control of 
the ADH promoter. WBs were developed with a FLAG antibody to probe for 3FLAGEuc1 (PD and input), a ubiquitin blot 
served as NiNTA-PD control and Dpm1 as input control. The catalytic dead slx8-CD allele carries the C206S, C209S 
mutations (Xie et al, 2007). 
(B) Slx5 is required for Euc1 ubiquitylation. Denaturing NiNTA-PDs with HisUbi as in (A). Note that Euc1-ubiquitylation 
levels are abolished in slx5∆ cells, but also reduced in cdc48-3 cells. 
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Based on these data, it would be an appealing hypothesis that Euc1 is the main Slx5/Slx8 
ubiquitylation substrate at ub-hotspots, and therefore the subject of Cdc48-mediated 
extraction, and possibly subsequent degradation. Consequently, Euc1 levels should be 
enhanced or turnover kinetics slowed down when the ub-hotspot pathway is impaired.  
 
 
Figure 11. Slx5/Slx8-mediated ubiquitylation does not lead to fast Euc1 degradation.  
(A–B) Euc1 levels increase in slx5∆ and for euc1-KR. Euc1 levels were quantified from WBs of three replicate samples 
(A) using a LI-COR Odyssey Fc imaging system and were normalized to Pgk1 and wild-type levels (B). Pgk1 served as 
loading control. Data represent means ± SD (n = 3). p-values of Student’s t-tests for comparisons to WT are indicated 
above the bars. euc1-DBD* signifies a DNA binding-deficient mutant variant (W333A, R334A, see also Fig. 18). 
(C) Euc1 shows slow degradation kinetics. Cells were treated with 0.5mg/ml cycloheximide (CHX) to shut down protein 
translation and samples were taken at the indicated times. Quantification was done as in (A–B). Relative Euc1 signals 
were normalized to Dpm1 levels and to t = 0. 
(D) Euc1 and ub-K48 ChIP signal strengths do not correlate. ChIP against Euc1 (top) and ub-K48 (bottom) analyzed by 
qPCR for all ub-HSs. Separate primer pairs were used for distinct motif occurrences within ub-HS1 and ub-HS4. Note 
that Euc1 signals did not increase in a cdc48-3 strain. Data represent means ± SD (n = 2). 
(E) Euc1 binding to ub-HS sites is reduced, rather than increased, in slx5∆ and slx8∆ cells. ChIP against Euc1 was 
quantified by qPCR in the indicated strains. Note that the binding defect for Euc1 is similar for the euc1-KR and slx5∆ 
strains. Data represent means ± SD (n = 2). 
Probing total protein amounts, steady-state levels of Euc1 were mildly increased in 
slx5∆ and euc1-KR cells, but not in cdc48-3 cells (Fig. 11A–B). To test turnover, I used 
cycloheximide to shut down protein synthesis and followed Euc1 levels. Interestingly, WT 
Euc1 is a rather stable protein and degradation rates seemed similar for Euc1-KR (Fig. 
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11C). Also, Euc1 stability did not change in slx5∆ or cdc48-3 cells (not shown). These 
results indicate that ubiquitylation by Slx5/Slx8 does not cause rapid Euc1 degradation, or 
that only a small fraction of Euc1 undergoes Slx5/Slx8-mediated ubiquitylation. 
Additional evidence suggests that Euc1 is not the only or main ubiquitylation 
substrate at ub-hotspots: First, ubiquitylated Euc1 species were reduced, rather than 
enhanced in cdc48-3 cells in denaturing NiNTA-PDs (Fig. 10B). Second, Euc1 signals at 
different ub-hotspots did not correlate with ubiquitin signals, and Euc1 did also not 
accumulate at these sites in cdc48 mutant strains—in contrast to ubiquitin (Fig. 11D). 
Third, Euc1 enrichment at ub-hotspots in ubiquitylation-deficient slx5∆ and slx8∆ strains 
was decreased, arguing against Slx5/Slx8-dependent degradation of Euc1 at ub-hotspots 
(Fig. 11E). 
If it is not the substrate for turnover at ub-hotspots, what then is the role of Euc1? 
As an alternative hypothesis, SUMOylated Euc1 could act as a cofactor to signal Slx5/Slx8 
localization to ub-hotspots, given that Euc1 (and SUMOylation) are required for Slx8 
recruitment (Fig. 6D). As a first step to elucidate how Euc1 might achieve the highly 
specific recruitment of Slx5/Slx8 (Fig. 6D), I decided to investigate recruitment of both 
heterodimer subunits separately in different genetic backgrounds. Signals for tagged Slx5 
and Slx8 were mildly enhanced in cdc48-3 cells when probed by ChIP-qPCR (Fig. 12A–
B). Notably, Slx5 and Slx8 levels correlated well with WT Euc1 enrichment patterns at the 
tested sites (compare Fig. 12A–B and Fig. 11E). Consistent with a strict dependence on 
Euc1 and its SUMOylation, both Slx5 and Slx8 were entirely lost from ub-hotspots in 
euc1∆ and euc1-KR strains (Fig. 12A–B). Furthermore, the data suggested that Slx5 was 
 
 
Figure 12. SUMOylated Euc1 recruits Slx5/Slx8 via the Slx5 subunit to ub-hotspots.  
ChIP against 3HA-Slx5 (A) and Slx8-9myc (B) in the indicated genetic backgrounds were quantified by qPCR. Note that 
Slx5 is still partially recruited in the absence of Slx8 (3HA-Slx5 slx8∆), but not vice versa (Slx8-9myc slx5∆). Data 
represent means ± SD (n = 2). 
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still recruited in the absence of Slx8 (3HA-Slx5 slx8∆, Fig. 12A), albeit to a lower extent, 
while Slx8 recruitment to ub-hotspots was strictly Slx5 dependent (Slx8-9myc slx5∆, Fig. 
12B).  
Taken together, these data demonstrate that Euc1 and its SUMOylation play major 
roles in controlling ub-hotspots by enabling Slx5/Slx8 recruitment. Additionally, they 
identify Euc1 as a novel Slx5/Slx8 ubiquitylation substrate, but it appears likely that 
additional proteins bind and get ubiquitylated at ub-hotspots. These proteins are putative 
Slx5/Slx8 ubiquitylation substrates, which get extracted from chromatin by Cdc48. 
3.3 Specific Interaction Sites Mediate SUMO–SIM-independent 
Euc1–Slx5 Binding 
A hallmark of many STUbL substrates is modification with polySUMO chains 
(polySUMOylation) or multiple SUMO moieties (multiSUMOylation), which is thought to 
facilitate STUbL recruitment through polyvalent SUMO–SIM contacts (Sriramachandran 
& Dohmen, 2014). However, Euc1 seems to be predominantly monoSUMOylated (Fig. 
9B), and expressing lysine-free SUMO (SUMO-KRall) as only copy of SUMO to block 
chain formation did not affect ub-hotspots (Fig. 13A). This raises the question of how 
Slx5/Slx8 can be targeted to ub-hotspots with high specificity, while SUMOylation on 
chromatin is prevalent (Chymkowitch et al, 2015a)? 
ChIP-qPCR data suggested that Slx5 could be recruited by SUMOylated Euc1 
independently of its dimerization partner Slx8 (Fig. 12), and I could show an interaction 
between Euc1 and Slx5 using a yeast two-hybrid (Y2H) assay (Fig. 13B, bottom row, 
Appendix Fig. A1A–C) (Yu et al, 2008). This interaction was mildly enhanced upon 
truncation of the C-terminal Slx5 RING domain (Slx5-RING∆, aa 1–487), and was still 
detectable for a SUMOylation-deficient Euc1-KR construct (Fig. 13B, bottom rows). To 
map an interaction site within Euc1, I expressed truncations spanning the N-terminal half 
of Euc1 and found that amino acids 81-183 were required and sufficient for interaction 
with Slx5 (Fig. 13B, Appendix Fig. A1A–C). Of note, Euc181-183 does not contain the 
SUMOylation site, but spans a CC domain that mediates Euc1 homodimerization in Y2H 
assays (Appendix Fig. A1D–E). A SUMO-independent interaction was also substantiated 
by direct binding of unmodified recombinant Euc1 to purified Slx5 in in vitro GST-
pulldown assays (Fig. 13C). Similarly, the in vivo binding did not strictly depend on Euc1 
SUMOylation, as 3FLAGEuc1 and 3FLAGEuc1-KR both interacted similarly with Slx5 in 
co-immunoprecipitation (co-IP) experiments. A recent study demonstrated that DNA 
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binding of Matα2 was required for degradation by Slx5/Slx8 (Hickey et al, 2018). 
However, even an Euc1 DNA binding-deficient mutant variant interacted with Slx5 (Fig. 
13D, lane 4, 3FLAGEuc1-DBD*, W333A, R334A, see also Fig. 18). In summary, these data 
argue for the existence of SUMO–SIM independent binding sites between Euc1 and Slx5. 
 
 
Figure 13. SUMOylation independent interactions of Slx5 with Euc1.
(A) PolySUMO-chain formation is not required for ub-hotspot formation. ChIP against ub-K48 in strains expressing a 
SUMO variant with all lysines mutated to arginines (SUMO-KRall) as the only source of SUMO. ubx5∆ cells were used 
to enhance ubiquitin signals, as Ubx5 is required for Cdc48-dependent extraction of ubiquitylation substrates. Enriched 
DNA was analyzed by qPCR. Data represent means ± SD (n = 3). Data courtesy of Maximilian J. Kern. 
(B) The region of Euc1 required for interaction with Slx5 maps to aa 81–183. Yeast two-hybrid (Y2H) assay to map the 
Slx5 interaction site on Euc1. A Y2H reporter strain (PJ69-7a) was transformed with Gal4 DNA-binding domain (BD) 
and Gal4 activation domain (AD) fusion constructs in the indicated combinations. Note that SUMOylation-deficient 
Euc1-KR still interacts with Slx5-RING∆ (∆aa 488–619), albeit weaker than wild-type Euc1 (bottom 2 rows). Cells were 
spotted on control media or selective media (- His) and grown at 30°C for 2 days. See also Appendix Fig. A1A–C. 
(C) Euc1 binds to Slx5 in vitro. Recombinant purified GST or GSTEuc1 were used in GST pull-down assays to 
coprecipitate recombinant 6HisSlx5. 
(D) Euc1 binds to Slx5 in vivo. Cell lysates from an euc1∆ strain expressing the indicated 3FLAGEuc1 constructs from 
plasmids (under EUC1 promoter) were subjected to immunoprecipitation (IP) using anti-FLAG beads. IP-eluates were 
probed by WB with Slx5, SUMO and Euc1 antibodies, inputs were probed with Slx5, FLAG and Dpm1 antibodies (top 
to bottom). Note that the Euc1–Slx5 interaction is independent of the Slx8 ligase activity (slx8-CD, lanes 5–8). 
To identify potential binding motifs, a customized version of the software HH-
MOTiF (Prytuliak et al, 2017) for de novo motif prediction was employed1. With 
                                                
1 in collaboration with Roman Prytuliak and Bianca Habermann, MPI Computational Biology Group/CNRS, 
IBDM UMR 7288 Marseille, France 
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Euc181-183 and a set of putative Slx5 substrates2 as input data, three potential binding sites 
were predicted within Euc181-183. Mutation of two of those sites indeed led to a reduction in 
interaction with Slx5 in Y2H and co-IP experiments (Fig. 14A and B (lanes 2–5), Slx5-
binding mutants SBM1 and SBM2, SBM1: aa 139–143 ENQKK>ANAAA, SBM2: aa 
162–165 KEVF>AAAA, see also Appendix Fig. A2A). Of note, additional mutation of the 
Euc1 SUMOylation site had little effect on Slx5 binding in co-IP (Fig. 14B, lanes 6–9). In 
Y2H experiments, the stretch between Euc1 aa 140–183 was required for interaction with 
Slx5, but not for dimerization (Fig. 13B, Appendix Fig. A1D). In agreement with that, the 
SBM1/SBM2 mutations left Euc1 dimerization intact (Appendix Fig. A2B), suggesting 
that impaired dimerization did not account for the loss of Slx5 interaction. 
 
 
Figure 14. Euc1 interaction with Slx5 is mediated by specific interaction sites. 
(A) Euc1 Slx5-binding mutants (SBM1, SBM2) affect Euc1–Slx5 interaction in Y2H assays. AD-Euc181-183 constructs 
harboring mutations in the region required for Slx5 binding were probed for interaction with BD-Slx5 constructs as 
described in Fig. 13B. Mutations: SBM1: aa 139–143 ENQKK>ANAAA, SBM2: aa 162–165 KEVF>AAAA. Serial 
dilutions were spotted and cells were grown at 30°C for 2 days. See Appendix Fig. A2A for expression levels. 
(B) Euc1-SBM constructs show defective Slx5 binding in vivo. Mutations described in (A) were introduced into full-
length 3FLAGEuc1 constructs (with or without the K231R mutation) and FLAG IPs were performed as described in Fig. 
13D. WB analysis showed strong Slx5-binding defects for the SBM1/SBM2 and SBM1+2 constructs (top panel, 
immunoprecipitated Slx5). IP-eluates were probed by WB with Slx5, SUMO and Euc1 antibodies, inputs were probed 
with Slx5, FLAG and Dpm1 antibodies (top to bottom). 
So far, all characterized Slx5/Slx8 substrates required the Slx5 SIMs for their 
recognition, but the interaction with Euc1 did not comprise the Euc1 SUMOylation site. To 
identify which features within Slx5 were required for interaction with Euc1, I truncated 
Slx5 constructs and performed Y2H assays to assess interaction with Euc1. Consistent with 
a SUMO–SIM-independent interaction, the mapped fragment between aa 201–335 did not 
contain any SIM (Fig. 15A). This part of the protein was poorly characterized, and I 
designated it the Slx5 middle domain (Slx5-Md). The Slx5-Md is required and sufficient 
                                                
2 unpublished data kindly provided by Ivan Psakhye, FIRC Institute of Molecular Oncology, Milan 
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for interaction with the Euc81-183 fragment (Fig. 15B) and Slx5-binding-deficient mutants 
of Euc1 (SBM1/2) strongly diminished the interaction (Fig. 15C). 
  
 
Figure 15. The Slx5 middle domain (Slx5-Md) interacts with Euc1. 
(A) The region of Slx5 required to interact with Euc1 maps to aa 201–335 (Slx5-Md). C-terminal Gal4-BD-Slx5 
truncation constructs were probed for interaction with AD-Euc181-183 in Y2H. Note that the interaction gradually 
decreased when truncations between aa 201 and 487 were introduced. The Slx5-Md was defined to be the minimal region 
required for robust interaction with Euc1, however, the region between aa 336–487 also contributes to the interaction 
(compare Slx5-RING∆ and Slx5-Md in Fig. 14A and 15C, respectively). Cells were grown at 30°C for 3 days. 
(B) The Slx5-Md is sufficient for interaction with Euc1. Y2H assays with AD-Euc181-183 and BD-Slx5 constructs. Slx5-
Md: aa 201–335, Slx5-Md∆: ∆aa 201–338. Serial dilutions were spotted and cells were grown at 30°C for 4 days. 
(C) Euc1-SBM constructs show defective binding to the Slx5-Md. Y2H assay with the indicated constructs as in Fig. 
14A. See Appendix Fig. A2A for expression levels. 
(D) Schematic representation of Euc1, Slx5 and Slx8, domain features and interactions. Domains and protein lengths are 
drawn to scale, numbers below schemes denote amino acid positions. The mapped interaction between Euc1 and Slx5 is 
indicated by an arrow. CC: coiled-coil domain, SBM: Slx5-binding mutant, Md: middle domain, S: SUMO, SIM: SUMO 
interacting motif. 
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In conclusion, the interaction between Euc1 and Slx5 is independent of polySUMO 
chains and involves contacts between Euc181-183 and the Slx5-Md, possibly requiring Euc1 
dimerization. SUMO–SIM contacts are not strictly required, but likely contributing to the 
interaction in vivo, suggesting bipartite substrate recognition (summarized in Fig. 15D). 
3.4 Specific Euc1–Slx5 Interaction Sites are Required for Ub-
hotspots 
To validate the functional relevance of the SUMO-independent contacts between Euc1 and 
Slx5, I tested whether ubiquitylation of Euc1 or ub-hotspot formation would be affected by 
mutations of the respective interaction sites. Using denaturing NiNTA-PDs with His-
ubiquitin, I found that both Euc1 Slx5-binding mutants (SBM1, SBM2), as well as the 
double mutant exhibited reduced Euc1 ubiquitylation (Fig. 16A, lanes 3–6). Adding the 
SUMOylation site mutation (KR) to these constructs further decreased the ubiquitylation 
efficiency (lanes 7–10), suggesting that both specific contact sites and SUMOylation 
contribute to Slx5/Slx8 recruitment. 
 
Figure 16. Euc1 ubiquitylation depends on specific Slx5-interaction sites. 
(A) Euc1 Slx5-binding mutations impair Euc1 ubiquitylation. His-ubiquitin-modified proteins were enriched by 
denaturing NiNTA-PDs as described in Fig. 10. 3FLAG-tagged Euc1 constructs with the indicated mutations were 
expressed from plasmids under the control of the ADH promoter. NiNTA-PD eluates were probed with FLAG and 
ubiquitin (P4D1) antibodies. Whole cell lysates (input) were probed with FLAG and Dpm1 antibodies. Asterisk denotes a 
non-specific band. For quantification of relative Euc1Ubi(n) levels in NiNTA-PD samples, signals were quantified using 
ImageStudio Lite from the section indicated by dashed lines, normalized to free ubiquitin (HisUbi) and WT 3FLAGEuc1. 
(B) The Slx5-SIMs and Slx5-Md are required for Euc1 ubiquitylation. NiNTA-PDs for His-ubiquitin as in (A). All 
strains expressed WT 3FLAGEuc1 from plasmids under the ADH promoter and His-ubiquitin. Slx5 constructs were 
expressed from plasmids under control of the endogenous promoter. WBs were probed as described in (A), Slx5 levels 
were probed using an hemagglutinin (HA) antibody. Slx5-SIM*: SIMs 1–4 were mutated as described (Xie et al, 2010), 
for SIM5, aa 477–479 (IIV) were mutated to alanines. To avoid possible mislocalization by deletion of the Slx5-Md, 
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(Figure 16, continued)  
which overlaps with a putative nuclear localization signal (NLS) (Westerbeck et al, 2014), an N-terminal NLS was fused 
to all constructs. See Appendix Fig. A3C for HU complementation. Quantification of relative Euc1Ubi(n) as in (A) with 
normalization to (HisUbi) and WT NLS-3HASlx5. For quantification of relative Slx5 levels, signals were normalized to WT 
NLS-3HASlx5. 
Moreover, when I performed NiNTA-PDs of His-tagged ubiquitin with slx5∆ cells, 
plasmid-borne expression of a WT Slx5 construct restored Euc1 ubiquitylation (Fig. 16B, 
lane 2). In contrast, expressing Slx5-SIM* with all SIMs mutated led to reduced Euc1 
ubiquitylation, and Slx5-Md∆ failed to restore Euc1 ubiquitylation (Fig. 16B, lanes 3–4). 
The central region of Slx5, part of which overlaps with the Slx5-Md (aa 201–335), 
has previously been implicated in mediating Slx5 nuclear localization, shows interactions 
with Slx8 and Slx5 itself (Westerbeck et al, 2014), and comprises a so-called “lysine 
desert”, a lysine-free stretch that separates the N-terminal SIM-containing region from the 
RING domain and apparently protects from auto-ubiquitylation (Sharma et al, 2017). To 
rule out that Slx5-Md∆ was generally defective or comprised in its catalytic function, I 
tested whether the different SLX5 alleles would be able to complement slx5∆ growth 
phenotypes when challenged with replication stress by HU, or upon exposure to low 
temperatures (Xie et al, 2007). As expected, the Slx5-SIM* construct was deficient in 
slx5∆ complementation, but Slx5-Md∆ restored WT growth (Appendix Fig. A3A–C). 
Fusion of an N-terminal nuclear localization signal led to reduced protein levels, but did 
not influence the complementation in growth assays (Appendix Fig. A3A–C). 
Additionally, I followed turnover of a known Slx5/Slx8 substrate in CHX chase 
experiments. A Matα2 fragment previously described as model substrate (Hickey & 
Hochstrasser, 2015) was stabilized in slx5∆ cells compared to WT cells, but both WT Slx5 
and Slx5-Md∆ constructs fully restored substrate degradation (Appendix Fig. A3D). This 
argues that Slx5-Md∆, likely in complex with Slx8, is functional as a STUbL and that the 
Slx5-Md is required only for ubiquitylation of a subset of substrates, including Euc1. 
Consequently, I tested whether Euc1–Slx5 binding defects would affect ub-
hotspots. Ub-K48 ChIP-qPCR experiments revealed a reduced ubiquitylation signal for 
euc1-SBM1 cells, while it was entirely lost in euc1-SBM2 and euc1-SBM1+2 cells (Fig. 
17A). In agreement with compromised Slx5 interaction, the signals for Slx5 at ub-hotspots 
were reduced in euc1-SBM1 cells and abolished in euc1-SBM2 and euc1-SBM1+2 cells 
(Fig. 17B). Interestingly, Euc1 binding was also reduced in the same pattern (Fig. 17C), 
reminiscent of defective binding in SUMOylation-deficient euc1-KR cells (Fig. 9C). 
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Figure 17. Ub-hotspots depend on specific Euc1–Slx5 interactions. 
(A–C) Euc1 Slx5-binding mutations (SBM1/SBM2) reduce/abolish ub-hotspots (A), recruitment of Slx5 (B) and Euc1 
(C) to ub-hotspots. ChIP-qPCR for ub-K48, Slx5 (using Slx5 antibody) or Euc1 (Euc1 antibody) in euc1∆ ubx5∆ cells 
expressing the indicated Euc1 constructs from plasmids under the control of the EUC1 promoter. Note that Euc1 Slx5-
binding mutants (SBM1, especially SBM2, SBM1+2) show reduced binding to ub-hotspots (C). ChIP for (A–C) was 
performed using the same cell lysates. Data represent means ± SD (n = 3). See also Appendix Fig. A3E–F for expression 
levels and Y1H DNA-binding assay of Euc1-SBM1/2 constructs. 
(D–F) Slx5-SIMs and the Slx5-Md are required for the formation of ub-HSs and recruitment of Slx5. ChIP-qPCR for ub-
K48 (D), Slx5 (anti-HA ChIP, E) and Euc1 (F) in ubx5∆ cells or slx5∆ ubx5∆ cells complemented with plasmids 
expressing the indicated Slx5 constructs under control of the SLX5 promoter. Note that also Euc1 recruitment to ub-HS 
sites is impaired when Slx5-SIMs are mutated or the Slx5-Md is deleted. ChIP for (D–F) was performed using the same 
cell lysates. Data represent means ± SD (n = 2). 
Vice versa, to test whether the Slx5-Md and -SIMs would be required for ub-
hotspot formation, I complemented an slx5∆ ubx5∆ strain with different SLX5 encoding 
plasmids. The WT SLX5 allele restored ubiquitylation and the protein was recruited to ub-
hotspots, while slx5-SIM* and slx5-Md∆ alleles were deficient in ubiquitylation and ub-
hotspot binding (Fig. 17D–E). Like for the Euc1 Slx5-binding mutants (SBM1/2), 
recruitment of WT Euc1 was eliminated in slx5-SIM* and slx5-Md∆ cells (Fig. 17F), 
suggesting mutually dependent binding of Slx5/Slx8 and Euc1 and possibly formation of a 
stable Euc1SUMO–Slx5/Slx8 complex at ub-hotspots.  
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Overall, these data indicate that Euc1 SUMOylation and SUMO–SIM mediated 
interactions, as well as specific contacts between Euc1 and the Slx5-Md are required for 
proper recruitment of Slx5/Slx8. Therefore, it appears likely that Slx5/Slx8 targeting to ub-
hotspots is facilitated by a bipartite or multivalent substrate recognition mode that is 
distinct from STUbL-typical mechanisms relying primarily on multiple SUMO–SIM 
contacts. 
3.5 The Transcription Factor-like Euc1 Shows Transactivation in 
Reporter-gene Assays 
Prior to the discovery of its role in ub-hotspot formation, Euc1 had been uncharacterized. It 
features a predicted coiled-coil (CC) domain in its N-terminal part and a GCR1 domain at 
its C-terminus (Fig. 9A), a domain found to confer sequence-specific DNA-binding in 
Gcr1 and the related transcription factors (TFs) Msn1 and Hot1 (Huie et al, 1992; 
Hohmann, 2002). Gcr1 acts as a transcriptional regulator of glycolytic genes, while Msn1 
and Hot1 mediate transcriptional responses to osmotic and other environmental stress 
conditions (Hohmann, 2002). Another GCR1 domain is predicted for Cbf2, which is also a 
DNA-binding protein and part of the CBF3 complex that is required for kinetochore 
attachment to centromeres (Espelin et al, 2003).  
For Euc1, structure prediction suggested a myb-like DNA-binding fold within the 
GCR1 domain (Fig. 18A) (Kelley et al, 2015; Biedenkapp et al, 1988). To map the region 
of Euc1 required for DNA binding, I used a yeast one-hybrid (Y1H) strategy to test 
specific association of Euc1 constructs with the ub-hotspot motif (ub-HS-motif). The yeast 
one-hybrid strain carried a stably integrated reporter construct with three copies of the ub-
HS-motif of ub-hotspot 4 cloned in the promoter region of HIS3 (3x ub-HS4-HIS3, Fig. 
18B, scheme on top right, (Kern, 2013)). Plasmids encoding Euc1 truncation constructs 
fused to a Gal4 transactivation domain (AD) were transformed into cells to assay growth 
on media lacking histidine (-His), which indicates DNA binding and HIS3 activation. My 
mapping results establish that the complete GCR1 domain and C-terminus are essential for 
Euc1 association with the ub-HS-motif (amino acid (aa) 291–462, Fig. 18B). Mutations 
introduced in the predicted, conserved DNA-binding loop (W333A, R334A, euc1-DBD*) 
led to a loss of binding to ub-HS-motifs in Y1H assays (Fig. 18C). When I replaced 
endogenous EUC1 with euc1-DBD*, Euc1 binding to endogenous ub-hotspots was lost in 
ChIP experiments, as was ubiquitin enrichment (Fig. 18D–E). 
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Figure 18. Euc1 binds to the ubiquitin hotspot motif via its GCR1 domain. 
(A) Phyre2 structural prediction result (Kelley et al, 2015) for part of the Euc1 GCR1 domain (aa 322–346) that shows 
homology to the DNA/RNA-binding 3-helical bundle fold of myb-like DNA-binding domains (DBD) of the 
homeodomain family. Structural prediction is color-coded for the alignment confidence with PDB-entry d1x58a1 (Mus 
musculus Terb1). A conserved tryptophan (W333) predicted to display strong mutational sensitivity is highlighted in red. 
(B) The GCR1 domain and C-terminus (aa 291–462) of Euc1 are required and sufficient for DNA binding in yeast one-
hybrid (Y1H) assays. A growth-based Y1H assay was established by cloning three copies of the ub-HS4-motif upstream 
of a minimal promoter followed by a HIS3 reporter-gene and integrated at the URA3 locus (3x ub-HS4-HIS3, top right). 
Gal4-AD- or Gal4-AD-Euc1-encoding plasmids harboring the indicated Euc1 truncations were transformed into the Y1H 
reporter strain and serial dilutions were spotted on control plates and plates lacking histidine supplemented with 3-amino-
1,2,4-triazole (3AT) to suppress background activation. Cells were grown at 30°C for 3–5 days as indicated (3d/5d). The 
Y1H strain also carried a deletion of the Cdc48 cofactor UBX5, which leads to accumulation of ubiquitylated proteins 
bound at ub-hotspots.   
(C) Mutation of the myb-like DNA-binding domain leads to loss of Euc1 binding to the ub-HS-motif in Y1H assays. The 
W333A, R334A-mutation (hereafter euc1-DBD*) led to a complete loss of Euc1 DNA binding. Assay was performed as 
in (B), cells were grown for 3 days at 30°C. 
(D) Expression levels of Euc1 in WT and euc1-DBD* strains used in (E) as probed by WB. The euc1-DBD* allele was 
integrated at the endogenous EUC1 locus. Euc1 was probed with the Euc1 antibody and Dpm1 levels served as loading 
control. Sections were cropped from the same exposure. 
(E) The Euc1-DBD is required for Euc1 binding and ubiquitin enrichment at endogenous ub-HS sites. ChIP followed by 
qPCR quantification of selected ub-hotspots using an Euc1-specific or ub-K48 antibody was performed in either WT or 
euc1-DBD* cells. Data represent means ± SD (n = 2). 
(F) A single point mutation within the ub-HS-motif abolishes Euc1 enrichment. Schemes: A 39-bp stretch of WT or a 
mutated ub-HS4 sequence was cloned and integrated at the LEU2 locus (grey) using the integrative YIplac128 vector 
(green) (Kern, 2013). For ub-HS4-mut, a G>T mutation was introduced in one of the conserved TGTT repeats. ChIP-
qPCR for Euc1 demonstrated that Euc1 binding was lost upon mutation of the ub-HS-motif. Experiments were performed 
in cdc48-6 strains. Data represent means ± SD (n = 2). 
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Supporting direct binding of Euc1 to the ub-HS-motif, I found that Euc1 no longer 
bound to a mutated ub-hotspot 4 motif that was integrated at an ectopic chromosomal 
location (Fig. 18F). Here, a single point mutation had been introduced in one of the central, 
conserved TGTT repeats of the ub-HS-motif (Fig. 18F, top). Using the same strategy, it 
had previously been demonstrated that ubiquitin was enriched at the ectopically integrated 
WT ub-HS4, but was lost at the mutated ub-HS4-mut (Kern, 2013). Taken together, these 
experiments demonstrate that Euc1 binds the ub-HS-motif via its GCR1 domain and that 
both Euc1 binding and ubiquitin enrichment depend on the ub-HS-motif. Importantly, 
Euc1 binding and ub-hotspot formation are independent of the genomic location of the ub-
HS-motif. 
To investigate the evolutionary conservation of Euc1, I performed phylogenetic 
analysis, which identified EUC1-like genes in several other Saccharomyces species with 
most pronounced sequence similarity in the CC and GCR1 domains (Fig. 19A–B). 
Likewise, ub-hotspot-related sequences were found in those yeast species, where 
intergenic regions corresponding to ub-hotspot loci could be identified (Fig. 19C). Of 
interest, the residues most conserved within the S. cerevisiae ub-HS-motifs also showed 
the highest degree of homology in other yeasts, suggesting that Euc1 orthologs might bind 
them and fulfill a related function at those sites (Fig. 19C, right panels). Using standard 
sequence alignment and homology search tools like BLAST, no homologs of Euc1 could 
be identified in distantly related yeast species or higher eukaryotes. Hence, it remains 
elusive whether Euc1 or its function is conserved in higher eukaryotes. 
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Figure 19. Euc1 and the ub-hotspots are conserved in closely related yeast species. 
(A) Conservation of Euc1 domains. Euc1-like protein sequences from closely related Saccharomyces species were 
aligned and a phylogenetic tree was generated using Clustal Omega. Jalview was used to graphically display the degree 
of sequence conservation. 
(B) Phylogenetic tree of YMR111C/EUC1-like genes. The Yeast Gene Order Browser was used to identify orthologs of 
YMR111C/EUC1 in other yeasts and to generate a phylogenetic tree with the MUSCLE algorithm and PhyML 
(http://ygob.ucd.ie/ (Byrne & Wolfe, 2005)). 
(C) The ub-HS-motif is conserved in closely related yeast species. The 7 yeast Multiz Alignment & Conservation tool of 
the UCSC Genome Browser was used to retrieve alignments of sequences corresponding to ub-HS-motifs from other 
Saccharomyces species. Local conserved stretches within the mostly intergenic regions are marked by dark blue peaks of 
the Conservation score track (left panel) and examples for two ub-HS-motifs are highlighted at base-pair resolution (right 
panels). Note that several ub-hotspots harbor multiple ub-HS-motifs. Dot (.) indicates a conserved base, (|) denotes a gap. 
Sc: Saccharomyces cerevisiae.  
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HS4-HIS3 Y1H strain, which led to reduced background activation of the HIS3 reporter in 
euc1∆ cells (Fig. 20A). Reciprocally, complementing the euc1∆ reporter strain with EUC1 
encoding plasmids (under the control of the endogenous EUC1 promoter) restored reporter 
gene expression and growth on selective -His plates (Fig. 20B–C). The presence of an 
acidic patch (aa 19–28) in the Euc1 N-terminus, together with several aromatic residues 
hinted at a possible function of this part of the protein in transactivation, since this feature 
combination often mediates transcriptional activation (Fig. 20B, bottom, (Sigler, 1988; 
Ravarani et al, 2018)). Consistently, truncation of the first 15 or 30 amino acids led to 
strong defects in HIS3 activation by Euc1 (Fig. 20B), and fusion of Euc11-30 to the Gal4 
BD was sufficient for activation of a GAL1-promoter controlled reporter gene (Fig. 20D). 
 
 
Figure 20. Euc1 can mediate transactivation via its N-terminus. 
(A) Endogenous Euc1 acts as a TF in reporter-gene assays. The Y1H reporter strain described in Fig. 18B (3x ub-HS4-
HIS3 ubx5∆) or the same strain with EUC1 deleted (euc1∆) was transformed with the indicated plasmids and a growth 
assay was performed as described in Fig. 18B. Note that endogenous Euc1 weakly drives activation of the HIS3 reporter 
gene (compare orange and red dashed boxes). Cells were grown at 30°C for 5 days. 
(B) Euc1 can induce transactivation via its N-terminal 30 amino acids. Euc1 constructs under control of the endogenous 
EUC1 promoter were transformed in a reporter strain as described for Fig. 18B and serial dilutions were spotted on 
control or selective media to test HIS3 activation. Note that no Gal4 AD was fused to Euc1 constructs. Cells were grown 
at 30°C for 3 days. Bottom: Euc1 aa 1–30 are shown with negatively charged residues shaded in red and positively 
charged residues in blue. Underlined residues have been annotated to be phosphorylation sites in UniProt. 
(C) Quantification of HIS3 mRNA levels from strains used in (B). Cells with full-length Euc1 or empty vector were 
grown in liquid media with selection for the transformed plasmids (SC-Leu medium), harvested in logarithmic growth 
phase and total mRNA was prepared. After reverse transcription, HIS3 mRNA levels were quantified using qPCR (RT-
qPCR), normalized first to ACT1 mRNA and then to the empty vector control strain. Data represent means ± SD (n = 4). 
p = 2.43*10-5 (Student’s t-test). 
(D) The Euc1 N-terminal 30 amino acids are sufficient for transactivation. The Gal4-BD was C-terminally fused to 
Euc11-30 and the activation of a GAL1 promoter controlled HIS3 reporter gene was monitored. The PJ69-7a Y2H strain 
with EUC1 deleted was used. 
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These data suggest that Euc1 might act as transcription factor at ub-hotspots. 
However, it remains a possibility that Euc1 is required to establish a particular chromatin 
domain or structure at ub-hotspots for different purposes, like Cbf2 does at centromeres. 
3.6 Euc1 in Transcriptional Regulation 
Inspired by the data obtained in the reporter-gene assays (Fig. 20), a plausible hypothesis 
for Euc1 function is that it acts as a transcription factor, and the ub-hotspot pathway could 
regulate transactivation by Euc1.  
To investigate a potential role of Euc1 as TF, I performed RNA sequencing 
(RNAseq) to compare transcriptome alterations in euc1∆ cells and EUC1 overexpression 
cells (pGAL-EUC1) to WT/control strains3. Out of 15 genes in direct proximity to ub-
hotspots, only 2 showed a significant change in expression levels in euc1∆ cells, with 
 
 
                                                
3 Sequencing was performed with help from Marja Driessen, MPI Biochemistry Core Facility, Bioinformatic 
analysis was performed in collaboration with Tobias Straub, BMC/LMU, Munich 
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Figure 21 (previous page). Euc1 has only minor effects on ub-hotspot adjacent gene transcription. 
(A) Deletion of EUC1 does not lead to ub-HS adjacent gene deregulation, but rather widespread transcriptome changes. 
Total RNA isolated from WT and euc1∆ cells grown under standard growth conditions was polyA enriched and 
sequenced (RNAseq in triplicates). Significance testing was based on the Wald test, see Materials and Methods for 
details. baseMean: mean expression levels across all samples. 
Highlighted transcripts: RCO1: Rpd3S histone deacetylase subunit; SSF2: ribosomal large subunit maturation factor; 
MED11: RNA Pol II mediator subunit (ORF adjacent to EUC1, MED11 downregulation likely contributes to some euc1∆ 
phenotypes, see Appendix Fig. A6C–F); SIR2: Sirtuin family histone deacetylase; HSP12: plasma membrane protein 
involved in membrane organization.  
Metabolic functions: ALD5: mitochondrial aldehyde dehydrogenase; PFK1: phosphofructokinase subunit; ILV5: 
acetohydroxyacid reductoisomerase and mitochondrial DNA binding protein. 
(B) RT-qPCR quantification of selected transcripts deregulated in the euc1∆ transcriptome (A). Quantification was 
performed as for Fig. 20C, but normalization was performed with PGK1, because ACT1 appeared mildly upregulated in 
euc1∆ cells in RNAseq. RT-qPCR was performed on the same three replicate samples as used for RNAseq. Data 
represent means ± SD (n = 3), for statistical analysis an unpaired, two-tailed Student’s t-test was performed. For (B) and 
(D): (*): p ≤ 0.05, (**): p ≤ 0.01, (***): p ≤ 0.001, n.s.: not significant. 
(C) RNAseq transcriptome analysis of EUC1 overexpression as in (A). ∆euc1 cells with pGAL-EUC1 (overexpression) or 
pEUC1-EUC1 (control) integrated at the URA3-locus (YIplac211) were grown to mid-log phase and 2% galactose was 
added for 3h. 
Highlighted transcripts: PEX9: peroxisomal membrane signal receptor for peroxisomal matrix proteins; MCH1: protein 
with similarity to mammalian monocarboxylate permeases; ISF1: serine-rich, hydrophilic protein, molecular function 
uncharacterized; CIT2: peroxisomal citrate synthase, involved in glyoxylate cycle; CIN5: basic leucine zipper TF of the 
yAP-1 family, mediates pleotropic drug and salt tolerance; TIR1: cell wall mannoprotein; TEC1: TF targeting 
filamentation genes and Ty1 expression; MRH1: membrane protein related to Hsp30, localizes primarily to plasma 
membrane; PMA1: plasma membrane P2-type H+-ATPase, major regulator of cytoplasmic pH. 
Metabolic functions: GPM2: nonfunctional phosphoglycerate mutase homolog; ADH2: glucose-repressible alcohol 
dehydrogenase II; CDC19: pyruvate kinase; MCH1, CIT2. 
(D) RT-qPCR quantification of genes misregulated in the pGAL-EUC1 transcriptome (C). Data was obtained from 
samples independent of the RNAseq experiment. Data represent means ± SD (n = 3), for statistical analysis an unpaired, 
two-tailed Student’s t-test was performed. 
opposing trends (RCO1 up, SSF2 down, Fig. 21A–B). In total, around 150 genes were 
significantly deregulated (up or down) in euc1∆ cells (p < 0.01), possibly reflecting a more 
general function of Euc1 in transcriptional regulation, or indicating an adaptation response 
to loss of EUC1. When functional categories of the deregulated genes were analyzed, gene 
ontology (GO) term enrichments identified an upregulation of small molecule metabolic 
processes (e.g. organic, carboxylic and amino acid metabolism). These data overall do not 
seem to support a model whereby Euc1 directly activates transcription of ub-hotspot 
adjacent genes. 
In agreement with this notion, EUC1 overexpression did not lead to strong 
deregulation of ub-hotspot adjacent genes as well (Fig. 21C). Four of them showed mild 
up- or downregulation, while in contrast many other genes showed stronger changes in 
expression levels (Fig. 21C–D), especially genes involved in cellular metabolism (e.g. 
carboxylic and organic acid metabolism were upregulated; and translation, peptide 
biosynthesis and ribosome biogenesis appeared downregulated). These results from 
RNAseq experiments largely agree with a previous characterization of Euc1-mediated 
transcriptional regulation using microarrays, in particular in that ub-hotspot adjacent genes 
did not exhibit strong deregulation (Kern, 2013).  
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Interestingly, in reporter gene assays Euc1-KR exhibited higher activity than WT 
Euc1, suggesting that SUMOylation might negatively regulate transactivation (Kern, 
2013). Confirming these results, Euc1 constructs with the endogenous DBD replaced with 
Gal4-BD showed a similar behavior: Abolishing Euc1 SUMOylation by introducing the 
K231R mutation or interfering with the SUMOylation machinery (siz1∆ siz2∆) led to 
enhanced reporter gene activation (Appendix Fig. A4A–B). However, similar assays with 
endogenous Euc1 and different ub-hotspot sequences in the promoter region of a reporter 
gene did not give consistent results regarding the regulation by the ub-hotspot pathway 
machinery (Appendix Fig. A4C–D), or when different Euc1 mutants were tested 
(Appendix Fig. A4E–F). Additionally, transcriptome analysis of euc1-KR cells failed to 
reveal any strongly deregulated genes or activation of ub-hotspot adjacent genes (Kern, 
2013). 
A previous study addressing transcriptome changes in slx5∆ and slx8∆ cells found 
several hundred genes deregulated (321 and 132, respectively, with fold-change > 1.7 and 
p < 0.05, (van de Pasch et al, 2013)). Of note, only 2 ub-hotspot adjacent genes were 
significantly changed (ATG34 and ATG19 around ub-HS7 upregulated), while other ub-
hotspot adjacent genes showed minor changes, both up- or downregulation. The authors 
conclude that most changes observed in slx5∆/slx8∆ transcriptomes arise from genome 
instability-induced stress, rather than direct effects on transcriptional regulation by 
Slx5/Slx8 (van de Pasch et al, 2013). 
Taken together, genes around the endogenous Euc1 binding sites at ub-hotspots do 
not appear to underlie direct regulation by Euc1 or Slx5/Slx8. This suggests that Euc1’s 
primary function might not be in transcriptional regulation of ub-hotspot adjacent genes, at 
least not under the conditions tested.  
3.7 The Slx5/Slx8-dependent Ub-hotspot Pathway Controls 
Aberrant Euc1 
To gain insight into physiological functions of Euc1 and the ub-hotspot pathway, I tested 
cellular fitness of strains deleted for EUC1 or overexpressing EUC1 in growth assays 
under various conditions. While euc1∆ cells did not exhibit any noticeable growth defect 
compared to WT cells, overexpression of EUC1 (pGPD-EUC1, pGAL-EUC1) led to 
lethality at high temperatures or upon treatment with the membrane-fluidizing drug benzyl 
alcohol (Lone et al, 2015) (Fig. 22A–B). Highlighting a crucial role for Slx5/Slx8 in the 
control of overexpressed EUC1, the toxicity was increased when EUC1 overexpression 
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was paired with slx5∆ or slx8∆ via mating and tetrad analysis, even under normal growth 
conditions (Fig. 22C). Interestingly, EUC1 alleles deficient in ub-hotspot formation, like 
SUMOylation-deficient euc1-KR or Euc1 Slx5-binding mutants (euc1-SBM1/2), showed 
the same toxicity as overexpressed WT EUC1 (Fig. 22D, Appendix Fig. A5A). In contrast, 
alleles deficient in DNA binding (euc1-DBD*) and/or transactivation (euc1-N30∆, -CC∆, 
see also Appendix Fig. A4E–F) caused milder or no toxicity (Fig. 22D, Appendix Fig. 
A5A). As Euc1-WT, -KR and -DBD* all show a similar nuclear localization, it is unlikely 
that a change in cellular localization could explain the different growth phenotypes 
(Appendix Fig. A5B). Together, these data indicate that EUC1 overexpression toxicity 
does not arise from over-active ub-hotspots formation. 
 
 
Figure 22. EUC1 overexpression is toxic. 
(A) EUC1 overexpression is toxic at elevated temperatures and upon exposure to the membrane fluidizing drug benzyl 
alcohol (BenzAlc). Serial dilutions of the indicated strains were spotted and grown on YPD control (30°C) or under 
conditions as indicated. 
(B) Western blot against Euc1 (and Dpm1 as loading control) to compare expression levels in WT and pGPD-EUC1 
cells. Asterisk denotes an unspecific band. 
(C) EUC1 overexpression leads to strong phenotypes or lethality in slx5∆ and slx8∆ cells. Individual cells from tetrads 
(arranged in vertical columns) of pGPD-EUC1 slx5∆ or pGPD-EUC1 slx8∆ diploid cells were grown on YPD plates at 
30°C for 3 days. Data for top panel courtesy of Julian Stingele. 
(D) EUC1 overexpression toxicity depends on DNA binding and transactivation. The indicated EUC1 alleles with 
endogenous (pEUC1) or galactose-inducible promoters (pGAL) were integrated at the URA3 locus (YIplac211, euc1∆ 
background) and spotted on glucose control or galactose plates to induce EUC1 overexpression, supplemented with 
benzyl alcohol as indicated. See also Appendix Fig. A4E–F and A5A. 
To address how then the observed toxicity arises, I performed ChIP-chip 
experiments to monitor genomic binding sites of Euc1 upon overexpression. Compared to 
control conditions, overexpressed Euc1 bound to additional loci, including the STI1-CIN5 
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intergenic and the TEC1-upstream (us) region (Fig. 23A). ChIP-qPCR experiments showed 
a marked increase in Euc1 binding to unrelated control regions (“contr.”, Fig. 23B, top), 
suggesting higher background binding across the genome. Yet, ChIP-qPCR also confirmed 
significant additional enrichment of Euc1 at STI1-CIN5 and TEC1-us (Fig. 23B, top). The 
additional binding to those sites was strongly reduced in euc1-DBD* and euc1-N30∆ cells, 
offering a rationale for the weaker growth phenotypes of those mutants. Importantly, no 
additional ubiquitin enrichments were detected at the aberrantly bound loci, supporting the 
hypothesis that EUC1 overexpression toxicity is unrelated to ub-hotspot formation on 
chromatin (Fig. 23B, bottom). 
The observed widespread transcriptome changes in pGAL-EUC1 cells could 
indicate direct Euc1-dependent transcriptional deregulation of additionally bound genes, 
but also indirect effects are conceivable. Of note, CIN5 (a TF involved in pleiotropic drug 
resistance and salt tolerance) and TEC1 (a TF controlling filamentation genes), which are 
in close proximity to abnormally bound regions, were deregulated in the pGAL-EUC1 
transcriptome (Fig. 21C–D). Since both genes encode transcriptional regulators, they could 
also further propagate transcriptional aberrations. 
Importantly, overexpression of SLX5/SLX8 (pADH-SLX5+SLX8) mitigated 
spurious Euc1 binding at STI1-CIN5 and TEC1-us loci and could relieve Euc1 toxicity 
(Fig. 23C–D, Appendix Fig. A5C). In contrast, overexpression toxicity of the 
SUMOylation- and Slx5-binding-deficient euc1-KR-SBM1+2 could only be alleviated to a 
minor extent by additional SLX5/SLX8 overexpression (Fig. 23C–D, Appendix Fig. A5C). 
Taken together, the data indicate that Euc1 needs to be tightly controlled by 
Slx5/Slx8 in order to confine its action to sites of ub-hotspots. Aberrant Euc1 leads to 
transcriptome changes, likely via its transactivation function, and probably by a 
combination of direct effects on abnormally bound genes and indirect effects. In contrast, 
the primary function of endogenous Euc1 appears independent of transcriptional activation 
of ub-hotspot adjacent genes. 
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Figure 23. SLX5/SLX8 rescue aberrant Euc1 binding and overexpression toxicity. 
(A) Snapshots of ChIP-chip tracks from regions showing additional EUC1 binding signals upon EUC1-overexpression 
(pGAL-EUC1, 3h induction). pGAL-EUC1 or an empty plasmid (contr.) was integrated at the URA3 locus (YIplac211). 
Data represent means from two independent replicates. 
(B) Top: Binding of overexpressed EUC1 to aberrant loci depends on Euc1 DNA binding. ChIP-qPCR for Euc1 after 3h 
galactose induction. Note that IP/input ratios of Euc1 signals are shown, also for the control locus (contr.: TOS1 
promoter) to highlight Euc1 binding at non-ub-HS sites upon overexpression. STI1-CIN5: intergenic region. TEC1-us: 
upstream (promoter) region of TEC1. Bottom: Ubiquitin (ub-K48) ChIP-qPCR for the same samples. Data represent 
means ± SD (n = 3). 
(C) Simultaneous overexpression of SLX5 and SLX8 leads to a reduction of aberrant Euc1 binding to non-ub-HS loci. 
Experiment as in (B, top), but with concomitant plasmid-borne overexpression (ADH promoter) of SLX5 and SLX8. 
ChIP-qPCR analysis of selected strains from (D) as indicated, after 3h galactose induction. Data represent means ± SD (n 
= 3). p-values from Student’s t-tests for the indicated comparisons are shown. 
(D) SLX5/SLX8 overexpression rescues EUC1 toxicity. Experiment as in Fig. 22D, but with concomitant plasmid-borne 
overexpression (ADH promoter) of SLX5 and SLX8 (bottom panels) and on media selecting for SLX5/SLX8 plasmids. See 
also Appendix Fig. A5C. 
3.8 EUC1 Shows Genetic Interactions with Regulators of Gene 
Expression upon Thermostress 
As mentioned above, euc1∆ cells did not show any growth defect when compared to WT 
cells, even in a wide range of stress conditions, including cold, heat and oxidative stress, 
exposure to reducing agents, ER protein folding stress, hypoxia, DNA-damage inducing 
agents, drugs targeting lipid biosynthesis, and growth on various different carbon sources 
(not shown). Although this might suggest that EUC1 is not required for growth in any of 
ChIP: Euc1
contr. STI1-CIN5 TEC1-us
0.0
0.2
0.4
0.6
0.8
IP
/in
pu
t [A
.U
.]
WT
euc1
pGAL-EUC1
pGAL-euc1-KR
pGAL-euc1-DBD*
pGAL-euc1-N30
pEUC1-EUC1
EUC1-WT
KR
SBM1+2
KR-SBM1+2
contr.
0.1%
BenzAlc
0.1%
BenzAlc
 pADH-
SLX5
+SLX8
day 3
+ galactose
pGAL-
euc1
pEUC1-EUC1
EUC1-WT
KR
SBM1+2
KR-SBM1+2
pGAL-
euc1
ChIP: Ub-K48
contr. STI1-CIN5 TEC1-us
0.00
0.02
0.04
0.06
0.08
IP
/in
pu
t [A
.U
.]
ChIP: Euc1
contr. STI1-CIN5 TEC1-us
0.0
0.5
1.0
1.5
IP
/in
pu
t [
A.
U.
] .436
.050
.064
.486
.0004
.063
.043
.769
.148
contr.
pGAL-EUC1
STI1
CIN5
ChrXV
383248
ChrII
408781
TEC1
Ch
IP
: E
uc
1
contr.
contr. +SLX5/SLX8
pGAL-EUC1
pGAL-EUC1 +SLX5/SLX8
pGAL-euc1-KR-SBM1+2
pGAL-euc1-KR-SBM1+2 +SLX5/SLX8
A C
D
B
Results 
52 
those conditions, another possibility is that redundant pathways compensate for loss of 
EUC1. 
Supporting the notion of redundancy, other studies using high-throughput genetic 
screens have reported a number of genetic interactions of EUC1 with genes showing GO-
term enrichments for genetic pathways including chromatin organization, negative 
regulation of transcription, histone deacetylation, and related processes (Zheng et al, 2010; 
Costanzo et al, 2010; 2016). I could confirm some of these interactions, for example 
deleting EUC1 markedly enhanced phenotypes of strains deleted for HTZ1, the gene 
encoding the histone variant H2A.Z, specifically upon exposure to thermostress (heat or 
cold) and when challenged with dimethyl sulfoxide (DMSO) or HU (Fig. 24A). Similar 
genetic interactions were observed with SWR1 and YAF9, which encode for members of 
the H2A.Z remodeling complex SWR1-C (Appendix Fig. A6A–B). The H2A.Z–SWR1-C 
axis has previously been ascribed to functions in the regulation of inducible promoters, 
heterochromatin maintenance and genome stability (Billon & Côté, 2013). Of note, H2A.Z 
itself was proposed to act as a nucleosomal “thermosensor”, in Arabidopsis thaliana and S. 
cerevisiae, and several studies described a requirement for H2A.Z and associated 
remodelers for resistance to DMSO (Lindstrom et al, 2006; Zhang et al, 2005; Gaytán et 
al, 2013; Kumar & Wigge, 2010). On a molecular level, the causes of DMSO toxicity are 
not well understood, however, perturbation of membrane organization and weak inhibition 
of histone deacetylases (HDACs) have been reported (Gurtovenko & Anwar, 2007; Marks 
& Breslow, 2007). Additional genetic interactions were found with NPL3, which is 
required for proper mRNA splicing and processing, and STB5 encoding for a TF mediating 
oxidative and multidrug stress responses (Fig. 24A, Appendix Fig. A6A, C–F). 
Most prominently, deletion of EUC1 led to a strong aggravation of the described 
heat sensitivity of cells deleted for accessory members of the Rpd3L HDAC complex 
(dep1∆, rxt2∆, sds3∆, Fig. 24B–C) (Ruiz-Roig et al, 2010). The catalytic subunit Rpd3 is a 
homolog of human class I HDACs and is a shared component of three distinct HDAC 
complexes in yeast (Carrozza et al, 2005; McDaniel & Strahl, 2013): (i) Rpd3L, which is 
primarily recruited to gene promoters to mediate repression, but also activation in some 
stress conditions, such as heat stress (de Nadal et al, 2004; Carrozza et al, 2005; Ruiz-Roig 
et al, 2010); (ii) Rpd3S, which is primarily recruited to transcribed regions, where it binds 
to methylated H3K36 and suppresses cryptic intragenic transcription by deacetylating 
histones (Carrozza et al, 2005); and (iii) Rpd3µ, a less-well-described complex (formed by 
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Rpd3/Snt2/Ecm5) mediating transcriptional regulation related to oxidative stress resistance 
(Baker et al, 2013).  
 
 
Figure 24. EUC1 shows genetic interactions with regulators of gene expression upon thermostress and DMSO 
exposure. 
(A–B) EUC1 displays negative genetic interactions with genes involved in general and specific transcriptional regulation 
(A), and in particular with members of the Rpd3L histone deacetylase complex (B). For (A–D), serial dilutions of the 
indicated strains were spotted and grown on YPD control or selective media plates, or under conditions as indicated. 
Dashed boxes highlight genetic interactions with EUC1, color code as in (E). Note that all strains used in (A–D) 
contained an extra copy of MED11, see Fig. 21A and Appendix Fig. A6C–F for details. 
(C) Plasmid-borne EUC1 complements genetic interactions with Rpd3L subunits. Empty vector (-) or a plasmid encoding 
EUC1 with its endogenous promoter were transformed in the indicated strains and spotted on selective media. 
(D) EUC1 and Rpd3S act in a common pathway which is redundant with Rpd3L. rco1∆ and eaf3∆ (Rpd3S) show similar 
phenotypes when paired with sds3∆ (Rpd3L complex, genetic interaction indicated by arrows) as euc1∆ (dashed box) 
and are epistatic with euc1∆. 
(E) Graphic summary of EUC1 genetic interactions as tested in (A–D) and Appendix Fig. A6. Arrows indicate negative 
genetic interactions upon cold (blue), heat (red) or DMSO stress (black), dashed grey arrows indicate epistatic 
relationships. 
A
C
D E
B
dep1∆ -
-
EUC1
EUC1
-
-
EUC1
-
-
plasm.
30°C 37°C 37°C
day 3 day 5
euc1∆
dep1∆
euc1∆
rxt2∆
euc1∆
sds3∆
rxt2∆
sds3∆
Rpd3L-
HDAC
subunits
WT
euc1∆
rxt2∆
euc1∆ rxt2∆
30°C22°C 37°C 4% DMSO
dep1∆
euc1∆ dep1∆
sds3∆
euc1∆ sds3∆
50mM HU
day 3
2% DMSO 3% DMSO
day 2
22°C 30°C 37°C
WT
euc1∆
htz1∆
euc1∆ htz1∆
stb5∆
euc1∆ stb5∆
npl3∆
euc1∆ npl3∆
22°C
day 5
3% DMSO
WT
euc1∆
sds3∆
euc1∆ sds3∆
rco1∆
euc1∆ rco1∆
sds3∆ rco1∆
euc1∆ sds3∆ rco1∆
eaf3∆
euc1∆ eaf3∆
sds3∆ eaf3∆
euc1∆ sds3∆ eaf3∆
22°C 30°C 35°C 36°C
day 2
DMSO
Rpd3S-HDAC Rpd3L-HDAC
Euc1
Npl3
Stb5
H2A.Z
Swr1
Yaf9
Pho23
Sds3 Cti6
Rxt3
Sap30
Sin3
Rpd3
Ume1Sin3
Rpd3
Ume1
Dep1Eaf3
Rco1
Rxt2
SWR1-C
epistasis
Results 
54 
Notably, mutant cells deleted for common Rpd3L and Rpd3S subunits (rpd3∆, 
sin3∆) showed strong heat and DMSO sensitivity, which was not further enhanced by 
euc1∆ (Appendix Fig. A6G–H). Similarly, no genetic interactions of EUC1 were observed 
with Rpd3S-specific deletion strains (Fig. 24D, rco1∆, eaf3∆). Interestingly, when 
mutations for Rpd3S subunits (rco1∆, eaf3∆) were combined with Rpd3L mutations 
(sds3∆), enhanced heat and DMSO sensitivity became apparent (Fig. 24D, red/black 
arrows), suggesting overlapping functions of the Rpd3L and Rpd3S complexes. Strikingly, 
these genetic interactions were reminiscent of euc1∆ sds3∆ phenotypes (Fig. 24D, red 
dashed box), and additional deletion of EUC1 did not further enhance Rpd3L/Rpd3S 
combination phenotypes (Fig. 24D, labels highlighted with dashed grey boxes). This 
epistatic relationship between EUC1 and Rpd3S places them in a common genetic pathway 
(Fig. 24D–E). Consistent with shared functions between EUC1 and Rpd3S, significant 
correlations of gene sets downregulated in euc1∆ cells were identified not only with genes 
downregulated in published rpd3∆ transcriptome data, but also with genes downregulated 
in set2∆ datasets, which is an upstream regulator of H3K36 methylation and the Rpd3S 
pathway (Appendix Fig. A7)4 (McKnight et al, 2015; McDaniel et al, 2017). Overall, I 
therefore conclude that Euc1 works in a common pathway with Rpd3S that counteracts 
cellular stress induced by exposure to heat or DMSO. 
3.9 Euc1-mediated Ub-hotspots are Crucial during Stress 
Responses when Gene Expression Control is Impaired 
To substantiate a possible role of Euc1 in the response to heat stress, I performed Euc1 and 
ub-K48 ChIP experiments in cells shifted from 30°C (control) to 37°C (mild heat stress) 
and detected a significant increase of Euc1 binding to ub-hotspots, especially in sds3∆ 
cells (Fig. 25, left panel, Appendix Fig. A8A). In contrast, ubiquitin signals were reduced 
at 37°C, but this effect was also observed for an Euc1-independent ubiquitin-bound region 
(ub-only-site1), possibly because free ubiquitin becomes limiting at higher temperatures 
(Fig. 25A, right panel) (Finley et al, 1987).  
Noteworthy, Euc1 recruitment to ub-hotspots was also significantly increased in 
sds3∆ cells compared to WT cells at 37°C (Fig. 25, left panel). Similar effects were 
observed for htz1∆ cells, and for npl3∆ cells at 25°C (Appendix Fig. A8B–D). Together, 
this indicates that Euc1 occupancy at ub-hotspots is increased in conditions or genetic 
backgrounds where its function becomes critical (Fig. 24). Although ubiquitin levels 
                                                
4 Data analysis performed by Tobias Straub, LMU/BMC, Munich 
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themselves did not show consistent changes under these conditions (Fig. 25, Appendix Fig. 
A8), these data support a model whereby Euc1 serves a role in gene expression control or 
chromatin maintenance. This function becomes critical upon exposure to thermo- and other 
stress conditions, in particular when other factors controlling gene expression are impaired. 
 
 
Figure 25. Euc1 is recruited to ub-hotspots upon mild heat stress in sds3∆ cells.  
ChIP-qPCR experiments for Euc1 and ub-K48 with strains and conditions as indicated. For mild heat stress, cells were 
grown at 30°C to mid-log phase and shifted to 37°C for 90 minutes. Data represent means ± SD (n = 4). For statistical 
analysis an unpaired, two-tailed Student’s t-test was performed, see Appendix Fig. A8A for detailed results. (*): p ≤ 0.05, 
(**): p ≤ 0.01, (***): p ≤ 0.001. 
Therefore, I tested which features of Euc1 would be required for rescuing the 
observed genetic interaction phenotypes of euc1∆ cells using a plasmid-based 
complementation approach. Interestingly, the ability of the EUC1 alleles to alleviate the 
heat and DMSO sensitivity of euc1∆ sds3∆ or euc1∆ npl3∆ cells fully depended on the 
ability to restore ub-hotspots, but not on the N-terminal transactivation domain: ub-hotspot 
proficient WT EUC1 and euc1-N30∆ restored growth, but not the ub-hotspot deficient KR, 
SBM1+2, KR-SBM1+2, DBD* and CC∆ alleles (Fig. 26A, Appendix Fig. A9A–B). 
Furthermore, I found that abolishing ub-hotspots by deletion of SLX5 or SLX8 enhanced 
sds3∆ heat sensitivity as well (Fig. 26B, red dashed box, Appendix Fig. S12C). Deletion of 
EUC1 did not further exacerbate these phenotypes, and these genetic interactions are most 
likely dependent on ub-hotspot function, since they could be alleviated by plasmid-borne 
expression of WT SLX5, but not by slx5-SIM*, and only to a minor extent by slx5-Md∆ 
(Fig. 26C). 
In conclusion, Euc1 and Slx5/Slx8-dependent ub-hotspots are critical for 
thermotolerance and the response to other stresses, and Euc1 is functionally linked to 
chromatin regulation by the Rpd3S HDAC complex. Overall, my data support a model that 
places EUC1 and SLX5/SLX8 together with Rpd3S in a common genetic pathway, which 
acts redundantly with the Rpd3L complex. 
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Figure 26. The ub-hotspot pathway is required to complement genetic interactions of EUC1. 
(A) The ability to form ub-hotspots is crucial for endogenous EUC1 function. The genetic interaction of EUC1 with 
SDS3 (Rpd3L complex) was rescued with plasmid-borne EUC1 alleles and serial dilutions were spotted on selective 
media. (-) denotes empty vector. See also Appendix Fig. A9A–B. 
(B) SLX5 shows negative genetic interactions with SDS3 upon heat stress. Serial dilutions of the indicated strains were 
spotted on YPD and incubated as indicated, dashed boxes highlight the sds3∆ slx5∆ synthetic sickness in this case. See 
also Appendix Fig. A9C. 
(C) The Slx5-SIMs and Slx5-Md are required for full complementation of slx5∆ sds3∆ phenotypes. Strains were 
transformed with plasmids expressing SLX5 alleles under control of the endogenous promoter and spotted on selective 
media and grown as indicated. Note that all strains used in (A–C) contained an extra copy of MED11, see Fig. 21A and 
Appendix Fig. A6C–F for details. 
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4 Discussion 
4.1 An Euc1- and Slx5/Slx8-dependent Pathway Controls Protein 
Turnover at Ub-hotspots 
Protein–DNA transactions and chromatin composition underlie extensive regulation by 
various mechanisms, including post-translational protein modifications, and global as well 
as local turnover of chromatin proteins. Removal or degradation of proteins is typically 
achieved by the ubiquitin–proteasome system and within this framework, the Cdc48/p97 
segregase and STUbLs take key positions, as evidenced by the identification of numerous 
critical substrates over the last years (Ramadan et al, 2007; Wilcox & Laney, 2009; Maric 
et al, 2014; Ndoja et al, 2014; Franz et al, 2016; Nie & Boddy, 2016). By profiling the 
genome-wide binding landscape of ubiquitin, Slx8 and Euc1, I could extend the 
understanding of the complex mechanism at work at ub-hotspots. Furthermore, my data 
demonstrate that ub-hotspots are not only major enrichment sites for ubiquitin on budding 
yeast chromosomes, but also for Slx8 and Euc1, and genetic analysis established important 
connections between these factors and cellular physiology related to environmental stress 
adaptation. 
Together with data from a previous PhD project that originally identified the ub-
hotspots (Kern, 2013), a refined picture of the cascade of events at ub-hotspots emerges 
(summarized in Fig. 27, (Höpfler et al, 2019)): (1) Euc1 binds to the ub-hotspot DNA 
motif via its GCR1 domain. (2) Euc1 is SUMOylated by Ubc9, Siz1 or Siz2, which 
supports Euc1 binding to DNA. (3) Slx5/Slx8 is recruited via multivalent interactions that 
rely on both direct Euc1–Slx5 contacts and SUMO–SIM interactions. (4) Slx5/Slx8 
recruitment leads to ubiquitylation of Euc1, and likely other substrates at ub-hotspots. (5) 
Cdc48 in complex with Ufd1–Npl4, and assisted by the cofactors Ubx4 and Ubx5, 
segregates K48-linked ubiquitylated proteins from chromatin. After extraction, these 
ubiquitylated proteins could be handed over to the proteasome for degradation, as it is 
typical for proteins modified with K48-linked ubiquitin chains (Finley et al, 2012). 
Alternatively, deubiquitylation could facilitate substrate recycling, as it has been found for 
other DNA-binding proteins like TFs, even when marked with K48-linked ubiquitin chains 
(Inui et al, 2011; Flick et al, 2004). 
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Figure 27. Refined model of the molecular mechanism of ub-hotspot formation.  
See text for details. S: SUMO, Ub: ubiquitin, SIM: SUMO-interacting motif. Figure modified from (Kern, 2013). 
Of note, while the described mechanism (Fig. 27) applies for all seven ub-hotspots, 
there are strong variations regarding the relative amounts of bound Euc1, Slx5/Slx8 and 
ubiquitylated proteins between individual ub-hotspots. Signals for Euc1 and Slx5/Slx8 
seem to correlate well, consistent with direct STUbL recruitment by Euc1 (Fig. 17), but 
ubiquitylation signals deviate from that pattern (Fig. 11D). This discrepancy could be due 
to variable ubiquitylation efficiencies, or due to alternative complexes forming with 
accessory proteins or ubiquitylation substrates at the different sites. Of note, Euc1 might 
not be the main ubiquitylaton substrate, as it is a rather stable protein and does not seem to 
underlie strong STUbL-dependent turnover, nor does it accumulate in cdc48 mutants at ub-
hotspots or on total protein level (Fig. 11). Despite extensive efforts to identify 
ubiquitylation substrates at ub-hotspots other than Euc1, including mass spectrometry 
based proteomics approaches and a Y2H screen designed to identify physical Euc1 
interactors, it remains enigmatic whether other proteins are bound at ub-hotspots. 
If so, these proteins are likely to be targets of Slx5/Slx8-dependent ubiquitylation 
and subsequent Cdc48-mediated extraction. In line with this “in trans ubiquitylation” 
model, other studies have found that Slx5/Slx8 and other STUbLs can target binding 
partners of SUMOylated proteins (Abed et al, 2011a; Schweiggert et al, 2016). Notably, 
following this “in trans ubiquitylation” model, ubiquitylation substrates might not 
necessarily be the same for all ub-hotspots. Euc1 is ubiquitylated by Slx5/Slx8, but if Euc1 
were not the primary Slx5/Slx8 target, a role for Euc1 as an Slx5/Slx8-recruitment factor 
or cofactor for ubiquitylation of a specific subset of target proteins would also be 
consistent with this model.  
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Overall, the ub-hotspot pathway exemplifies a complex pathway where the SUMO 
and ubiquitin pathways converge on chromatin to control protein abundance at highly 
specific loci in the yeast genome. As discussed in the following sections, open questions 
remain, especially regarding the exact molecular mechanism by which Euc1 exerts its 
functions in stress adaptation, opening up new research questions. Importantly, this work 
provides rich insight into a novel STUbL-recruitment mechanism, and is likely to 
contribute to a better understanding of STUbL specificity in general. 
4.2 High Local Enrichment of Ub-hotspot Factors at Seven 
Genomic Sites 
Two particular features seem to distinguish the ub-hotspots most from previously 
published chromatin binding events of UBLs or UPS components: First, the remarkably 
low number of ub-hotspots; and second, the specific and high local enrichment of ubiquitin 
and other ub-hotspot factors. In this section, I will discuss the potential reasons for such 
highly localized signals, and I will compare ub-hotspots with data from the literature on 
genome-wide binding studies of UPS components and UBLs 
During the initial characterization of ub-hotspots, hundreds of regions with local 
enrichment of ubiquitin had been identified with a ubiquitin antibody (clone FK2) that 
recognizes a wide range of ubiquitin conjugates (mono-ubiquitylation, K29-, K48-, K63-
linked chains), most of which could be attributed to histone H2B ubiquitylation (Kern, 
2013). Some of the ub-hotspots stood out in WT cells, but the seven ub-hotspots, along 
with the two ub-only-sites (Fig. 6–7), showed a dramatic increase of ubiquitin signal in 
cdc48 mutant cells, while other ubiquitin peaks were lost or diminished. This effect might 
be due to overall lower H2B ubiquitylation levels in cdc48 mutant cells (Kern, 2013), or 
due to the depletion of free ubiquitin in cdc48 mutant cells. Surprisingly however, these 
results also demonstrated that ub-hotspots seem to be the major sites of Cdc48-dependent 
extraction of ubiquitin conjugates from chromatin in yeast, although several other proteins 
were described to rely on Cdc48 for extraction from chromatin (Wilcox & Laney, 2009; 
Verma et al, 2011; Maric et al, 2014). 
What could be the reasons for the prominent appearance of ub-hotspots in ChIP-
chip profiles over other protein turnover events on chromatin? In part, this phenomenon 
can be explained by the apparent constant presence of ubiquitylated proteins at ub-hotspots 
in normal growth conditions and throughout the cell cycle (data not shown). Additionally, 
the ChIP-chip methodology has certain constraints in its resolution, and the necessary 
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PCR-based amplification steps could potentially introduce biases during sample 
preparation with regards to signal intensity readouts. State-of-the-art ChIP-seq techniques 
could provide a more differentiated picture.  
Moreover, several known chromatin-bound Cdc48 substrates might not lead to 
highly localized ubiquitin signals, because they do not bind DNA in a sequence-specific 
manner. Prominent examples include RNA Pol II, which is extracted upon transcriptional 
stalling at DNA lesions, or Mcm7 that is removed to disassemble the replicative helicase 
after termination (Verma et al, 2011; Maric et al, 2014). Cdc48-dependent extraction of 
sequence-specific TFs has been described for a model TF and Matα2, however, in the latter 
case extraction of Matα2 was specifically triggered by changing growth conditions 
(Wilcox & Laney, 2009; Ndoja et al, 2014). The low number of ubiquitin peaks in the 
cdc48-3 ChIP-chip data does not suggest a widespread function for Cdc48 in extraction of 
TFs from chromatin, though. In contrast, many TFs appear be removed from DNA directly 
by the proteasome ((Auld et al, 2006), see below). Hence, it seems reasonable to speculate 
that ub-hotspots do not mark TF turnover sites, but might represent a genomic region with 
particular chromatin composition or a specific chromatin domain (see section 4.5.2). 
4.2.1 Ub-hotspots Compared to Genome-wide UPS-component- and 
UBL-binding Studies 
Cdc48-dependent turnover of proteins from chromatin has not been investigated on a 
genome-wide level by other laboratories so far. Other studies addressing protein turnover 
on chromatin in human cells have reported over 33,000 ubiquitin peaks in control 
conditions, and over 46,000 peaks upon proteasome inhibition, indicating thousands of 
sites of active protein turnover (Catic et al, 2013). Most of the sites overlapped with 
promoter regions, and transcription start or termination sites, which is in agreement with 
other studies showing that transcriptional regulators often underlie rapid turnover 
(Schwanhäusser et al, 2011). Although the identity of the ubiquitylated proteins remained 
largely elusive, one study specifically identified the transcriptional corepressor NCoR1 as 
ubiquitylation substrate (Catic et al, 2013). In line with widespread proteasomal turnover 
of transcriptional regulators also in yeast, genome-wide binding profiles of proteasome 
subunits identified several hundred peaks, which largely correlated with highly transcribed 
ORFs and their regulatory regions (Auld et al, 2006).  
Similar to ubiquitin, SUMO ChIP experiments identified numerous peaks in yeast 
(670), and from 13,000 up to 46,000 peaks in human cells, depending on the experimental 
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conditions and setup (Neyret-Kahn et al, 2013; Seifert et al, 2015; Niskanen et al, 2015; 
Chymkowitch et al, 2015b). Although the effect of SUMO on transcription rates seems 
context dependent, these studies largely agree in that SUMOylated proteins predominantly 
also bind in gene regulatory and intergenic regions. In particular, binding of RNA Pol III-
dependent tRNA gene promoters seems to be conserved between yeast and human cells 
(Chymkowitch et al, 2015b; Neyret-Kahn et al, 2013). 
Previous ChIP experiments for Slx5 and Slx8 did not identify specific binding 
regions other than centromeres for Slx5, however, these results might be influenced due to 
the use of a non-functional Slx5 allele in that study (van de Pasch et al, 2013). Highly 
localized signals for Slx5/Slx8 are somewhat unexpected, as the STUbL most likely does 
not directly bind DNA at specific sequences and ubiquitin ligases often modify their 
substrates in a touch-and-go fashion. This could also explain why Slx5/Slx8 is not enriched 
at the 670 SUMO peaks, of which only 3 overlap with ub-hotspots. At ub-hotspots, the 
apparent presence of a relatively stable Euc1–SUMO–Slx5/Slx8 complex is probably 
responsible for the remarkably specific signals for Slx5/Slx8. Taken together, both the low 
number of ubiquitin peaks in cdc48 mutant cells and the almost exclusive localization of 
Slx8 (and presumably Slx5) to ub-hotspots are surprising findings. 
4.3 Specificity in the STUbL Pathway is Achieved by Multivalent 
Substrate–Ligase Contacts 
STUbL recruitment is thought to primarily rely on recognition of polySUMO chains by 
multiple SIMs, however, how STUbLs select their substrates amongst abundant 
SUMOylated proteins in the nucleus remains largely enigmatic. So far, all currently known 
Slx5/Slx8 substrates require Slx5-SIMs for ubiquitylation, and in the majority of cases 
substrate SUMOylation is indeed a prerequisite for recognition. A notable exception to the 
latter rule is Matα2: Here, Matα2 DNA binding and Slx5-SIMs are required for its STUbL-
dependent ubiquitylation, but not SUMOylation (Xie et al, 2010; Hickey et al, 2018). The 
authors speculated that Slx5-SIMs could interact with hydrophobic Matα2 features (Xie et 
al, 2010). 
Interestingly, although the primary sequence and domain organization of the 
mammalian STUbLs RNF4 and Arkadia (RNF111) are only distantly related to Slx5 and 
Slx8 (Fig. 4), both enzymes (or variants thereof) can complement certain phenotypes 
observed for slx5∆ and slx8∆ cells: In particular, the accumulation of high molecular 
weight conjugates and the typical sensitivity to hydroxyurea-induced replication stress can 
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be alleviated by the mammalian homologs (Uzunova et al, 2007; Prudden et al, 2007; Sun 
et al, 2007; 2014). In both cases, complementation strictly requires multiple SIMs within 
the heterologous ligase. Hence, complementation might depend primarily on a 
“polySUMO–SIM interaction mode” for recognition of yeast substrates, rather than 
specific substrate interactions. 
 
 
Figure 28. Bipartite recognition of Euc1 by Slx5/Slx8. 
(A) Schematic domain structures of Euc1, Slx5 and Slx8 with features highlighted. Light blue shading highlights 
domains characterized in this study. 
(B) Close-up view of a model for Slx5/Slx8 recruitment to ub-hotspots by Euc1. Two Euc1 molecules might bind to the 
repetitive ub-HS-motif (orange DNA) via their GCR1 domains (orange) and dimerize via the coiled-coil (CC) domains 
(black/green). Besides SUMO, Slx5 recognizes interaction surfaces close to the dimerization site (blue diamonds) via its 
middle domain (Md). Slx5 and Slx8 likely dimerize via their ring domains, as previously demonstrated for other RING 
ligases (Plechanovová et al, 2011; 2012). All components are required for formation of a stable Euc1–SUMO–Slx5/Slx8 
complex. Slx8 DNA binding might contribute to recruitment and stability (Yang et al, 2006). 
Interestingly, RNF4 and Arkadia were unable to complement ub-hotspot formation 
in slx5∆ cells, even when fused to the Slx5-Md (not shown). Moreover, for Euc1 there is 
currently no evidence for modification with long polySUMO chains (Fig. 9B, 13A). 
Therefore, it is unlikely that such a “polySUMO–SIM interaction mode” is sufficient for 
recognition of Euc1. In contrast, my data suggest that in addition to a SUMO–SIM 
interaction, direct contacts between the Slx5-Md and Euc1 are required for Slx5/Slx8 
recruitment and ubiquitylation of Euc1, and possibly other substrates at ub-hotspots. For 
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such a “bipartite recognition mode” (Höpfler et al, 2019), multiple interactions likely 
provide the required affinity/avidity for accurate recognition specifically of SUMOylated 
Euc1 (Fig. 28). Such bipartite recognition would not be without precedent, as 
SUMOylation had previously been described to allow specific recognition of modified 
binding partners in other contexts, e.g. the selective recruitment of the Srs2 helicase by 
SUMOylated PCNA (Pfander et al, 2005; Papouli et al, 2005; Armstrong et al, 2012). 
Even within the STUbL protein family, bipartite substrate recognition might be the 
rule, rather than the exception: For RNF4, a basic patch enables interactions with 
nucleosomes to allow recognition of chromatin bound SUMOylated proteins (Groocock et 
al, 2014), and recognition of phosphorylated substrates is facilitated by an arginine-rich 
motif (Kuo et al, 2014; Thomas et al, 2016). Arkadia relies on its Mn/Mc domains 
comprising a His-rich motif for proper localization to Polycomb bodies and its role in 
transcriptional regulation of the TGFβ-pathway, which additionally requires SIMs (Sun et 
al, 2014). Drosophila Degringolade/Dgrn interacts with the transcriptional repressor Hairy 
via its RING domain, and its SIMs simultaneously interact with the SUMOylated 
transcriptional corepressor Gro. Ultimately, this mechanism leads to ubiquitylation of 
Hairy to break up the Hairy–Gro complex and allow corepressor exchange (Abed et al, 
2011a; 2011b). For Slx5/Slx8, Euc1 represents the first example of bipartite substrate 
recognition and the insights gained in this study might serve as a guide for future research 
investigating the manifold functions of STUbLs in the DNA damage response, oncogene 
degradation, and early embryonic development. 
4.4 Euc1 and Ub-hotspots Function in Tolerance to Cellular 
Stress 
What could be the cellular function of Euc1 and ub-hotspots? My phenotypic 
characterization of EUC1 genetic interactions highlight synthetic growth defects with 
factors attributed to gene expression control and chromatin maintenance, in particular upon 
exposure to thermostress (heat/cold) and DMSO (Fig. 24, Fig. 29). Previous studies have 
established functions in stress adaptation for several of these factors, including the H2A.Z–
SWR1-C axis, NPL3, STB5 and the Rpd3L complex, primarily through their roles in gene 
expression control (de Nadal et al, 2004; Ruiz-Roig et al, 2010; Gaytán et al, 2013; 
Moehle et al, 2012; Kumar & Wigge, 2010). Notably, epistasis analysis revealed that 
EUC1 acts in a common pathway with Rpd3S with regards to genetic interactions with the 
Rpd3L complex (Fig. 24D and Fig. 29). Both complexes form around the catalytic HDAC 
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subunit Rpd3, of which HDAC1 family enzymes represent homologs in higher eukaryotes 
(Carrozza et al, 2005; Yang & Seto, 2008). Histone deacetylation by Rpd3 typically serves 
repressive functions, but some heat- or osmo-stress-responsive genes have also been 
shown to be activated by Rpd3, in particular by the Rpd3L complex (de Nadal et al, 2004; 
Ruiz-Roig et al, 2010). In contrast, Rpd3S has its main function in the prevention of 
aberrant intragenic transcription initiation (Carrozza et al, 2005). Mechanistically, Set2 
methylates histone H3K36 cotranscriptionally, which signals recruitment of the Rpd3S 
complex to deacetylate histone H4 and maintain a repressed state after transcription 
(Carrozza et al, 2005). Interestingly, it has recently been demonstrated that Rpd3S-
controlled non-coding cryptic transcripts can also regulate the promoters of protein-coding 
genes, establishing a role for Rpd3S in gene expression control during adaptation to 
changing nutrient conditions and in aged cells (Sen et al, 2015; Kim et al, 2016; McDaniel 
et al, 2017). 
 
 
Figure 29. Summary model of genetic interactions of EUC1 and the ub-hotspot pathway. 
Arrows indicated genetic interactions of Euc1, dashed arrows highlight epistatic relationships between Euc1 and Rpd3S 
or Euc1 and Slx5/Slx8 with regards to genetic interactions with Rpd3L components. See main text for details. 
While the precise mechanism by which Euc1 exerts its function in cellular stress 
responses as part of an Rpd3S-dependent pathway remains a subject of speculation (see 
below), my data provide cues to guide future research: Transcriptome analysis revealed 
widespread alterations in euc1∆ cells and upon EUC1 overexpression. Particularly 
interesting, RCO1 of the Rpd3S complex was upregulated, and SIR2, an HDAC of the 
sirtuin family, was downregulated in euc1∆ cells, which might underlie certain phenotypes 
or reflect adaptations. Noteworthy, HSP12, which gets activated by Rpd3 upon osmotic 
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stress (de Nadal et al, 2004), showed opposing expression changes upon EUC1 deletion 
(downregulated) and overexpression (upregulated). Hsp12 binds and stabilizes the plasma 
membrane and is induced in various stress conditions, including osmotic, heat, and 
oxidative stress (Welker et al, 2010). Compromised membrane organization could also 
provide a link to the observed phenotypes of EUC1-overexpressing cells upon heat and 
benzyl alcohol exposure, a drug that is known to impair cellular membrane integrity (Lone 
et al, 2015). On the other hand, DMSO enhances several genetic interactions of euc1∆ 
cells, and it has been described that DMSO modulates membrane structure (Gurtovenko & 
Anwar, 2007). Moreover, mutants in the H2A.Z–Swr1-C axis are hypersensitive to DMSO 
treatment (Gaytán et al, 2013; Zhang et al, 2013). Interestingly, DMSO also acts as a weak 
inhibitor of HDACs (reviewed in (Marks & Breslow, 2007)), which could lead to an 
exacerbation of phenotypes in mutants with partially compromised gene expression 
control.  
Taken together, a reasonable interpretation of the genetic and transcriptome data 
could be as follows: Full adaptation to cellular stress conditions like thermo- and DMSO 
stress relies on several redundant regulatory pathways, one of them being mediated by 
Euc1, the ub-hotspots and the Rpd3S complex. If other gene expression control systems 
fail (Rpd3L, H2A.Z–SWR1-C), the ub-hotspot pathway becomes indispensable under 
these conditions. 
4.5 Euc1 and Ub-hotspots in the Context of the Nucleus 
Despite the physiological implications for the functions of ub-hotspots suggested by 
genetic experiments and a good understanding of the mechanism of ub-hotspot formation, 
it remains mysterious how Euc1 and ub-hotspots fulfill their functions. In this section, I 
aim to place the Euc1–ub-hotspot pathway in the cellular context of the yeast nucleus and 
will discuss functional similarities with other pathways. Although other hypotheses cannot 
be ruled out, two main concepts for Euc1 function deserve consideration based on the 
available data: First, Euc1 might act as a transcriptional regulator; second, Euc1 and ub-
hotspots could be required to establish a specialized chromatin domain for regulatory 
purposes. 
4.5.1 Euc1 as a Putative Transcription Factor 
The domain structure of Euc1 (Fig. 28A) is reminiscent of several other GCR1 domain 
TFs, which in addition to the defining DNA-binding domain also feature transactivation 
and coiled-coil dimerization domains (Holland et al, 1987; Hohmann, 2002). Sequence 
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alignments suggested that Cbf2 is more distantly related (not shown). The three GCR1 
domain TFs Gcr1, Hot1, and Msn1 all act as transcriptional regulators in the adaptation to 
various cellular stress conditions, like carbon source switches or in osmotic stress 
(reviewed in (Hohmann, 2002)). My data show that Euc1 can act as a transcriptional 
activator in reporter-gene assays as well (Fig. 20). However, there is only very limited 
evidence for a transcriptional regulation of ub-hotspot adjacent genes by Euc1 (Fig. 21). 
Transcriptome analysis showed that neither deletion of EUC1, nor overexpression of 
EUC1, nor expression of Euc1-KR leads to strong changes in expression of ub-hotspot 
adjacent genes. Notably, RNAseq with high read numbers also did not reveal strong effects 
on several annotated non-coding RNAs around ub-hotspots when DNA-binding deficient 
Euc1-DBD* was expressed (not shown). It remains possible that Euc1’s role as 
transcription factor is only triggered upon a specific, currently elusive stimulus. Moreover, 
other regulators might be required for triggering transactivation at ub-hotspots, or 
compensatory mechanisms for misregulated EUC1 could exist. Hypothetically, the ub-
hotspot pathway, and in particular SUMOylation, might then act as negative regulators of 
Euc1-mediated transactivation, as suggested by reporter-gene assays (Fig. 30, see also 
Appendix Fig. A4A and D). 
 
 
Figure 30. Schematic model of transactivation by Euc1. 
In reporter-gene assays, the Euc1 N-terminus comprising an acidic patch can mediate transactivation, while 
SUMOylation (green) is inhibitory. At ub-hotspots, other factors or external stimuli might be required to activate 
transactivation. Orange: ub-HS motif/GCR1 domain. 
In contrast to metazoan transcriptional regulation, upstream activating sequences or 
enhancers are usually found close to their target genes in S. cerevisiae, typically within 
several hundred base pairs (Dobi & Winston, 2007). Therefore, it appears unlikely that ub-
hotspots act as enhancers for specific, distant genes in trans. Since the N-terminal 
transactivation domain is dispensable for complementation of EUC1 genetic interactions, a 
model whereby Euc1 fulfills its major function as key component for the formation of ub-
hotspots rather than as TF seems more plausible based on the available data. 
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4.5.2 Ub-hotspots as Specialized Chromatin Domains 
As an alternative, and more complex model than direct transcriptional activation or 
repression by Euc1, it could be speculated that the ub-hotspots are required for gene 
expression regulation or chromatin maintenance through a more indirect mechanism. 
Hypothetically, ub-hotspots could represent a kind of specialized chromatin domain. To 
regulate and organize the genome, and to separate biochemical activities, several distinct 
compartments exist in the yeast nucleus, and many (but not all) basic principles are 
conserved in higher eukaryotes. The yeast interphase nucleus displays several prominent 
features, which can be visualized as nuclear subcompartments (Fig. 31A). These include 
centromeres clustered at the spindle pole body (SPB), telomere clusters, the nucleolus, 
tRNA gene clusters close to nucleoli, so-called “transcription factories” at NPCs, transient 
foci for DNA replication or repair (reviewed in (Taddei & Gasser, 2012), and the recently 
described intranuclear quality control compartment (INQ, (Gallina et al, 2015)). 
Importantly, specific DNA sequences and DNA-binding proteins, or activities such 
as transcription, replication or other DNA transactions are often required for the formation 
of these compartments. Of note, several nuclear subcompartments underlie regulation by 
SUMO or STUbL-mediated ubiquitylation. Examples include the SUMO- and Slx5/Slx8-
dependent control of the centromeric histone variant Cse4 upon mislocalization (Ohkuni et 
al, 2016; 2018; Cheng et al, 2017). At telomeres, tethering mechanisms are regulated by 
SUMOylation, and the second S. cerevisiae STUbL Uls1 controls unwanted NHEJ by 
preventing accumulation of polySUMOylated Rap1, a key binding factor of telomeric 
repeats (Lescasse et al, 2013). Within the nucleolus, the SUMO pathway and Slx5/Slx8 
critically regulate DNA association of factors involved in rDNA transcription, including 
Net1 and Tof2 (Gillies et al, 2016; Liang et al, 2017). Furthermore, in the environmental 
stress response to ethanol, the SUMO isopeptidase Ulp1 was found to relocate from NPCs 
to the nucleolus, leading to changes in cellular SUMOylation (Sydorskyy et al, 2010). 
Related to tRNA gene transcription, SUMOylation targets several subunits of RNA Pol III, 
and their deSUMOylation upon nutrient depletion leads to decreased tRNA gene 
transcription (Chymkowitch et al, 2017). It remains unclear whether this mechanism is 
connected to the above-mentioned tRNA gene clusters, however. For some inducible RNA 
Pol II transcribed genes, it has been demonstrated that relocalization to the nuclear pore 
leads to derepression, which is facilitated by the deSUMOylation activity of the NPC-
tethered Ulp1 on transcriptional corepressors (Texari et al, 2013). Also Slx5/Slx8 have 
been reported to localize to the nuclear pore by an interaction with the NPC protein Nup84 
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(Nagai et al, 2008). Interestingly, this localization seems to be important to target 
irreparable DNA double strand breaks to the NPC via recognition of SUMOylated proteins 
at the break site. This mechanism has been proposed to enable non-canonical repair 
pathways (Nagai et al, 2008; Horigome et al, 2016). SUMOylation and STUbLs also 
contribute to the regulation of nuclear subcompartments that are specific to mammalian 
cells, most prominently the SUMO-dependent formation of PML bodies, which also 
underlie the control of the STUbL RNF4 (Shen et al, 2006; Tatham et al, 2008).  
 
Figure 31. Ub-hotspots in the context of the yeast nucleus. 
(A) Schematic drawing of the yeast interphase nucleus. In yeast, centromeres stay attached to short microtubules and the 
spindle pole body (SPB) throughout interphase, which leads to a permanent V-shaped Rabl conformation of 
chromosomes. Telomeres cluster into three to six foci at the nuclear envelope, where heterochromatin and a repressive 
environment are established (red). Opposite of the SPB, the nucleolus forms as a crescent-shaped body around the rDNA 
repeats (light brown). Many of the approximately 270 tRNA genes from all chromosomes cluster together in RNA Pol III 
transcription foci close to the nucleolus (yellow). For RNA Pol II-dependent genes, so-called “transcription factories” 
(green) can form for highly expressed or inducible genes around nuclear pore complexes (NPCs). Adapted from (Taddei 
& Gasser, 2012). N: nucleus, C: cytoplasm. 
(B) Hypothetical representation of putative ub-hotspot chromatin domains. Left: Ub-hotspots could be tethered to the 
NPC by Slx5/Slx8 via an iteraction with Nup84 (Nagai et al, 2008). Right: ub-hotspots could form specific chromatin 
domains or nuclear territories that mediate specific functions or gene regulation in trans. 
In the light of the widespread functions of SUMO and STUbLs in the regulation of 
nuclear subcompartments and their functions, it is attractive to speculate that Euc1-
dependent ub-hotspots could localize to a specific subcompartment, or themselves define a 
discrete chromatin compartment or nuclear territory that mediates gene expression control 
on a more global level (Fig. 31B). Interestingly, deletion of NUP84 leads to a loss of ub-
hotspots, although it remains unclear whether this is related to a possible association of ub-
hotspots with Slx5/Slx8 at NPCs or due to indirect effects (Kern, 2013). A microscopy-
based approach to study the localization of ub-hotspots within the nucleus could benefit 
our further understanding of ub-hotspots. Although published chromosome conformation 
capture datasets did not reveal a physical association of all the ub-hotspot loci (Duan et al, 
2010), it remains open whether ub-hotspots might cluster together under certain conditions, 
Discussion 
69 
or whether such a putative chromatin domain features epigenetic signatures other than the 
defining ubiquitylation marks. 
4.6 Concluding Remarks 
In this study, by investigating the previously poorly characterized yeast “ubiquitin 
hotspots”, I was able to uncover a novel recruitment mechanism for the key yeast SUMO-
targeted ubiquitin ligase Slx5/Slx8. The proposed “bipartite recognition mode” sheds light 
on how specificity might be achieved in the STUbL pathway in S. cerevisiae, with 
important implications for other STUbLs. Furthermore, my data identify not only Euc1 and 
the ub-hotspots, but also Slx5/Slx8 as part of a cellular stress response pathway that is 
required in particular in the context of impaired gene expression control. Unresolved 
questions remain regarding the exact molecular mechanism of ub-hotspot function, 
however, this study showcases a highly sophisticated mechanism where the SUMO and 
ubiquitin pathways are tightly interlinked to control ub-hotspots on chromatin. 
Collectively, my data add an intriguing new facet to the variegated functions of the SUMO 
and ubiquitin systems in cellular stress adaptation (Tempé et al, 2008; Enserink, 2015; 
Dikic, 2017). 
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5 Appendix Figures 
 
Appendix Figure A1, related to Fig. 13. 
(A–B) Endogenous Euc1 and Slx8 are not required for the Euc1–Slx5 interaction in Y2H. Experiment was performed as 
in Fig. 13B in an euc1∆ (A) or an slx8∆ genetic background (B). Cells were grown at 30°C for 2 days (A) or 3 days (B). 
(C) Euc181-183 is sufficient for Slx5 binding in Y2H assays. Y2H assay performed as in (A). Two dilutions were spotted 
for each plasmid combination and cells were grown at 30°C for 2 days. 
(D) The minimal region of Euc1 required for dimerization maps to aa 81–140. Y2H assay to map the stretch required for 
dimerization of Euc1 around the CC domain. To avoid artifacts by interactions with endogenous Euc1, I used an euc1∆ 
strain. Note that the region between aa 140–183 likely also contributes to dimerization. Serial dilutions were spotted and 
cells were grown at 30°C for 2 (control) or 4 days (- His).  
(E) The Euc1 CC domain is required for dimerization. Y2H assay to test the requirement for the Euc1 CC domain for 
dimerization. Euc1-CC∆: ∆aa 104–129. Serial dilutions were spotted and cells were grown at 30°C for 2 or 6 days as 
indicated. 
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Appendix Figure A2, related to Fig. 14–15. 
(A) Expression levels of the constructs expressed for Y2H assays in Fig. 14A and 15C analyzed by WB. AD-Euc1 
constructs were probed with a Gal4-AD-specific antibody, BD-Slx5-constructs were probed with a polyclonal Slx5 
antibody (raised against Slx5 aa 1–487). Note that for BD-Slx5-Md constructs levels cannot be directly compared with 
full length or Slx5-RING∆ constructs, because the polyclonal Slx5 antibody might recognize more epitopes in the latter 
constructs. Pgk1 was probed to ensure equal amounts of cell material. 
(B) Euc1-SBM1/2 constructs are proficient for dimerization. Y2H assay to test the effects of Slx5-binding site mutations 
on Euc1 dimerization. 
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Appendix Figure A3, related to Fig. 16–17. 
(A) The Slx5-Md is not required to rescue the slx5∆ replication stress phenotype caused by hydroxyurea (HU) or cold 
sensitivity. WT or slx5∆ cells were transformed with plasmids expressing the indicated constructs and spotted in serial 
dilutions. Cells were grown for 2 days (30°C, 25°C) or 3 days (150 mM HU at 30°C). Note that addition of an N-terminal 
NLS did not affect the complementation. 
(B) Expression levels of Slx5 constructs in cells used in (A) probed by WB against the HA-tag (top), Slx5 (middle) and 
Dpm1 as loading control (bottom). 
(C) HU-complementation assay as described in (A) for cells used in Fig. 16B. 
(D) The Slx5-Md is dispensable for Matα2 degradation. Degradation of a Matα2 fragment (α2-103–189-UH (Ura3-
3HA)) that has previously been shown to rely on Slx5 for rapid degradation (Hickey & Hochstrasser, 2015), has been 
monitored in CHX-chase experiments (0.5 mg/ml cycloheximide from t=0). An slx5∆ strain was complemented with the 
indicated constructs expressed from plasmids under the SLX5 promoter. WB for α2-103–189-UH was probed with an HA 
antibody and Pgk1 levels are shown as loading control.  
(E) Expression levels of Euc1 constructs in cells used in (E) and Fig. 6C–D probed by WB against Euc1. Pgk1 served as 
loading control. Sections were cropped from the same exposure. 
(F) Euc1-SBM1/2 constructs bind the ub-HS-motif in Y1H assays. Gal4-AD fusions with the indicated constructs were 
used in a Y1H assay as described in Fig. 18B. 
min after CHX5 20 60 5 20 60 5 20 60 5 20 60
50 -
37 -
- Pgk1
- α2-103-189-UH
W
T 
+ 
ve
ct
or
ve
ct
or
NL
S-
3H
A-
Sl
x5
N
L
S
-3
H
A
-S
lx
5-
M
d
∆
slx5∆
A
B
euc1∆ ubx5∆
ve
ct
or
Eu
c1
50 -
- Pgk1
- Euc1
Eu
c1
-S
BM
1
Eu
c1
-S
BM
2
Eu
c1
-S
BM
1+
2
100mM HU
vector
NLS-3HASlx5
NLS-3HASlx5-SIM*
NSL-3HASlx5-Md∆
30°C
slx5∆, HisUbi + 3FLAGEuc1
AD-empty
AD-Euc1
AD-Euc1-KR
AD-Euc1-DBD*
AD-Euc1-SBM1
AD-Euc1-SBM2
AD-Euc1-SBM1+2
contr.
- His
20mM 3AT
day 3
HIS3
Euc1
AD
WB:
anti-HA
WB:
Slx5
75 -
100 -
75 -
100 -
- Dpm1
W
T 
+ 
ve
ct
or
ve
ct
or
3H
A S
lx
5
3H
A S
lx
5-
SI
M
*
3H
A S
lx
5-
M
d
∆
NL
S-
3H
A S
lx
5
NL
S-
3H
A S
lx
5-
SI
M
*
NL
S-
3H
A S
lx
5-
M
d
∆
WT + vector
vector
3HASlx5
3HASlx5-SIM*
3HASlx5-Md∆
NLS-3HASlx5
NLS-3HASlx5-SIM*
NLS-3HASlx5-Md∆
30°C 25°C 150mM HU
day 2 day 3
sl
x5
∆
E F
C
D
Appendix Figures 
73 
 
Appendix Figure A4, related to Fig. 21. 
(A) SUMOylation controls TF activity of an Euc11-295-Gal4-BD hybrid construct. Euc1-Gal4-BD fusion constructs as 
described in 20D were expressed and HIS3 activation was monitored. Data for Gal4-BD are reproduced from Fig. 20D 
for comparison. 
(B) Expression levels of constructs used in (B) probed by an HA antibody that recognizes an internal HA tag upstream of 
Gal4-BD. Dpm1 served as loading control. 
(C) Reporter-gene assays using the 3x ub-HS4-HIS3 reporter construct (scheme) in the indicated genetic backgrounds. 
All strains have EUC1 deleted and were complemented with plasmids as indicated on the top. 
(D) As in (C), but using a different reporter construct featuring ub-HS5 with 100 bp genomic context flanking on both 
sides (scheme).  
(E) The reporter strain used in (A), top row: “WT + euc1∆”, was transformed with plasmids expressing the indicated 
Euc1-constructs and transcriptional activation was tested by HIS3 activation on selective media.  
(F) As in (E), but with the ub-HS5 reporter strain. 
Note that for the ub-HS5-HIS3 reporter construct transcriptional activation seems to be enhanced when SUMOylation is 
impaired (siz1∆ siz2∆, Euc1-KR construct), comparable to (A). In contrast, SUMOylation does not affect activation of 
the 3x ub-HS4-HIS3 construct. 
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Appendix Figure A5, related to Fig. 22–23. 
(A) WB of galactose-induced  (3h) euc1 alleles used in Fig. 22D. 
(B) Microscopy of pADH-GFP-EUC1 cells (or euc1-KR, euc1-DBD*) showing similar nuclear localization of tagged 
Euc1 constructs. Cells were counterstained with Hoechst 33342 dye to visualize DNA and maximum Z-projections of 
images recorded on a GE Deltavision Elite are shown. The FIJI software was used for image processing. Scale bar 5µm. 
(C) WB for strains used in Fig. 23C–D after 2h galactose induction. 
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Appendix Figure A6, related to Fig. 24. 
(A) Table summarizing genetic interactions manually tested in growth-based spotting assays as shown in Fig. 24A. 
Scores were given relative to WT growth in the respective conditions. For genetic interactions with EUC1 (highlighted in 
red), at least two independent clones were tested. Note that all strains were generated from diploid strains via tetrad 
dissection and contained an extra copy of MED11 (see C–F), except for rpn12-1 strains. 
(B) EUC1 shows genetic interactions with SWR1. Spotting assay as described for Fig. 24A. 
(C) Certain euc1∆ phenotypes can partially be rescued by introducing an extra copy of MED11 (3% DMSO). Plasmid 
complementation with EUC1 or MED11 plasmids with their endogenous promoters as indicated. I noticed a mild 
downregulation of the RNA Pol II mediator component MED11, which is encoded by the ORF adjacent to EUC1, in the 
euc1∆ transcriptome data and on protein level ((D), Fig. 21A). Therefore, I introduced an extra copy of MED11 at the 
URA3 locus (YIplac211) for the genetic analysis. See also (D–F). 
(D) Med11 protein levels are mildly reduced in euc1∆ npl3∆ cells. WB against Euc1, Med11 and Dpm1. 
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(E) EUC1 and NPL3 show genetic interactions also in the presence of an extra copy of MED11. Spotting assay as 
described in Fig. 24A. 
(F) Plasmid-borne EUC1 expression rescues euc1∆ phenotypes. Indicated strains were transformed with EUC1 or 
MED11 plasmids and grown on selective media.  
(G–H) EUC1 does not show genetic interactions with the Rpd3S/L core subunits RPD3 and SIN3. Spotting assays as 
described in Fig. 24A. Note the stronger growth phenotypes of rpd3∆ and sin3∆ at elevated temperatures or on DMSO 
compared to sds3∆.  
 
 
 
Appendix Figure A7, related to Fig. 21 and 24. 
Genes deregulated in euc1∆ (A), see Fig. 21A, or upon EUC1 overexpression (B), pGAL-EUC1, see Fig. 21C, show 
correlations with genes deregulated in published rpd3∆ and set2∆ transcriptomes. Genes up- or downregulated in the 
query datasets (rpd3∆, set2∆) were marked in the gene rank plots of euc1∆ or pGAL-EUC1 datasets. NES: normalized 
enrichment score (negative values for a correlation with genes downregulated in euc1∆/pGAL-EUC1, positive values for 
correlation with upregulated genes), padj: adjusted p-value. See Appendix Supplementary Methods for details. Data 
analysis was performed by Tobias Straub. 
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Appendix Figure A8, related to Fig. 25. 
(A) Euc1 is recruited to ub-hotspots upon heat stress. Statistical analysis of ChIP-qPCR data presented in Fig. 25. An 
unpaired, two-tailed Student’s t-test was performed (n = 4). 
(B) Euc1 is recruited to ub-hotspots in htz1∆ cells. ChIP-qPCR analysis of ubiquitin-K48, Euc1 and H2A.Z enrichments 
at selected ub-hotspots. p-values for comparisons of ubiquitin and Euc1 enrichments in WT ant htz1∆ are indicated. For 
ub-K48 and Euc1 experiments n = 3, for H2A.Z n = 2. For statistical analysis an unpaired, two-tailed Student’s t-test was 
performed. 
(C–D) Euc1 is recruited to ub-hotspots in npl3∆ cells upon cold stress. ChIP-qPCR for cells grown at 30°C, shifted to 
25°C for 1h, or grown at 25°C. Note that ubiquitin is enriched at 25°C also at the Euc1-independent ub-only-site1, 
arguing for an Euc1-independent effect. Statistical analysis was performed for triplicate experiments (duplicates for ub-
only-site1) using an unpaired, two-tailed Student’s t-test (D). 
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Appendix Figure A9, related to Fig. 26. 
(A) Complementation of euc1∆ npl3∆ phenotypes with plasmid-borne EUC1 alleles as in Fig. 26A. 
(B) Euc1-N30∆, but not Euc1-CC∆ is proficient in forming ub-hotspots. ChIP-qPCR quantification of ubiquitin and Euc1 
in euc1∆ ubx5∆ cells complemented with the indicated plasmids. Data represent means ± SD (n = 3), for Euc1-CC∆ n = 
2. 
(C) SLX8 shows genetic interactions with SDS3 upon heat stress. Spotting as in Fig. 26B, but with slx8∆ strains as 
indicated. 
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6 Materials and Methods 
All molecular biology and cloning techniques followed standard procedures (Ausubel et al, 
1988; Green & Sambrook, 2012), unless described specifically, and were commonly used 
in the Jentsch department, as described previously (Kern, 2013). Sterilized flasks, 
glassware, solutions and deionized water were used for all experiments. Unless stated 
otherwise, analytical grade chemicals and reagents were purchased from Agilent, Applied 
Biosystems, BD, Biomol, Bioneer, Bio-Rad, GE Healthcare, Life Technologies, Merck 
Millipore, New England Biolabs (NEB), PeqLab, Promega, Qiagen, Roth, Roche, Serva, 
Sigma-Aldrich, or Thermo Scientific. 
All Escherichia coli strains, Saccharomyces cerevisiae strains, plasmids and 
vectors, primary antibodies, and primers used for qPCR are listed in Tables 1–5 in 
section 6.6. 
6.1 Escherichia Coli (E. coli) Methods 
E. Coli Media 
LB Medium/Plates   1% (w/v) Bacto tryptone 
     0.5% (w/v) Bacto yeast extract 
     0.5% (w/v) NaCl 
     1.5% (w/v) agar (for plates)  
sterilized by autoclaving 
 
To select for plasmids harboring antibiotic resistance genes, ampicillin (100 µg/ml), 
kanamycin (30 µg/ml), or chloramphenicol (34 µg/ml) were added. 
Competent E. Coli Cells and Transformation 
Chemically competent E. coli cells were prepared by inoculating 1 l LB medium with a 
fresh overnight (o/n) culture to an optical density at 600 nm wavelength (OD600) of 0.05, 
and cells were grown at 37°C with shaking to OD600 ~0.5. The culture was then chilled on 
ice for 15 minutes (min) and cells were pelleted by centrifugation (3500 rpm, 15 min, 
4°C). The pellet was resuspended in 300 ml Tfb1 solution (30 mM KOAc, 50 mM MnCl2, 
100 mM KCl, 15% (v/v) glycerol, pH adjusted to 5.8 with HOAc) and incubated on ice for 
15 min. Bacteria were pelleted again (1500 rpm, 15min, 4°C) and resuspended in 40 ml 
Tfb2 solution (10 mM MOPS, 7.5 mM CaCl2, 10 mM KCl, 15% (v/v) glycerol, pH 
adjusted to 7 with NaOH). Competent cells were aliquoted on ice and stored at -80°C. 
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For transformation, cells were thawed on ice and ~50–500 ng plasmid DNA or 5–
30 µl of a cloning product were mixed with 50–100 µl of competent cells. The mixture was 
incubated on ice for 20 min and subsequently heat-shocked (45 seconds (sec), 42°C 
waterbath) and chilled on ice again. Cells were either plated directly (for ampicillin 
resistance) or allowed to recover in 1 ml LB for 1 hour (h) shaking at 37°C before plating. 
6.2 Saccharomyces Cerevisiae (S. cerevisiae) Methods 
Buffers and Solutions 
YP media/plates:   1% (w/v) Bacto yeast extract 
2% (w/v) Bacto peptone 
2% (w/v) carbon source (glucose (D),  
galactose (Gal), raffinose (Raf)) 
2% (w/v) agar (only for plates)  
sterilized by autoclaving 
 
YP-lactate medium:    1% (w/v) Bacto yeast extract  
2% (w/v) Bacto peptone  
3% (w/v) lactic acid 
pH adjusted to 5.5 with NaOH (ca. 12 g/l final) 
sterilized by autoclaving 
 
YPD G418/NAT/Hph plates:  after autoclaving, YPD medium with 2% (w/v) agar 
was cooled to 50°C, and 200 mg/l G418 (geneticine 
disulphate, PAA Laboratories), 100 mg/l NAT 
(nourseothricin, HK Jena) or 500 mg/l Hph 
(hygromycin B, PAA Laboratories) were added. 
 
Synthetic dropout media:   0.67% (w/v) yeast nitrogen base 
0.133% (w/v) amino acid master mix -8  
+ amino acid supplements (omitting individual ones) 
2% (w/v) glucose 
2% (w/v) agar (for plates)  
sterilized by autoclaving 
 
Amino acid master mix -8 stock:  25 g each: Ala, Asn, Asp, Cys, Gln, Glu, Gly, Ile,  
Phe, Pro, Ser, Thr, Tyr, Val, myo-Inositol 
2.5 g para-Aminobenzonic acid 
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Amino acid supplements: 0.0175% (w/v) final: Leu 
0.00875% (w/v) final: His, Met, Arg, Trp, Uracil, 
Lys-monohydrate 
0.00225% (w/v) final: Adenine hemisulfate salt 
 
Sporulation medium:   2% (w/v) KAc, sterilized by autoclaving 
 
SORB Buffer:    100 mM LiOAc 
10 mM Tris-HCl, pH 8.0 
1 mM EDTA, pH 8.0 
1 M sorbitol 
sterilized by filtration 
 
PEG Solution:    100 mM LiOAc 
10 mM Tris-HCl, pH 8 
1 mM EDTA, pH 8.0 
40% (w/v) PEG-3350 
sterilized by filtration 
stored at 4°C 
 
One-step mix    40% (w/v) PEG-3350 or -6000 
    200 mM LiAc 
    0.5 mg/ml herring sperm DNA (Invitrogen) 
Basic Yeast Protocols 
Yeast cells were typically streaked freshly from glycerol stocks (saturated yeast culture 
with 15% v/v glycerol, stored at -80°C) on YPD or selective media plates and grown for 1–
3 days at 30°C, or 25°C for temperature-sensitive (ts) alleles. Plates were stored for up to 2 
weeks for consecutive experiments. For experiments, precultures were inoculated in 5–25 
ml appropriate liquid media and incubated with shaking (150–220 rpm) o/n at 25°C/30°C. 
For main experimental cultures, cells were diluted to an OD600 of 0.1–0.2 in fresh medium 
and incubated in Erlenmeyer flasks or glass tubes with continuous shaking at 30°C (110–
220 rpm). Temperature-sensitive mutants were also grown at the semi-permissive 
temperature of 30°C unless stated otherwise. Of note, all used ts-alleles showed 
phenotypes at this temperature and an increase in temperature did not substantially change 
the results. Cells were typically allowed to go through at least two division cycles before 
any treatment was applied, and cells were harvested in mid-log phase (OD600 = 0.6–1). 
Within experiments, equal amounts of cells were harvested according to cell density, and 1 
OD600 unit (i.e. 1 ml culture at OD600 = 1) corresponds to ~3*10^7 cells.  
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For galactose induction, cells were cultured in YP + 2% raffinose (or YP-lactate for 
ChIP-chip experiments), grown to OD600 = 0.4–0.5 and galactose was added to a final 
concentration of 2%, typically for 3 h. 
Competent Yeast Cells and Transformation 
Competent yeast cells were prepared as described (Knop et al, 1999). Briefly, cells were 
grown to mid-log phase in 50 ml YPD and pelleted (1200 g, 2–5 min, room temperature 
(RT)), washed in 25 ml water, and 0.2 volumes of SORB buffer and were finally 
resuspended in 360 µl SORB buffer and 50 µl carrier DNA (10 mg/ml herring sperm 
DNA, Invitrogen). Competent cells were aliquoted and stored at -80°C. 
For transformation with PCR products or linearized plasmids, 50 µl of competent 
cells were mixed with 6 volumes of PEG solution and either 10–20 µl PCR product or 0.2–
1 µg linearized plasmid and incubated at RT for 30 min. Subsequently, 1 volume of 
DMSO was added, cells were heat-shocked (42°C, 10–15 min) and chilled on ice. Cells 
were pelleted (1500 g, 1 min, RT) and plated on selective media plates, or allowed to 
recover in 5 ml YPD for 2–6 h before plating when antibiotic resistance marker cassettes 
were used (natNT2, hphNT1, kanMX4). Plates were incubated at 25°C or 30°C until single 
colonies appeared, or replica plated using sterile velvet if necessary. 
For plasmid transformations, the above method was scaled down (0.2x volumes, 
~100ng plasmid DNA). Alternatively, the one-step protocol was used: ~5 OD600 of freshly 
streaked cells were mixed with 50 µl one-step mix, 5 µl of 1 M dithiothreitol (DTT) and 
100–200 ng of plasmid DNA. Cells were then heat-shocked (42°C, 20 min), cooled on ice, 
and streaked on selective plates. 
Yeast Genetic Manipulation 
Chromosomal deletion or tagging of S. cerevisiae genes largely followed published 
standard procedures (Knop et al, 1999; Janke et al, 2004). Briefly, marker cassettes 
(optionally with epitope tags) were amplified by PCR from plasmid vectors of the pYM 
series using primers that carried 50 basepair (bp) overhangs homologous to the targeted 
region. Cells were transformed with PCR products and selected for the used marker 
cassette. Homologous recombination initiated by the 50 bp overhangs directed cassette 
integration and correct insertion was tested by yeast colony PCR or western blot (WB) to 
test for absence of a deleted ORF, or correct epitope-tagging. 
For transformation of integrative yeast vectors (YIplac211, YIplac128) to integrate 
genes at URA3 or LEU2 loci, 1 µg of plasmid was linearized by restriction enzyme (RE) 
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digest and transformed as described. Single integration at the correct locus was tested by 
yeast colony PCR. 
For the introduction of point mutations at endogenous loci (EUC1-tADH::caURA3 
(as WT control), euc1-K231R-tADH::caURA3, euc1-W333A,R334A-tADH::caURA3, slx8-
C206S,C209S-tADH::NatNT2), the ORFs were cloned into the pGAD-C1 vector, 
mutations were introduced via site-directed mutagenesis, and a marker cassette was cloned 
downstream of the ADH terminator sequence (pMH201/202/204 for EUC1 mutations and 
pMH212 for slx8-CD, respectively). Subsequently, the mutated ORF together with the 
ADH terminator and marker cassette were amplified (with 50 bp overhang reverse primers) 
and cells were transformed as described. Colony PCR was performed to check integration 
and to amplify the complete ORF, which was purified and sequenced to verify mutations. 
Mating, Sporulation and Tetrad Analysis 
To mate yeast cells with opposing mating types, similar amounts of yeast cells were mixed 
from fresh plates or directly from glycerol stocks and incubated on a YPD plate for ~3 h or 
o/n. Cells were then restreaked or replica plated on selective media plates to select diploid 
cells. If selection was not feasible, zygotes were picked from mating cells using a 
micromanipulator (Singer MSM Systems) and mating type analysis was performed to test 
absence of haploid mating types in diploid cells. 
For sporulation, cells were grown o/n in YPD and 500 µl of culture was pelleted, 
cells were washed 4 times with water and resuspended in 5 ml 2% KAc. Cells were 
incubated for 3–5 days with shaking (220 rpm) at 25°C. To dissect tetrads, 10–20 µl of 
sporulation culture was mixed with an equal amount of zymolase solution (Amsbio 100T, 
1 mg/ml in water) and incubated at RT for 7 min. Individual cells from tetrads were 
separated using a micromanipulator, grown on YPD plates for 2–5 days, plates were 
scanned (optionally), and genotypes were tested by replica plating on selective media and 
mating type test plates. 
Mating Type Analysis 
To identify mating types, the RH448 (Mat a, Y0934) and RC757 (Mat α, Y0933), which 
are hypersensitive to the opposing mating type pheromones, were used as test strains. Cells 
from freshly streaked test strains were dissolved in 1% melted agar or agarose (precooled 
to ~45°C) and a layer of the mixture was poured on top of a regular YPD plate. Strains to 
be tested were then streaked or replica plated on the a/α test plates and mating types were 
identified by halos of inhibited growth of the opposing mating type test strains. 
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Spotting or Cell Growth/Survival Assay 
Spotting assays were used for qualitative and semi-quantitative assessment of yeast 
survival and growth rates, e.g. for testing cellular fitness under different growth conditions 
or drug/chemical treatments, for growth-based readouts of yeast one-/two-hybrid assays or 
for reporter-gene assays. Typically, cells were freshly streaked from glycerol stocks and 
grown for 1–3 days, or several clones from plasmid-transformed cells were mixed, 
resuspended in water and adjusted to OD600 = 0.5. Optionally, serial five-fold dilutions 
were prepared to better visualize differences in growth/survival rates. Cell suspensions 
were arranged in 96-well plates and spotted on plates using a custom-made stamp, which 
transfers approximately 5 µl per spot. 
Yeast Two-Hybrid (Y2H) Assay 
To test in vivo protein–protein interactions and for mapping of interaction domains, a yeast 
two-hybrid assay was employed. Genes encoding proteins to be tested for interaction were 
cloned into pGAD-C1/pGBD-C1 vectors to allow their expression with N-terminally fused 
Gal4 transactivation/DNA-binding domains (AD/BD). AD/BD plasmid combinations were 
then transformed into a Y2H test strain (Pj69-7a or derivatives thereof) that features GAL-
promoter-controlled reporter genes (HIS3, ADE2, lacZ) (James et al, 1996). In some cases, 
the endogenous genes of the proteins to be tested or of binding partners were deleted to 
avoid interference with the assay (e.g. EUC1, SLX8). Transformed cells were then 
prepared for spotting assays as described and spotted on control (SC-Leu-Trp ) or selective 
media plates (SC-Leu-Trp-His) and growth was scored after 2–5 days. To test for auto-
activation artifacts, control combinations for all constructs with an empty vector of the 
complementary domain (AD-empty, BD-empty) were included. 
Yeast One-Hybrid (Y1H) and Reporter Gene Assays 
Yeast one-hybrid assays were performed to test binding of query proteins to a specific 
DNA sequence. Briefly, sequences of interest (3x ub-HS4: chromosome XIII 308901–
308939 (Kern, 2013), ub-HS5 + 100 bp flanking: chromosome XIII 413497–413733) were 
cloned into YIplac211 vectors upstream of a minimal promoter followed by a HIS3 
reporter gene obtained from pHISi-1 (Clontech). The plasmid with the reporter construct 
was then integrated into a reporter strain (derived from YM4271, Clontech) and Gal4-AD-
fusion constructs were expressed to assess their binding to the query sequences. Cells were 
then spotted on control (SC-Leu) or selective media plates (SC-Leu-His). To suppress 
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background activity of the HIS3 reporter gene due to the leaky minimal promoter, variable 
amounts of 3-amino-1,2,4-triazole (2–40 mM) were added to selection plates. 
For reporter-gene assays to test transactivation by Euc1 constructs (without any 
fused AD) the same reporter genes were used and EUC1 alleles were expressed from 
plasmids under the control of the EUC1 promoter. Optionally, the endogenous EUC1 ORF 
or other ub-hotspot-pathway genes were deleted to test their influence on reporter-gene 
activation. 
A modified reporter-gene assay was used to test transactivation of isolated N-
terminal Euc1 fragments fused to a C-terminal Gal4 BD. Here, Euc1 fragments were 
cloned into YEplac195-pADH-BD-tADH (Moldovan et al, 2006) and plasmids were 
transformed into a PJ69-7a derived Y2H strain with EUC1 deleted. GAL-promoter-
controlled HIS3 expression was used as a readout for transactivation by Euc1 fragments in 
spotting assays on SC-His plates. 
6.3 Molecular Biological Methods 
6.3.1 DNA Purification and Analysis 
DNA purification methods followed standard procedures and, if commercially available 
kits were used, they were performed according to the manufacturer’s instructions unless 
stated otherwise. Briefly, for plasmid purification from XL1-Blue E. coli cells (mini prep), 
single colonies of transformed cells were inoculated in 2–5 ml LB supplemented with 
appropriate antibiotics and grown for 8 h to o/n. Cells were pelleted and plasmid DNA was 
extracted (AccuPrep Plasmid Mini Extraction Kit, Bioneer). 
Genomic DNA from S. cerevisiae cells for use as PCR template for cloning was 
extracted using the MasterPure Yeast DNA Purification kit (Epicentre). Linear DNA 
fragments from PCR or cloning reactions were purified using the Qiagen PCR purification 
kit. DNA fragments separated on agarose gels were purified using the AccuPrep Gel 
Purification Kit (Bioneer). DNA concentrations were measured using a NanoDrop ND-
1000 instrument (PeqLab), and sequencing service was typically performed by Eurofins. 
Agarose Gel Electrophoresis 
For separation of DNA fragments to visualize PCR product size or for cloning, gel 
electrophoresis was performed. Low-melt agarose (Invitrogen) was dissolved at 0.7–2% 
(w/v) in 1x TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM EDTA) and melted by 
boiling. Ethidium bromide was added before polymerization, 6x DNA loading dye 
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(Invitrogen) was added to DNA and gels were run at 100–120 V in 1x TBE buffer. The 
1 kb plus DNA ladder (Invitrogen) was used as size marker and DNA bands were 
visualized using a UV transilluminator (VWR GenoSmart).  
6.3.2 Polymerase Chain Reaction (PCR) 
PCR was used to amplify fragments for cloning (Phusion PCR, NEB) or to test genetic 
modifications of S. cerevisiae (yeast colony PCR/Taq polymerase, MPI Biochemistry Core 
Facility) as detailed below. For amplification of deletion/epitope tagging cassettes, the 
Taq/Vent (NEB) protocol was used as described (Janke et al, 2004) and plasmids of the 
pYM collection were used as templates (Knop et al, 1999; Janke et al, 2004). Primers were 
designed manually or assisted by web-based applications 
(http://tmcalculator.neb.com/#!/main, https://www.ncbi.nlm.nih.gov/tools/primer-blast/) 
and purchased from Eurofins. PCR reactions were performed in a thermal cycler (Applied 
Biosystems). 
PCR reaction setups 
Reagent Phusion PCR Taq PCR 
DNA template 2 µl* 2 µl** 
dNTPs (10 mM) 1 µl 0.9 µl 
Primer for (10 µM) 2.5 µl 1.6 µl 
Primer rev (10 µM) 2.5 µl 1.6 µl 
Polymerase buffer 10 µl§ 2.5 µl§§ 
Water 31.5 µl 16.15 µl 
Polymerase 0.5 µl 0.25 µl 
Total 50 µl 25 µl 
*10 ng plasmid or 200 ng genomic DNA, **typically yeast colony PCR template 
§ 5x Phusion HF or GC buffer (NEB), §§ 10x ThermoPol reaction buffer (Thermo) 
Yeast Colony PCR 
To test correct integration of deletion/tagging cassettes, yeast colony PCR was performed. 
For template DNA extraction, a single yeast colony was resuspended in 50 µl 0.02 M 
PCR amplification protocols 
 Phusion PCR Taq PCR 
Step Temperature Duration Temperature Duration 
Initial Denaturation 98 °C 2 min 94°C 5 min 
Denaturation 98°C 20 sec 94°C 30 sec 
Annealing 60°C* 20 sec 55°C* 30 sec 
Elongation 72°C 30–60 sec/kb 72°C 1 min/kb 
Final extension 72°C 7 min 72°C 5 min 
Cooling 4°C hold 4°C hold 
*variable, shaded steps were cycled (30x) 
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NaOH and heated to 99°C for 10 min in a thermal cycler. Cell debris was pelleted by a 10-
sec spin in a micro centrifuge and 2 µl were used as template for Taq PCR as detailed 
above. 
Site-Directed Mutagenesis 
Site-directed mutagenesis was performed using the Pfu Turbo polymerase (Stratagene) and 
according to instructions of the QuikChange Site-Directed Mutagenesis Kit manual 
(Stratagene). Primers were designed according to the manual and PCR was performed as 
detailed below, or optimized if necessary. After the PCR, template DNA was digested 
using the methylation specific restriction enzyme DpnI (NEB, 1 µl, 1 h, 37°C) and 5 µl of 
the reaction were used for transformation of 80 µl chemically competent XL1-Blue E. coli 
cells. Before plating on selective plates, cells were allowed to recover for 3 h in 1 ml LB at 
37°C. 
Pfu Turbo PCR protocol 
Step Temperature Duration 
Initial Denaturation 95 °C 2 min 
Denaturation 95°C 30 sec 
Annealing 50°C 45 sec 
Elongation 68°C 15 min 
Final extension 68°C 15 min 
Cooling 4°C hold 
shaded steps were cycled (19x) 
6.3.3 Molecular Cloning 
Ligation-based Cloning 
For traditional ligation-based cloning, a vector (2.5 µg) and an insert (typically a PCR 
product, a synthesized gene strand (Eurofins), or annealed oligos) were digested in a 50 µl 
reaction using restriction enzymes (NEB) according to the manufacturer’s instructions. 
Vectors were dephosphorylated by addition of 1µl calf intestine phosphatase (CIP, NEB; 
30 min, 37°C) and purified using a PCR purification kit (Qiagen). Digested PCR products 
were separated on an agarose gel and purified (AccuPrep Gel Purification Kit, Bioneer). 
50–150 ng vector DNA were mixed with a 3–10-fold molar excess of insert DNA and 
ligated in a 30 µl reaction using T4 ligase (NEB) for 30 min at RT according to the 
manufacturer’s instructions. Subsequently, the complete ligation reaction was used for 
transformation of 80 µl chemically competent XL1-Blue E. coli cells. 
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Gibson Cloning 
For recombination-based Gibson cloning, primers for PCR or gene strands were designed 
with 15–25 bp overhangs that were homologous to the target vector sequence. Vector 
DNA was digested, dephosphorylated and purified as above, while insert DNA (PCR 
product, gene strand) was purified from a gel without digest. 50 ng vector DNA was mixed 
with 3–10-fold molar excess of insert DNA and an equal volume of Gibson Assembly 
Master Mix (NEB) was added (typically in a 10 µl reaction). The reaction was performed 
for 15–60 min at 50°C and half of the reaction was used for transformation of 50 µl 
chemically competent XL1-Blue E. coli cells. 
6.4 Biochemical and Cell Biological Methods 
6.4.1 Protein Biochemical Methods 
Buffers and Solutions 
HU buffer    200 mM Tris, pH 6.8  
8 M urea 
5% (w/v) SDS 
1 mM EDTA 
0.1% (w/v) bromophenol blue 
100 mM DTT added before use 
 
2x SDS loading buffer  120 mM Tris pH 6.8 
(Laemmli sample buffer)  4% (w/v) SDS 
20% (w/v) glycerol 
0.02% (w/v) bromophenol blue 
10% (v/v) β-mercaptoethanol added before use 
 
MOPS buffer    50 mM MOPS 
     50 mM Tris base 
     3.5 mM SDS 
     1 mM EDTA 
 
Blotting buffer   250 mM Tris base 
     1.92 M glycine 
     0.1% (w/v) SDS 
     20% (v/v) methanol 
 
Blotting buffer (commercial)  5% (v/v) 20x Swift buffer (G-Bioscience) 
     10% (v/v) Methanol 
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TBS-T solution   25 mM Tris, pH 7.5 
     137 mM NaCl 
     2.6 mM KCl 
     0.1% (v/v) Tween 20 
 
PBS     10 mM phosphate, pH 7.4 
137 mM NaCl 
2.7 mM KCl 
 
FLAG-IP buffer (FIPB)  100 mM HEPES-KOH pH 7.6 
     200 mM KOAc 
     10% (v/v) glycerol 
     0.1% (v/v) NP-40 
Total Protein Analysis from Yeast Cell Lysates 
Proteins for analysis by SDS-PAGE and western blot analysis from yeast whole cell 
extracts (WCE) were prepared using the trichloroacetic acid (TCA) precipitation method 
(Knop et al, 1999). Cells were grown to mid-log phase and 1 OD600 unit was harvested by 
centrifugation. For cycloheximide (CHX) chase experiments, mid-log phase cells were 
pelleted gently, resuspended at OD600 = 1 in fresh medium supplemented with 0.5mg/ml 
CHX and samples were taken at the indicated time-points and harvested. 
The cell pellet was resuspended in 1 ml cold water and mixed with 150 µl freshly 
prepared lysis solution (1.85 M NaOH, 7.5% β-mercaptoethanol) and incubated for 15 min 
on ice. 150 µl of cold 55% TCA were added to precipitate proteins for 10 min on ice. 
Proteins were pelleted by centrifugation (10 min, 14000 rpm, 4°C), the supernatant (SN) 
was removed and a second 5 min centrifugation step was performed to remove residual 
SN. Protein pellets were then resuspended in 40–100 µl HU buffer and denatured at 65°C 
for 10 min with shaking (1400 rpm). 
Separation of Proteins via SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
to separate proteins according to their molecular weight. Typically, pre-cast NuPage gels 
were used (Invitrogen, 4–12% or 12% Bis-Tris, or 3–8% Tris-Acetate for GST-Euc1/6His-
Slx5 pull-down samples). Protein samples were prepared in HU buffer (denaturation for 10 
min, 65°C) or Laemmli sample buffer (denaturation for 5 min, 99°C), loaded, and gels 
were run in MOPS running buffer (Bis-Tris gels) or Tris-Acetate SDS running buffer 
(Invitrogen) at 120–200 V constant voltage. For molecular weight estimation of proteins, 
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the Precision Plus All Blue Standard (Bio-Rad) was used. For direct visualization of 
proteins, gels were stained with PageBlue Protein Staining Solution (Thermo Scientific). 
Western Blot (WB) 
For protein analysis via western blot, proteins separated by SDS-PAGE were transferred to 
a polyvinylidene difluoride (PVDF) membrane using a wet blot protocol. Briefly, the 
membrane was activated in methanol, the gel was placed on top and filter paper 
(Whatman) soaked in blotting buffer was added on the top and bottom in a sandwich-like 
fashion. Blots were assembled in a cassette and blotting was performed in Amersham 
Biosciences blot chambers at 75 V constant voltage at 4°C for 1:45 h. The membrane was 
then blocked in 5% (w/v) skim milk powder in TBS-T for 15–60 min at RT and 
subsequently incubated o/n with primary antibody dissolved in 5% milk/TBS-T (optionally 
with 0.02% sodium azide). Afterwards, the membrane was washed twice briefly with TBS-
T and incubated with secondary antibody coupled to horseradish peroxidase in 5% 
milk/TBS-T for 1–6 h (at least 3 h for Euc1 and Slx5 WBs). Lastly, the membrane was 
washed four times for 7 min in TBS-T, and detection of proteins was performed using 
chemiluminescence reagents (ECL or ECL plus, Thermo Scientific). Signals were detected 
using Amersham Hyperfilm ECL (GE Healthcare) or a camera-based detection system (LI-
COR Odyssey Fc) and processed in Adobe Photoshop or quantified using the ImageStudio 
Lite package (LI-COR). 
Co-immunoprecipitation (Co-IP) 
For FLAG-IPs, 300 OD600 units of cells were harvested (1500 g, 10 min, 4°C) from a mid-
log phase culture, washed once with 50 ml 1 M sorbitol/25 mM HEPES pH7.6, and 
pelleted again (3500 g, 5 min, 4°C). Cells were then resuspended in 3 ml FLAG-IP buffer 
(FIPB), freshly supplemented with 2 mM β-mercaptoethanol, 1x protease inhibitors 
(Roche cOmplete EDTA-free), 0.02 M N-ethylmaleimide (NEM), 1 mg/ml Pefabloc SC 
(Roche) and 2 mM MgCl2. Resuspended cells were snap-frozen as “yeast popcorn” in 
liquid nitrogen and stored at -80°C or processed directly in a Freezer/Mill (FM6870, SPEX 
SamplePrep). Cell lysates were thawed in a water bath, incubated on ice with 1.5 µl 
benzonase (Merck/Millipore) to digest nucleic acids for 15 min, and cleared by 
centrifugation (2000 g, 20 min, 4°C). Input samples were set aside and 50 µl slurry of anti-
FLAG agarose beads (M2, Sigma) pre-equilibrated in FIPB were added per sample. Co-
immunoprecipitation of FLAG-tagged proteins and binding partners was carried out for 2 h 
at 4°C on a rotating wheel and beads were then washed five times with 1 ml ice-cold FIPB 
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supplemented with inhibitors (as above). Finally, beads were eluted with 50 µl HU buffer 
(65°C, 10 min shaking 1400 rpm) and samples analyzed by SDS-PAGE and WB. 
GST-pulldown Assay 
For GST-pulldown assays, indicated recombinant proteins (8 µg GST, 15 µg GST-Euc1 or 
20 µg 6His-Slx5) were mixed in binding buffer (50 mM Tris pH 7.5, 5 mM DTT, 150 mM 
NaCl, 0.5% NP-40, 20 mM imidazole) and incubated for 30 min at room temperature to 
allow binding. Input samples were set aside, 50 µl magnetic glutathione bead slurry 
(ThermoFisher) were added and samples rotated for one hour at 4°C. Beads were washed 
four times with wash buffer (as binding buffer, but 300 mM NaCl) and eluted with 30 µl 
5 mM glutathione in wash buffer for 5 min at RT. All samples were dried in a vacuum 
concentrator (Eppendorf) and resuspended in 3 µl water and 12 µl Laemmli sample buffer. 
Finally, samples were separated by SDS-PAGE on 3–8% Tris-Acetate gels and stained 
with PageBlue (ThermoFisher). 
NiNTA Pulldown 
To investigate proteins covalently modified with either 7His-SUMO (HisSUMO) or 6His-
ubiqutin (HisUbi), nickel-nitrilotriacetic acid (NiNTA) pulldowns of yeast cell lysates were 
performed under denaturing conditions as described (Psakhye & Jentsch, 2016). Typically, 
200 OD600 units of cells from a mid-log phase culture were harvested by centrifugation 
(3500 g, 5 min, 4°C), washed with 25 ml cold PBS and pellets were snap-frozen in liquid 
nitrogen and optionally stored at -80°C. Cells were lysed on ice for 15 min in 6 ml 1.85 M 
NaOH with 7.5% β-mercaptoethanol freshly added. To precipitate proteins, 6 ml of cold 
55% TCA was added, samples were incubated on ice for 15 min, and proteins were 
pelleted by centrifugation (3000 g, 30 min, 4°C). Pellets were carefully washed twice 
(without resuspending) using ice-cold water and subsequently resuspended in buffer A (6 
M guanidinium hydrochloride, 100 mM NaH2PO4, 10 mM Tris-HCl, pH 8) supplemented 
with 0.05% Tween-20. To fully dissolve pellets, samples were incubated for 1–3 h at RT 
with shaking (220 rpm) and subsequently centrifuged to remove insoluble particles (23000 
g, 20 min, 4°C). The SN was transferred to 15 ml Falcon tubes and imidazole (final 
concentration of 20 mM) and NiNTA beads were added (50–100 µl agarose or magnetic 
agarose slurry, both Qiagen). Samples were incubated on a rolling platform o/n at 4°C and 
beads were recovered by centrifugation (1000 g, 5 min, 4°C, magnetic beads) or loaded on 
filter columns (Bio-Rad, for NiNTA agarose beads). For magnetic beads, beads were 
washed using a magnetic rack: 3 times with 1 ml buffer A (+ 20 mM imidazole, 0.05% 
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Tween-20), 5 times with 1 ml buffer C (8 M urea, 100 mM NaH2PO4, 10 mM Tris-HCl, 
pH 6.3) with 0.05% Tween-20, and once with 125µl buffer C without Tween-20. To elute 
proteins, beads were incubated for 10 min at 65°C shaking (1400 rpm) with 1% SDS (w/v) 
in water. Beads were discarded and the solution was dried in a vacuum concentrator 
(Eppendorf, 45°C, 30 min). Samples were resuspended in 10 µl water and 15 µl HU buffer 
and analyzed by SDS-PAGE and WB. 
NiNTA agarose beads were washed in filter columns twice with 7.5 ml buffer A (+ 
20 mM imidazole, 0.05% Tween-20), twice with 7.5 ml buffer C (+ 0.05% Tween-20), and 
once with 10 ml buffer C. To elute proteins, the column was sealed and beads were 
incubated twice with 1 ml elution buffer (0.75x buffer C, 250 mM imidazole) for 10 min. 
Proteins were then precipitated with the TCA method, pellets were optionally washed with 
cold acetone (-20°C), and resuspended in HU buffer for SDS-PAGE and WB. 
Antibodies 
All primary antibodies used in this study are listed in Table 4 in section 6.6. Primary 
antibodies against Slx5 (aa 1–487) and Slx8 were produced by Alexander Strasser (MPI of 
Biochemistry) using standard procedures. Briefly, GST-tagged proteins were expressed 
from pGEX-4T3 vectors in Rosetta 2 cells and purified, rabbits were immunized with 
several boosts (MPI Animal Facility), blood was collected, and serum was passed over 
columns with 6His-tagged proteins (expressed from pET28a vectors in Rosetta 2 (DE3) 
cells) to enrich specific antibodies. Columns were eluted, antibody specificity was tested in 
WBs and antibodies were stored in PBS/50% glycerol at -20°C. Notably, Slx5 and Slx8 
antibodies detect several non-specific targets besides their primary antigen. However, re-
using the antibody solution (in 5% milk/TBS-T) several times significantly improved the 
signal ratio between specific versus non-specific bands. Note that for all WBs using anti-
Euc1 antibody, 5% (w/v) BSA was used instead of milk powder for blocking and 
primary/secondary antibody dilutions. Secondary antibodies for WB detection were all 
purchased from Dianova and coupled to horseradish peroxidase (HRP, goat anti-
mouse/rabbit/rat). 
Recombinant Proteins 
Recombinant 6His-Slx5 for GST-pulldowns was produced by the MPI Biochemistry Core 
Facility exactly following a published protocol (Yang et al, 2006). Purified GST and GST-
Euc1 were kind gifts from A. Strasser and M. J. Kern and had been purified by standard 
procedures. 
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6.4.2 Chromatin immunoprecipitation (ChIP) 
ChIP Buffers 
FA lysis buffer (FA-LB)  50 mM Hepes, pH 7.5 
     150 mM NaCl 
     1 mM EDTA 
     1% (v/v) Triton X-100 
     0.1% (w/v) Deoxycholic acid, Na-salt 
     0.1% (w/v) SDS 
 
FA lysis buffer 500 mM NaCl 50 mM Hepes, pH 7.5 
(FA-LB500)    500 mM NaCl 
     1 mM EDTA 
     1% (v/v) Triton X-100 
     0.1% (w/v) Deoxycholic acid, Na-salt 
     0.1%  (w/v) SDS 
 
ChIP wash buffer   10 mM Tris, pH 8 
     250 mM LiCl 
     1 mM EDTA 
     0.5% (v/v) NP-40 
     0.5% (w/v) Deoxycholic acid, Na-salt 
 
ChIP elution buffer   50 mM Tris, pH 7.5 
10 mM EDTA 
1% (w/v) SDS 
 
TE     10 mM Tris, pH 8 
     1 mM EDTA 
ChIP Protocol 
ChIP was performed based on a published protocol (Aparicio et al, 2005), with minor 
modifications as described (Kalocsay et al, 2009; Renkawitz et al, 2013; Kern, 2013). 
Briefly, cells were grown to mid-log phase and for each IP, yeast cells equivalent to 75 
OD600 units were crosslinked with formaldehyde (1% final) for 16 minutes and the reaction 
was quenched by adding glycine (325 mM final) for 15 min. Cells were pelleted (3500 g, 5 
min, 4°C) and washed in 25 ml ice-cold PBS, transferred to 2-ml Eppendorf tubes (eppis), 
pelleted and snap-frozen in liquid nitrogen. Cells were resuspended in 800 µl FA lysis 
buffer freshly supplemented with protease inhibitors (PIs: cOmplete EDTA-free protease 
inhibitors and Pefabloc SC (1 mg/ml final), both Roche), and lysed by beat-beating 
(MM301 or MM200, Retsch GmbH) with zirconia/silica beads (BioSpec Inc.) for 6 cycles 
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with 3 min shaking (30/s) and 3 min breaks at 4°C. Lysates were transferred to fresh 2-ml 
eppis by the piggy-back elution method and pelleted by centrifugation (15 min, 14000 rpm, 
4°C). The SN was discarded and the chromatin pellet was resuspended in 1 ml fresh FA-
LB+PIs and transferred to 15 ml TPX tubes (Sumilon/Diagenode).  
Chromatin was sheared to 200–500 bp fragments using a Bioruptor UCD-200 
sonication system (Diagenode, 3 10-min cycles, high power, 30 sec on/off intervals, ice-
water bath). Cell debris was pelleted by centrifugation (6150 g, 30 min, 4°C), input 
samples (20 µl) were collected and 800 µl chromatin was subjected to 
immunoprecipitation with specific antibodies (90 min, RT) and pre-equilibrated Protein A 
Sepharose CL-4B (GE Healthcare, 10 µl bead volume per sample) was added for 30 min 
precipitation (RT). Beads were pelleted (500 g, 2 min, RT) and washed with 400 µl of FA-
LB (3x, 200 g, 1 min), FA-LB500 (1x), ChIP wash buffer (1x), and TE (1x). Elution was 
performed with 110 µl ChIP elution buffer for 10 min at 65 °C with shaking (1400 rpm). 
Beads were pelleted (8000 g, 2 min) and 100 µl SN were collected and mixed with 80 µl 
TE and 20 µl proteinase K (Sigma, 20 mg/ml in 10 mM Tris pH 8). Input samples were 
mixed with 100 µl ChIP elution buffer, 60 µl TE and 20 µl proteinase K. Protein digest and 
de-crosslinking was performed for 3 h at 42°C and 8 h at 65°C followed by cooling to 4°C. 
DNA was recovered using the PCR purification kit (Qiagen) according to the 
manufacturer’s instructions. Elution was performed with a 5 min incubation step and 
typically 75 µl of elution buffer. Enriched DNA was subjected to qPCR-analysis or 
processed for genome-wide quantification using NimbleGen arrays as detailed below. 
Quantitative Real-time PCR (qPCR) 
qPCR was performed to quantify DNA contents of ChIP samples (ChIP-qPCR) or cDNA 
levels of reverse-transcribed RNA samples (RT-qPCR) using a LightCycler 480 system 
(Roche). All qPCR primers used in this study are listed in Table 5 in section 6.6. For ChIP 
quantification, input DNA samples were diluted 1:10 and 2 µl of input or ChIP DNA were 
mixed with 10 µl KAPA-Mix (KAPA SYBR FAST qPCR Master Mix 2x, Roche), 7.92 µl 
water, and 0.04 µl forward and reverse primers each (100 µM stock). Reactions were set 
up in technical triplicates in 384-well LightCycler plates (Roche). To control for primer-
specific amplification efficiencies, a standard curve was set up using input DNA (1:3, 1:30, 
1:300, 1:3000 dilutions) for each primer pair and every experiment. The PCR was carried 
out as detailed below, including a melt-curve analysis to ensure amplification of a single 
PCR product. Quantification was performed using the “second-derivative maximum” 
Materials and Methods 
95 
mode of the LightCycler 480 software. To calculate relative enrichments at selected loci, 
ratios of IP/input signals were calculated and, unless stated otherwise, subsequently 
normalized to an unrelated control region that showed low fluctuations of ubiquitin, Euc1 
and Slx8 signals in ChIP-chip experiments (chromosome II, TOS1 promoter). Hence, 
background levels were defined as 1. 
Reaction conditions were the same for quantification of reverse-transcribed cDNA, 
which was diluted 1:5 prior to qPCR. A standard curve using ChIP input DNA (from a WT 
strain) as described above was also included for RT-qPCR, but normalization was carried 
out relative to expression of housekeeping genes (ACT1, PGK1) and to control 
strains/conditions as detailed in the respective figure legends. 
qPCR protocol (KAPA-Mix) 
Step Temperature Duration 
Initial Denaturation 95 °C 3 min 
Denaturation 95°C 10 sec 
Annealing 57°C 20 sec 
Elongation 72°C 1 sec 
Melt-curve analysis 95°C 5 sec 
 65°C 1 min 
 65–97°C 0.11°C/sec 
Cooling 4°C hold 
shaded steps were cycled (40x) 
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ChIP-chip 
Microarray-based genome-wide ChIP quantification (ChIP-chip) was performed as 
described before (Kalocsay et al, 2009; Renkawitz et al, 2013). Briefly, input and ChIP 
DNA samples were treated with RNase (Sigma) and amplified with the GenomePlex 
Complete Whole Genome Amplification kit (Sigma) in two steps as described (O'Geen et 
al, 2006). Labeling of input and ChIP DNA (Cy3 or Cy5), hybridization to S. cerevisiae 
tiling arrays, array scanning and raw data extraction was performed by Source BioScience 
Berlin (formerly imaGenes, NimbleGen ChIP-chip service). Custom-designed c12plex 
NimbleGen arrays with 84 bp median genomic probe spacing were used and only unique 
probes were analysed. A dye-swap was included for replicate experiments and genome-
wide binding profiles were generated from two independent experiments. Data presented 
in figures is on log2-scale, normalized to input DNA and plots were generated using IGB 
(Integrated Genome Browser). 
Bioinformatic Analysis of ChIP-chip Data5 
Data analysis was performed using R/Bioconductor as previously described 
(https://www.epigenesys.eu/images/stories/protocols/pdf/20111025114444_p43.pdf). Raw 
tiling array signals were log2 transformed and quantile normalized (library 
“preprocessCore”). For peak calling first a t statistic using the 90% rule of Efron (function 
“efron.stat”, library “st”) was calculated on IP versus background for the signals of each 
probe. Then the local false discovery rate (lfdr, library “locfdr”) on the t values for each 
probe was determined. Probes less than 350 bp apart with a lfdr < 0.2 and a log2 
(IP/background ratio) > 0.5 (1 in case of Euc1/Ymr111c) were merged. Merged regions 
broader than 500 bp were defined as peaks (enriched regions, ER). 
6.4.3 RNA Methods 
mRNA Quantification (RT-qPCR) 
Yeast total RNA was isolated form 4 OD600 units of yeast cells using the RNeasy Kit 
(Qiagen) following the manufacturer’s instruction, with beat-beating for cell lysis (MM301 
or MM200, Retsch GmbH) with zirconia/silica beads (BioSpec Inc.) for 6 cycles with 3 
min shaking (30/s) and 3 min breaks at 4°C. Before the on-column DNase I digest step, an 
optional wash step (buffer RW1, 5 min incubation) was included, all other steps followed 
                                                
5 Bioinformatic analysis was performed by Tobias Straub (LMU/BMC) 
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the provided protocol and RNA was eluted in 50 µl RNase-free water and concentration 
was measured on a NanoDrop ND-1000 instrument (PeqLab). 
For qPCR-based quantification of mRNA, two alternative methods were used to 
remove residual genomic DNA contamination. For both methods, isolated RNA was 
treated with an additional in solution DNase I digest (Qiagen DNaseI, NEB DNaseI 
incubation buffer) for 15 min at 25°C. For method 1, RNA was then precipitated with 
NaOAc pH 5.2 (0.3M final) and 70% EtOH (final) for >2 h at -20°C, pelleted by 
centrifugation (14000 rpm, 15 min, 4°C), washed with 70% EtOH, and resuspended in 
RNase-free water. For method 2, DNase I was inactivated by denaturation at 75°C for 10 
min and RNA was immediately processed for cDNA synthesis. To this end, a Transcriptor 
First Strand cDNA Synthesis Kit (Roche) was used according to the manufacturer’s 
instructions with oligo dT primers (55°C, 30 min synthesis). Resulting cDNA was diluted 
1:5 and qPCR (RT-qPCR) was performed on a Light Cycler 480 instrument (Roche). 
mRNA-levels were normalized to ACT1 (in case of HIS3) or PGK1-levels (others) for each 
sample and then normalized to the reference sample. 
Transcriptome Analysis (RNAseq)6, 7 
Total RNA was isolated as detailed above and samples were further processed and 
sequenced by the MPI Biochemistry Core Facility (Marja Driessen). Briefly, polyA RNA 
was enriched (NEBNext Poly(A) mRNA Magnetic Isolation Module #E7490), libraries 
were prepared for sequencing (NEBNext Ultra II RNA library prep Set for Illumina 
#E7770L) and barcoded (NEBNext Multiplex Oligo for Illumina #E7335L, #E7500L, 
#E7710L, #E7730L), all according to the manufacturer’s instructions. 75bp single-end 
reads were obtained by sequencing on an Illumina NextSeq 500 instrument using a 
NextSeq500/550 High Output kit v2 (75 cycles, Illumina).  
Sequencing reads were aligned to the yeast transcriptome (ENSEMBL R64-1-1, 
annotation version 94) using STAR (v. 2.6.0a). Read counts per gene were provided by 
STAR and TPM expression values were calculated with RSEM (v. 1.3.0). An unfiltered 
count table was used for differential expression analysis in DESeq2 (v. 1.22.2). Based on 
the standard pipeline, size factors and dispersion values were estimated for each gene and a 
generalized linear model was fitted with a single factor “genotype”. Significance testing 
                                                
6 Generation of sequencing libraries and sequencing performed by Marja Driessen (MPI Biochemistry Core 
Facility) 
7 Bioinformatic analysis including gene enrichment analysis performed by Tobias Straub (LMU/BMC) 
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was based on the Wald test (default parameters). The results were extracted with an alpha 
of 0.1, an lfcThreshold of 0, and independent filtering (default parameters). 
For gene enrichment analysis, sets of up- and downregulated genes upon deletion 
of RPD3 (GEO: GSE67151) and SET2 (GEO: GSE89265) were defined by an adjusted 
p-value cutoff of < 0.1 and a log2 fold-change cutoff of 1.5 (rpd3∆) and 2 (set2∆).  The 
four gene sets were tested for enrichment on the expression changes observed upon EUC1 
deletion (euc1∆) or overexpression (pGAL-EUC1) using fgsea (v. 1.8.0) with 1000 
permutations. 
6.5 Other Bioinformatic Methods and Software 
Slx5 binding site prediction8 
To identify the putative Euc1 sites responsible for interaction with Slx5, a de novo motif 
prediction was performed with a development version of HH-MOTiF (Prytuliak et al, 
2017). The input dataset consisted of putative Slx5 substrates identified in a mass 
spectrometry experiment (I. Psakhye). Additionally, Euc1 as putative Slx5/Slx8 substrate 
was included. From the obtained candidate motifs, only those containing an instance in the 
region aa 81–183 of Euc1 were retained. As a result, only three motif candidates passed the 
filtering procedure. Upon replacement of several charged/hydrophobic residues with 
alanines in Euc1 aa 81–183, mutations in two candidate binding sites led to decreased 
interaction with Slx5 in Y2H experiments (Slx5-binding mutant 1/2, SBM1/2). 
Online Resources and Software Packages 
To retrieve information about and sequences of S. cerevisiae genes or proteins, mainly the 
webpages of the S. cerevisiae Genome Database (https://www.yeastgenome.org/), the 
UniProt Consortium (https://www.uniprot.org/), the National Center for Biotechnology 
Information (https://www.ncbi.nlm.nih.gov/) were used. Protein structure prediction for 
Euc1 was performed using Phyre2 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) (Kelley et al, 2015), EUC1 
homologs were identified using the Yeast Gene Order Browser (http://ygob.ucd.ie/) (Byrne 
& Wolfe, 2005), sequence homology was calculated using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) and displayed using Jalview 
(http://www.jalview.org/), and ub-hotspot sequence conservation was investigated using 
the 7 yeast Multiz Alignment & Conservation tool of the USCS Genome Browser 
                                                
8 Binding site prediction was performed by Roman Prytuliak (MPI Computational Biology Group)  
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(https://genome.ucsc.edu/). For in silico DNA and protein sequence handling, the 
DNASTAR package (DNASTAR Inc.) or the ApE software 
(http://jorgensen.biology.utah.edu/wayned/ape/) was used. ChIP-chip data were visualized 
using R/Bioconductor and the Integrated Genome Browser (https://bioviz.org/). For 
analysis and presentation of quantitative data, Microsoft Excel or and GraphPad Prism 
were used routinely. Contrast adjustment for WBs was performed in Adobe Photoshop 
(Adobe Inc.) with linear adjustment and without highlight/shadow clipping, unless 
underexposed regions were of specific interest. Alternatively, the ImageStudio Lite 
software (LI-COR) for WB image processing/quantification and the FIJI software 
(https://fiji.sc/) for microscopy image processing were used. To create figures and 
schematics, Adobe Illustrator (Adobe Inc.) was used, and software of the Microsoft Office 
package (Microsoft Corp.) was used for text and tables. Papers 3 (Digital Science & 
Research Solution Inc.) was used for reference management. 
Data Availability 
ChIP-chip and RNAseq data are available from Gene Expression Omnibus (GEO, 
https://www.ncbi.nlm.nih.gov/geo/) entry GSE118818. 
6.6 Material Tables 
Table 1. E. Coli Strains 
Strain Genotype Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIq Z∆M15 Tn10 (Tetr )] 
Agilent 
Rosetta 2 F- ompT hsdSB(rB- mB-) gal dcm pRARE2 (CamR) Novagen 
Rosetta 2 (DE3) F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR) Novagen 
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Table 2. S. Cerevisiae Strains 
All yeast strains used in this study are isogenic to DF5 (Finley et al, 1987), unless noted 
otherwise in the table below. If possible, all strains were generated by mating and 
sporulation, or by genetic modification of diploid strains and subsequent sporulation (see 
below). Diploid strains marked with (*) were sporulated and haploid strains were used for 
testing of genetic interactions (not listed). 
Strain Relevant Genotype Ref./Source 
DF5 trp1-1 ura3-52 his3∆200 leu2-3,11 lys2-801 (Finley et al, 1987) 
MJK102 DF5, Mata ubx5::kanMX4 (Kern, 2013) 
MJK503 DF5, MATa cdc48-3::LEU2 (Kern, 2013) 
MJK354 DF5, MATα cdc48-6 YIplac128-Ub-HS4-F7::LEU2 (Kern, 2013) 
MJK355 DF5, MATα cdc48-6 YIplac128-Ub-HS4-F7-Mut::LEU2 (Kern, 2013) 
YM4271 
MATa, ura3-52, his3-200, ade2-101, ade5, lys2-801, leu2-3, 112, trp1-901, tyr1-
501, gal4D, gal8D, ade5::hisG 
Clontech 
MJK391 YM4271, ubx5::hphNT1 YIplac211-3xUb-HS4-F7-min.promoter-HIS3::URA3 (Kern, 2013) 
MJK447 
YM4271, ubx5::hphNT1 YIplac211-3xUb-HS4-F7-min.promoter-HIS3::URA3 
euc1::natNT2 
(Kern, 2013) 
MJK448 DF5, MATa euc1::natNT2 (Kern, 2013) 
PJ69-7A 
trp-901-, leu2-3,112 ura3-53 his3-200 gal4 gal80 GAL1::HIS 
GAL2-ADE2 met2::GAL7-lacZ 
(James et al, 1996) 
MH093 PJ69-7A, euc1::natNT2 This study 
MH443 PJ69-7A, slx8::caURA3MX4 This study 
MH719 PJ69-7A, euc1::hphNT1 This study 
MH725 PJ69-7A, siz1::kanMX4 siz2::natNT2 euc1::hphNT1 This study 
MJK612 DF5, MATa euc1-K231R::URA3 (Kern, 2013) 
MJK567 DF5, MATa Slx8-9myc::kanMX4  (Kern, 2013) 
MJK569 DF5, MATa Slx8-9myc::kanMX4 euc1::natNT2 (Kern, 2013) 
MJK609 DF5, MATa Slx8-9myc::kanMX4 ubc9-1::URA3 (Kern, 2013) 
MJK617 DF5, MATa Slx8-9myc::kanMX4 euc1-K231R::URA3 (Kern, 2013) 
MJK571 DF5, MATa Slx8-9myc::kanMX4 cdc48-3::LEU2 (Kern, 2013) 
MJK579 DF5, MATa slx5::HIS3MX6 (Kern, 2013) 
MJK595 DF5, MATa slx8::hphNT1 (Kern, 2013) 
MJK604 DF5, MATa pSMT3-smt3KRall-tSMT3 I. Psakhye 
MJK621 DF5, MATa pSMT3-smt3KRall-tSMT3 ubx5::NatMX M. J. Kern 
MH491 DF5, MATa pADH-3HA-Slx5::NatNT2 This study 
MH499 DF5, MATa pADH-3HA-Slx5::NatNT2 cdc48-3::LEU2 This study 
MH470 DF5, MATa pADH-3HA-Slx5::NatNT2 euc1::kanMX4 This study 
MH497 DF5, MATa pADH-3HA-Slx5::NatNT2 Euc1-K231R::URA3 This study 
MH493 DF5, MATa pADH-3HA-Slx5::NatNT2 slx8::HIS3MX4 This study 
MH489 DF5, MATa slx5::HIS3MX6 Slx8-9myc::kanMX4 This study 
MH745 DF5, MATa euc1::kanMX4 This study 
MH743 DF5, MATα euc1::kanMX4 YIplac211-pADH-HisSUMO-tADH::URA3 This study 
MH744 DF5, MATa euc1::kanMX4 YIplac211-pADH-HisUb-tADH::URA3 This study 
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MH747 
DF5, MATa euc1::kanMX4 slx8-C206S,C209S::NatNT2 YIplac211-pADH-HisUb-
tADH::URA3 
This study 
MH649 DF5, MATa euc1::kanMX4 slx8-C206S,C209S-tADH::NatNT2 This study 
MH845 DF5, MATa euc1::kanMX4 YIplac211-pADH-HisUbi-tADH::URA3 
slx5::HIS3MX4 
This study 
MH850 DF5, MATa euc1::kanMX4 YIplac211-pADH-HisUbi-tADH::URA3 cdc48-
3::LEU2 
This study 
MH629-1a1 DF5, MATa EUC1-tADH::caURA3 This study 
MH630-2a1 DF5, MATa euc1-K231R-tADH::caURA3 This study 
MH632-2a1 DF5, MATa euc1-W333A,R334A-tADH::caURA3 This study 
MHY501 = 
MH934 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 
(Chen et al, 1993) 
MHY3712 = 
MH935 MATα his3-∆200 leu2-3,112 ura3-52 lys2-801 trp1-1 slx5::kanMX4 
(Xie et al, 2007) 
MH1047 DF5, Mata YIplac211-MED11::URA3 This study 
MH1074 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 This study 
MH1172 DF5, Mata YIplac211-MED11::URA3 htz1::hphNT1 This study 
MH1173 DF5, Mata YIplac211-MED11::URA3 htz1::hphNT1 euc1::natNT2 This study 
MH1174 DF5, Mata YIplac211-MED11::URA3 stb5::hphNT1 This study 
MH1175 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 stb5::hphNT1 This study 
MH1221 DF5, Mata YIplac211-MED11::URA3 npl3::hphNT1 This study 
MH1222 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 npl3::hphNT1 This study 
MH1158 DF5, Mata YIplac211-MED11::URA3 dep1::kanMX4 This study 
MH1159 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 dep1::kanMX4 This study 
MH1160 DF5, Mata YIplac211-MED11::URA3 rxt2::kanMX4 This study 
MH1161 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 rxt2::kanMX4 This study 
MH1164 DF5, Mata YIplac211-MED11::URA3 sds3::kanMX4 This study 
MH1165 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 sds3::kanMX4 This study 
MH1229 DF5, Mata YIplac211-MED11::URA3 rco1::hph This study 
MH1230 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 rco1::hph This study 
MH1231 DF5, Mata YIplac211-MED11::URA3 sds3::kanMX4 rco1::hph This study 
MH1232 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 sds3::kanMX4 rco1::hph This study 
MH1233 DF5, Mata YIplac211-MED11::URA3 eaf3::hph This study 
MH1234 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 eaf3::hph This study 
MH1235 DF5, Mata YIplac211-MED11::URA3 sds3::kanMX4 eaf3::hph This study 
MH1236 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 sds3::kanMX4 eaf3::hph This study 
MH1189 DF5, Mata YIplac211-MED11::URA3 swr1::hphNT1 This study 
MH1190 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 swr1::hphNT1 This study 
MH1237 DF5, Mata YIplac211-MED11::URA3 yaf9::hph This study 
MH1238 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 yaf9::hph This study 
MH578 DF5, Mata npl3::hphNT1 This study 
MH580 DF5, Mata npl3::hphNT1 euc1::natNT2 This study 
MH1162 DF5, Mata YIplac211-MED11::URA3 sin3::kanMX4 This study 
MH1163 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 sin3::kanMX4 This study 
MH1203 DF5, Mata YIplac211-MED11::URA3 rpd3::kanMX4 This study 
MH1204 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 rpd3::kanMX4 This study 
MH1151* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 ume6::kanMX4 This study 
MH1178* DF5, Mata/α cim3-1 YIplac211-MED11::URA3 euc1::natNT2 This study 
Y0351 DF5, Matα ura3, his3, trp1, rpn12-1 Kominami 1994 
MH1184 DF5, Matα ura3, his3, trp1, rpn12-1 euc1::natNT2 This study 
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MH1180* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 doa1::kanMX4 This study 
MH1181* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 sem1::kanMX4 This study 
MH1182* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 san1::kanMX4 This study 
MH1126* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 snu66::kanMX6 This study 
MH1127* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 hub1::LEU2 This study 
MH1146* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 snt309::kanMX4 This study 
MH1129* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 bre1::kanMX4 This study 
MH1130* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 ubp8::hphNT1 This study 
MH1131* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 rad6::HIS3 This study 
MH1132* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 htb2::hphNT1 htb1-
K123R::kanMX4 
This study 
MH1227 DF5, Mata YIplac211-MED11::URA3 mot3::kan This study 
MH1228 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 mot3::kan This study 
MH1153* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 yef1::kanMX4 This study 
MH1154* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 rpl6b::kanMX4 This study 
MH1155* DF5, Mata/α YIplac211-MED11::URA3 euc1::natNT2 mco14::kanMX4 This study 
MH1176 DF5, Mata YIplac211-MED11::URA3 nup133::hphNT1 This study 
MH1177 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 nup133::hphNT1 This study 
MH063 DF5, Mata pGPD-EUC1::natNT2  This study 
Y2726 W303 (RAD5), Mata leu2-3,112 ade2-1 can1-100 his3-11,15 ura3-1 trp1-1 Xiaolan Zhao 
MH1125 W303 (RAD5), Mata euc1::natNT2 leu2-3,112 ade2-1 can1-100 his3-11,15 ura3-1 
trp1-1 
This study 
MH1133 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-empty-tADH::URA3 This study 
MH1134 W303 (RAD5), Mata euc1::natNT2 YIplac211-pEUC1-EUC1::URA3 This study 
MH1135 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-EUC1-tADH::URA3 This study 
MH1136 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-KR-tADH::URA3 This study 
MH1137 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-SBM1+2-tADH::URA3 This study 
MH1138 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-KR-SBM1+2-
tADH::URA3 
This study 
MH1139 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-333WR>AA334-
tADH::URA3 
This study 
MH1140 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-∆N30-tADH::URA3 This study 
MH1141 W303 (RAD5), Mata euc1::natNT2 YIplac211-pGAL-euc1-∆104-129(F104>L)-
tADH::URA3 
This study 
MH1191 DF5, Mata YIplac211-MED11::URA3 slx5::HIS3MX6 This study 
MH1192 DF5, Mata YIplac211-MED11::URA3 sds3::kanMX4 slx5::HIS3MX6 This study 
MH1193 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 slx5::HIS3MX6 This study 
MH1194 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 sds3::kanMX4 
slx5::HIS3MX6 
This study 
MH417 DF5, Mata/α Slx8::hphNT1 pGPD-EUC1::NatNT2 This study 
MH1239 DF5, Mata/α slx5::HIS3MX4 pGPD-EUC1::natNT2 This study 
MH709 YM4271, Mata YIplac211-3xub-HS4-pHIS3min-HIS3 euc1::kanMX4 This study 
MH713 YM4271, Mata YIplac211-3xub-HS4-pHIS3min-HIS3 euc1::kanMX4 
ubx5::hphNT1 
This study 
MH714 YM4271, Mata YIplac211-3xub-HS4-pHIS3min-HIS3 euc1::kanMX4 slx5::natNT2 This study 
MH715 YM4271, Mata YIplac211-3xub-HS4-pHIS3min-HIS3 euc1::kanMX4 slx8-
C206S,C209S-tADH::natNT2 
This study 
MH727 YM4271, Mata YIplac211-3xub-HS4-pHIS3min-HIS3 euc1::kanMX4 
siz1::hphNT1 siz2::natNT2 
This study 
MH868 YM4271, Mata YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 euc1::kanMX4 This study 
MH965 YM4271, Mata YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 euc1::kanMX4 
siz1::hphNT1 siz2::natNT2 
This study 
MH966 YM4271, Mata YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 euc1::kanMX4 
slx5::natNT2 
This study 
MH967 YM4271, Mata YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 euc1::kanMX4 
slx8::hphNT1 
This study 
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MH968 YM4271, Mata YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 euc1::kanMX4 
ubx5::hphNT1 
This study 
MH1109 DF5, Mata natNT2::pADH-GFP-EUC1 This study 
MH1166 DF5, Matα natNT2::pADH-GFP-euc1-K231R-tADH::caURA3 This study 
MH1169 DF5, Mata natNT2::pADH-GFP-euc1-333WR>AA334-tADH::caURA3 This study 
MJK347 W303 (RAD5), Mata YIplac211-pGAL-empty-tADH::URA3 (Kern, 2013) 
MJK534 W303 (RAD5), Mata YIplac211-pGAL-EUC1-tADH::URA3 (Kern, 2013) 
MH1199 DF5, Mata YIplac211-MED11::URA3 slx8::hphNT1 This study 
MH1200 DF5, Mata YIplac211-MED11::URA3 sds3::kanMX4 slx8::hphNT1 This study 
MH1201 DF5, Mata YIplac211-MED11::URA3 euc1::natNT2 slx8::hphNT1 This study 
MH1202 DF5, Matα YIplac211-MED11::URA3 euc1::natNT2 sds3::kanMX4 slx8::hphNT1 This study 
Table 3. Plasmids and Vectors 
Standard yeast vectors were used for molecular cloning procedures as described (Mumberg 
et al, 1995; James et al, 1996; Gietz & Sugino, 1988). Positions for all protein truncation 
constructs refer to amino acid (aa) positions in WT proteins.  
Plasmid Construct Ref./Source 
pMax144 YIplac128-Ub-HS4-F7 (Kern, 2013) 
pMax145 YIplac128-Ub-HS4-F7-mut (Kern, 2013) 
pMax197 YIplac211-min.promotor-HIS3 (Kern, 2013) 
pMax193 YIplac211-3xUb-HS4-F7-min.promoter-HIS3 (Kern, 2013) 
pGAD-C1 Gal4-AD (James et al, 1996) 
pGBD-C1 Gal4-BD (James et al, 1996) 
pMax209 pGAD-EUC1 (Kern, 2013) 
pMax198 pGBD-EUC1 (Kern, 2013) 
pMax242 pGAD-euc1-K231R (Kern, 2013) 
pMH237 pGAD-EUC1-aa16-end This study 
pMH238 pGAD-EUC1-aa31-end This study 
p415-ADH p415-pADH-empty (Mumberg et al, 1995) 
pMH281 p415-ADH-3FLAG-EUC1 This study 
pMH282 p415-ADH-3FLAG-EUC1-K231R This study 
pMH120 pGAD-EUC1-81-183 This study 
pMH53 pGBD-SLX5 This study 
pMH55 pGBD-SLX5-1-487 (RING∆) This study 
pMH11 p415-pEUC1-empty This study 
pMH197 p415-pEUC1-3FLAG-EUC1 This study 
pMH198 p415-pEUC1-3FLAG-EUC1-KR This study 
pMH217 p415-pEUC1-3FLAG-EUC1-W333A,R334A (DBD*) This study 
pMH294 p415-pEUC1-3FLAG-EUC1-SBM1 This study 
pMH295 p415-pEUC1-3FLAG-EUC1-SBM2 This study 
pMH296 p415-pEUC1-3FLAG-EUC1-SBM1+2 This study 
pMH300 p415-pEUC1-3FLAG-EUC1-KR-SBM1 This study 
pMH301 p415-pEUC1-3FLAG-EUC1-KR-SBM2 This study 
pMH302 p415-pEUC1-3FLAG-EUC1-KR-SBM1+2 This study 
pMH124 pGAD-EUC1-81-183_SBM1 This study 
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pMH125 pGAD-EUC1-81-183_SBM2 This study 
pMH135 pGAD-EUC1-81-183_SBM1+2 This study 
pMH57 pGBD-SLX5-1-337 This study 
pMH264 pGBD-SLX5-201-335 (Md) This study 
pMH266 pGBD-SLX5-1-200,339-end (Md∆) This study 
pMH318 p415-pADH-3FLAG-EUC1-SBM1 This study 
pMH319 p415-pADH-3FLAG-EUC1-SBM2 This study 
pMH320 p415-pADH-3FLAG-EUC1-SBM1+2 This study 
pMH321 p415-pADH-3FLAG-EUC1-KR-SBM1 This study 
pMH322 p415-pADH-3FLAG-EUC1-KR-SBM2 This study 
pMH323 p415-pADH-3FLAG-EUC1-KR-SBM1+2 This study 
p414-ADH p414-pADH-empty (Mumberg et al, 1995) 
pMH326 p414-pSLX5-NLS-3HA-SLX5 This study 
pMH327 p414-pSLX5-NLS-3HA-SLX5_SIM1-5mut (SIM*) This study 
pMH330 p414-pSLX5-NLS-3HA-SLX5_1-200_339-end (Md∆) This study 
pMH146 pGAD-EUC1-240-462 This study 
pMH147 pGAD-EUC1-291-462 This study 
pMH148 pGAD-EUC1-291-335 This study 
pMH149 pGAD-EUC1-291-385 This study 
pMH150 pGAD-EUC1-291-425 This study 
pMH151 pGAD-EUC1-336-462 This study 
pMH152 pGAD-EUC1-386-462 This study 
pMH153 pGAD-EUC1-426-462 This study 
pMH157 pGAD-EUC1-W333A,R334A (DBD*) This study 
D2431 YEplac195-pADH-BD-tADH (Moldovan et al, 2006) 
pMH273 YEplac195-pADH-EUC1-1-30-HA-BD-tADH This study 
pMH268 YEplac195-pADH-EUC1-1-295-HA-BD-tADH This study 
pMH269 YEplac195-pADH-EUC1-1-295KR-HA-BD-tADH This study 
pMH63 pGAD-EUC1-1-220 This study 
pMH77 pGAD-EUC1-1-183 This study 
pMH78 pGAD-EUC1-1-140 This study 
pMH79 pGAD-EUC1-1-100 This study 
pMH64 pGAD-EUC1-1-60 This study 
pMH68 pGAD-EUC1-161-220 This study 
pMH82 pGAD-EUC1-121-220 This study 
pMH81 pGAD-EUC1-81-220 This study 
pMH80 pGAD-EUC1-41-220 This study 
pMH222 pGBD-EUC1-81-183 This study 
pMH261 pGAD-EUC1_∆104-129 (F104>L), (CC∆)  This study 
pMH222 pGBD-EUC1-81-183 This study 
pMH223 pGBD-EUC1-81-183_SBM1 This study 
pMH224 pGBD-EUC1-81-183_SBM2 This study 
pMH225 pGBD-EUC1-81-183_SBM1+2 This study 
pMH249 pGBD-SLX5-1-275 This study 
pMH250 pGBD-SLX5-1-200 This study 
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pMH251 pGBD-SLX5-1-145 This study 
pMH252 pGBD-SLX5-1-90 This study 
pMH253 pGBD-SLX5-1-50 This study 
pMH324 p414-pSLX5-NLS-3HA This study 
pMH333 p414-pSLX5-3HA-SLX5 This study 
pMH334 p414-pSLX5-3HA-SLX5_SIM1-5mut (SIM*) This study 
pMH337 p414-pSLX5-3HA-SLX5_1-200_339-end (Md∆) This study 
pMH14 p415-pEUC1-EUC1 This study 
pMH291 p415-pEUC1-EUC1-SBM1 This study 
pMH292 p415-pEUC1-EUC1-SBM2 This study 
pMH293 p415-pEUC1-EUC1-SBM1+2 This study 
pMH368 p415-pGAD-C1-EUC1-SBM1 This study 
pMH369 p415-pGAD-C1-EUC1-SBM2 This study 
pMH370 p415-pGAD-C1-EUC1-SBM1+2 This study 
pMH365 p415-pMET25-a2(103-189)-URA3-3HA-6His (Hickey & Hochstrasser, 2015) 
pMH190 YCplac111-MED11 (ORF + 479us-307ds) This study 
pMH191 YCplac111-EUC1 (ORF + 403us-328ds) This study 
pMH447 p413-pADH-SLX5-tCYC1 This study 
pMH218 p414-pADH-SLX8-tADH This study 
pMH15 p415-pEUC1-euc1-K231R This study 
pMH299 p415-pEUC1-euc1-K231R-SBM1+2* This study 
pMH367 p415-pEUC1-euc1-W333A,R334A (DBD*) This study 
pMH244 p415-pEUC1-euc1-aa31-end (N30∆) This study 
pMH260 p415-pEUC1-euc1-∆104-129 (F104>L) (CC∆) This study 
pMH101 pET28a-6His-Slx5 (Yang et al, 2006) 
pGEX-4T3 pGEX-4T3-GST GE Healthcare 
pMax212 pGEX-4T3-GST-EUC1 M. J. Kern 
V0001 YIplac211-pGAL-empty-tADH Jentsch vector collection 
pMH405 YIplac211-pEUC1-EUC1 (ORF + 403us-328ds) This study 
pMH430 YIplac211-pGAL-EUC1-tADH This study 
pMH431 YIplac211-pGAL-euc1-KR-tADH This study 
pMH432 YIplac211-pGAL-euc1-SBM1+2-tADH This study 
pMH433 YIplac211-pGAL-euc1-KR-SBM1+2-tADH This study 
pMH434 YIplac211-pGAL-euc1-W333A,R334A-tADH This study 
pMH435 YIplac211-pGAL-euc1-∆N30-tADH This study 
pMH436 YIplac211-pGAL-euc1-∆104-129(F104>L)-tADH This study 
pMH311 YIplac211-ub-HS5-100bp-flanking-pHIS3min-HIS3 This study 
pMH201 pGAD-EUC1-tADH-pTEF1-caURA3-tTEF1 This study 
pMH202 pGAD-euc1-K231R-tADH-pTEF1-caURA3-tTEF1 This study 
pMH204 pGAD-euc1-W333A,R334A -tADH-pTEF1-caURA3-tTEF1 This study 
pMH212 pGAD-slx8-C206S,C209S-tADH-natNT2 This study 
pMH39 pET28a-6His-Slx5_1-487 This study 
pMH40 pGEX-4T3-GST-Slx5_1-487 This study 
pMH41 pET28a-6His-Slx8 This study 
pMH42 pGEX-4T3-GST-Slx8 This study 
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Table 4. Primary Antibodies 
Antigen Use Type Source 
anti-Myc (9E10) ChIP (3–5 µl) monoclonal (mouse IgG) Sigma 
anti-HA (ab9110) ChIP (3 µl) polyclonal (rabbit IgG) Abcam 
anti-HA (3F10) WB (1:500-1:1000) monoclonal (rat IgG) Roche 
anti-FLAG-HRP (M2) WB (1:3000) monoclonal (mouse, HRP-
coupled) 
Sigma (F8592) 
anti-ubiquitin-K48 (Apu2)  ChIP (4 µl) monoclonal (rabbit IgG) Merck/Millipore 
anti-ubiquitin (P4D1) WB (1:1000) monoclonal (mouse IgG) Santa Cruz 
anti-H2A.Z (= Htz1) ChIP (3 µl) polyclonal (rabbit IgG) Active Motif 
anti-Med11 (ab221200) WB (1:500-1:1000) polyclonal (rabbit IgG) Abcam 
anti-Dpm1 (5C5A7) WB (1:500) monoclonal (mouse IgG) Invitrogen 
anti-Pgk1 (22C5D8) WB (1:15000) monoclonal (mouse IgG) Invitrogen 
anti-Gal4-BD (RK5C1) WB (1:1000) monoclonal (mouse IgG) Santa Cruz 
anti-Gal4-AD (14-7E10G10) WB (1:1000) monoclonal (mouse IgG) Abcam  
IgG (mouse) ChIP (1.5 µl) monoclonal (mouse IgG) Bethyl Laboratories Inc. 
anti-Smt3 WB (1:10000) polyclonal (rabbit IgG) (Hoege et al, 2002) 
anti-Ymr111c/Euc1  
(aa 292-462) 
WB (1:5000/5% BSA) 
ChIP (1.5 µl) 
polyclonal (rabbit IgG) (Kern, 2013) 
anti-Slx5 (aa 1–487) 
WB (1:10000)  
ChIP (2.5 µl) 
polyclonal (rabbit IgG) A. Strasser (self-made) 
anti-Slx8 
WB (1:10000)  
ChIP (0.5 µl) 
polyclonal (rabbit IgG) A. Strasser (self-made) 
Table 5. Primers for qPCR 
Primers for qPCR were typically designed using an online tool 
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/index.cgi) to amplify 100–200 bp 
amplicons. All primers used for ChIP-qPCR and RT-qPCR are listed in the table below. 
Primers labeled with IH- or Max-prefixes were kind gifts from I. Heckmann or M. J. Kern, 
respectively. 
Name Label Position Sequence 
ub-HS1_F Max_420 ChrIII_123537 TTTCTGCCAGTAGCGACACCACACAT 
ub-HS1_R Max_421 ChrIII_123719  ATGACGATGGCAGGGAAAATAGGGCTGT 
ub-HS1_motif1_F MaH_67 ChrIII_123811 GTAACCCTGCGTCACACATGAGAA 
ub-HS1_motif1_R MaH_68 ChrIII_123985 TCACAGTTTACCCGGAGGTCATCA 
ub-HS1_motif2_F MaH_69 ChrIII_125415 TGTTTTATGCGGAAATTGCAGTGGA 
ub-HS1_motif2_R MaH_70 ChrIII_125547 ATGTATGGTTAAGCAGGCTTTGCG 
ub-HS2_F Max_769 ChrIV_358238  CCTTGTCAGATAATGTATGGGTGGTGTG 
ub-HS2_R Max_770 ChrIV_358367  TATTCTTTGTGTTCGCATTCGCTTCCC 
ub-HS3_F Max_698 ChrIV_1087121  AACAATAGAAAAACGCGGGACTCGAT 
ub-HS3_R Max_699 ChrIV_1087280  TGCTAATTTTCAGCCACATCACATGC 
ub-HS4_F Max_373 ChrXIII_309445  TGGAAGCATCACATCGTATGCTACTAGA 
ub-HS4_R Max_374 ChrXIII_309647  TATGTATGCGGCAATGAACTACTCCGA 
ub-HS4_motif1+2_F MaH_71 ChrXIII_308867 TAAAGTGCATTCAAACATCGGCAGG 
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ub-HS4_motif1+2_R MaH_72 ChrXIII_309021 CCCACGACAGCGGTATCTATCTTT 
ub-HS4_motif3_F MaH_73 ChrXIII_309619 TTTCGGAGTAGTTCATTGCCGCAT 
ub-HS4_motif3_R MaH_74 ChrXIII_309760 ACGCATCCATGTCGTGTACATTTC 
ub-HS5_A_F Max_437 ChrXIII_413843  AACGACGTACCCACTACGCGTTTGAA 
ub-HS5_A_R Max_438 ChrXIII_414033  AACTGTTGGAATGTGAGGGCGACCTAGT 
ub-HS5_B_F MaH_75 ChrXIII_413474 ATCTGAGCACACACTTCCTCCTGA 
ub-HS5_B_R MaH_76 ChrXIII_413659 GAAATCCTAGCTGCGAACGGGAAA 
ub-HS6_F Max_717 ChrXIII_433645  TCTTTGCACAATGCATTACGTGGGAG 
ub-HS6_R Max_718 ChrXIII_433789  GAGAAATAGATTCAATGCCGTGGCGA 
ub-HS7_F Max_702 ChrXV_168011  TGTTACGCGTTCCATTTGAGAAGCAA 
ub-HS7_R Max_703 ChrXV_168209  CGGCTTTAAACACCCGTGCCTATATT 
contr_F (pTOS1) Max_342 ChrII_564535  ACCGACTAATGCGGTCATGGAAAGC 
contr_R (pTOS1) Max_343 ChrII_564727  CTTTTCTCGCAAGAAGACTCCAGAATCA 
ect-ub-HS_F Max_433 YI128 backbone  CATTAATGCAGCTGGCACGACAGGTT 
ect-ub-HS_R Max_434 YI128 backbone  ACAATTCCACACAACATACGAGCCGGA 
ACT1_F MaH_90 ORF GAAATGCAAACCGCTGCTCAATCTTC 
ACT1_R MaH_91 ORF CAATACCGGCAGATTCCAAACCCAAA 
HIS3_F MaH_557 ORF TTACCCTCCACGTTGATTGTCTGC 
HIS3_R MaH_558 ORF AACACCTTTGGTGGAGGGAACATC 
ub-only-site1_F Max_371 ChrIV_1117000 GCATCTATCGTATTCTTGAGTTATTGCGAC 
ub-only-site1_R Max_372 ChrIV_1117000 ATGTCAATACCATCAGGATCTTGCATGA 
STI1-CIN5_F MaH_769 ChrXV_382999 GGACCATCTTTCCTGTCGTTCTCC 
STI1-CIN5_r MaH_770 ChrXV_383175 GCTTAGCGAATGTTGTCATGGAGC 
TEC1-us_F MaH_773 ChrII_408761 TGAATTCGGGAATGTGCGTGTTTC 
TEC1-us_R MaH_774 ChrII_408921 AGCACCATGGATTGCTGATGGTAG 
PGK1_F IH_316 ORF GTAAGGCTTTGGAGAACCCAACCA 
PGK1_R IH_317 ORF TGAAGGTGAAAGCCATACCACCAC 
ILV5_F IH_320 ORF AACTCTTCTTACGCCGTCTGGAAC 
ILV5_R IH_321 ORF AGAACATACCGTGGATACCACCCA 
SSF2_F MaH_559 ORF GGCTGTTAAAGATGCTAAAAAGCAACG 
SSF2_R MaH_560 ORF GAAGATCCATCATCGCTCATTGCAC 
EUC1_F MaH_480 ORF CCGTCAGTTCTTTCCCTTGAGAGG 
EUC1_R MaH_481 ORF CGACAACCTTGATGGCTTGGTTTC 
HSP12_F MaH_783 ORF TGTCCACGACTCTGCCGAAA 
HSP12_R MaH_784 ORF CAACTTGGACTTGGCGGCTC 
SIR2_F MaH_785 ORF CCTTCCCACGTTCCCCAAGT 
SIR2_R MaH_786 ORF TATGCGGAATCGTCCAGCCA 
SBH2_F MaH_787 ORF AGTTCCACCAGGAGGTCAGC 
SBH2_R MaH_788 ORF AAGACCCACCGTAACCAGCC 
RCO1_F MaH_794 ORF CCCAAAATGGCAATAGCGAGGA 
RCO1_R MaH_795 ORF GTTCGTTCGGCACGACTACG 
PFK1_F MaH_796 ORF ACTGCTATCCCAGGCCATGT 
PFK1_R MaH_797 ORF AGCGTCAGTGTTTGGAGAAGC 
ALD5_F MaH_798 ORF GGGCTCGTCTTGTGACTGGA 
ALD5_R MaH_799 ORF TGGGACCAAACACTTCCTCCT 
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CIN5_F MaH_800 ORF TGCAAGGCCGGTGACAATAA 
CIN5_R MaH_801 ORF ATGAAGCTGCCGGTTGGCTA 
MRH1_F MaH_802 ORF CGGTGCTGACAAATTGGGCT 
MRH1_R MaH_803 ORF TGGTGTAGCAGCAGGTCTTGG 
ADH2_F MaH_804 ORF CGTTAAGGCTACCAACGGCG 
ADH2_R MaH_805 ORF TTCCCCACGTAAGAGCCGAC 
CDC19_F IH_312 ORF TTACAACCCAAGACCAACCAGAGC 
CDC19_R IH_313 ORF CTTGTTCAGCAATGACAGCGGTTT 
Table 6. Ub-hotspot Name Conversion 
Note that for this study and a recent publication (Höpfler et al, 2019), the previously 
described ubiquitin hotspots (Kern, 2013) have been renamed according to the following 
conversion table. 
Ub-hotspot name conversion  
This study Kern 2013, PhD thesis 
ub-HS1 ubiquitin hotspot 1 
ub-HS2 ubiquitin hotspot 2 
ub-HS3 ubiquitin hotspot 3 
ub-HS4 ubiquitin hotspot 5 
ub-HS5 ubiquitin hotspot 6 
ub-HS6 ubiquitin hotspot 7 
ub-HS7 ubiquitin hotspot 8 
ub-only-site1 ubiquitin hotspot 4 
ub-only-site2 ubiquitin hotspot 9 
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Abbreviations 
Abbreviations for nucleotides and amino acids were used according to the standard definitions 
(1-letter or 3-letter code) and are not specifically listed in this section.  
3AT  3-amino-1,2,4-triazol 
A. U.  arbitrary units 
aa  amino acid(s) 
AAA+ ATPases associated with 
various cellular activities 
Ac acetyl group or acetate 
AD Gal4 (trans-) activation domain 
ARM  arginine-rich motif 
ATP  adenosine 5’-triphosphate 
BD  Gal4 DNA-binding domain 
BenzAlc benzyl alcohol 
BER base excision repair 
BMC Biomedizinisches Centrum 
München 
bp  base pair(s)  
C carboxy (C-terminal/-terminus), 
also cytoplasm 
°C  degree Celsius 
CC  coiled-coiled 
cDNA  complementary DNA 
ChIP chromatin immunoprecipitation 
ChIP-chip ChIP combined with genome-
wide tiling microarrays 
CHX  cycloheximide 
cl  clone 
contr.  control 
CRL  Cullin RING ligase 
Cy3  cyanine dye 3 
Cy5  cyanine dye 5 
d  day(s) 
D  dextrose 
DMSO   dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
DNase deoxyribonuclease 
dNTP 2’-deoxyribonucleoside-5’-
triphosphate 
DUB  deubiquitylating enzyme 
DSB  DNA double-strand break 
DTT  dithiothreitol 
E. coli   Escherichia coli 
e.g.   exempli gratia, for example 
E1  activating enzyme 
E2  conjugating enzyme 
E3  ligase 
E4  chain elongating ligase 
ECL  enhanced chemiluminescence 
EDTA   ethylenediaminetetraacetic acid 
ER  endoplasmic reticulum 
ERAD  ER-associated degradation 
EtOH ethyl alcohol 
Euc1 Enriches ubiquitin on 
chromatin 1 
FDR  false discovery rate 
g  gram 
g  gravity 
G1  gap 1 (cell cycle phase) 
G2  gap 2 (cell cycle phase) 
G418  geneticine disulfate 
Gal  galactose 
GEO  Gene Expression Omnibus 
GFP  green fluorescent protein 
GINS  go-ichi-ni-san 
GST  glutathione S-transferase 
h  hour(s) 
H. sapiens Homo sapiens 
HA influenza hemagglutinin epitope 
HAT histone acetyltransferase 
HDAC histone deacetylase 
HECT homologous to the E6-AP 
carboxyl terminus 
HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
His histidine 
HMW high molecular weight 
Hph hygromycin B 
hphNT1 gene conferring resistance to 
hygromycin 
HR  homologous recombination 
HRP  horseradish peroxidase 
HU  hydroxyurea 
i.e.  id est, in other words 
IgG  immunoglobulin G 
INQ intranuclear quality control 
compartment 
IP  immunoprecipitation 
JAMM JAB1/MPN/MOV34 
kanMX6 gene conferring resistance to 
G418 
kb  kilo base pair(s) 
kDa  kilo Dalton 
l  liter(s) 
LB lysogeny broth 
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LMU  Ludwig-Maximilians-
University Munich 
log  logarithmic 
M  molar 
m  milli (x10-3) 
Md  middle domain 
MN/C  middle domain N-/C-terminal 
M-phase  mitotic phase 
µ  micro (x10-6) 
µm  micrometre(s) 
MCM minichromosome maintenance 
MDa mega Dalton 
min minute(s) 
MINDY motif interacting with ubiquitin 
DUB family 
MOPS 3-(N-morpholino) 
propanesulfonic acid 
MPI Max-Planck-Institute 
mRNA messenger RNA 
Myc c-Myc epitope 
N amino (N-terminal/-terminus), 
also nucleus 
n nano (x10-9) 
n sample size 
NAT nourseothricin 
natNT2  gene conferring resistance to 
nourseothricin 
NEB New England Biolabs 
NEM N-ethylmaleimide 
NER nucleotide excision repair 
NES normalized enrichment score 
NFκB nuclear factor kappa-light-
chain-enhancer of activated B 
cells 
NHEJ non-homologous end joining 
NiNTA Ni2+ nitrilotriacetic acid 
NLS nuclear localization signal 
norm. normalized 
nm nanometre(s)  
NP-40  nonidet p-40 
NPC nuclear pore complex 
OD600 optical density at 600 nm 
wavelength 
ORF  open reading frame 
OTU  ovarian tumor protease 
p  promoter (with gene names) 
p-value, pval probability value 
padj adjusted p-value 
PAGE  polyacrylamide gel 
electrophoresis 
PBS  phosphate buffered saline 
PCNA proliferating cell nuclear 
antigen 
PCR  polymerase chain reaction 
PD  pulldown 
PEG  polyethylene glycol 
PH  pleckstrin homology 
PhD   doctor of philosophy 
PML  promyelocytic leukaemia 
PNGase  peptide N-glycanase 
Pol  polymerase 
PRC1  polycomb repressive complex 1 
PTM  post-translational modification 
PUB  PNGase/ubiquitin-associated 
PUL  PLAP, Ufd3 and Lub1 
PVDF  polyvinylidene fluoride 
QC  quality control 
qPCR  quantitative real-time PCR 
Rad  radiation 
Raf  raffinose 
RBR  RING-between-RING 
rDNA  ribosomal DNA 
Ref.  reference 
RING  really interesting new gene 
RMA  Robust Multiarray Analysis 
RNA  ribonucleic acid 
RNase  ribonuclease 
RNF  Ring finger protein 
rpm  rounds per minute 
RT room temperature 
RT-qPCR reverse transcription followed 
by qPCR 
S  Svedberg 
S  SUMO (in figures) 
S-phase  synthesis phase 
S. cerevisiae Saccharomyces cerevisiae 
S. pombe Schizosaccharomyces pombe 
SAP  SAF-A/B, Acinus, PIAS 
SBM  Slx5-binding mutant 
SC   synthetic complete 
SCF  Skp, Cullin, F-box 
SDS  sodium dodecyl sulfate 
sec  second(s) 
SENP  sentrin specific protease 
SHP  suppressor of high-copy PP1 
SIM  SUMO-interacting motif 
SPB  spindle pole body 
STUbL  SUMO-targeted ubiquitin ligase 
Sub  substrate 
SUMO  small ubiquitin-like modifier 
Swi/Snf  switch/sucrose non-fermentable 
t terminator (with gene names) 
TBE tris, boric acid, EDTA 
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TBS-T  tris-buffered saline with Tween-
20 
TCA trichloro acidic acid 
TE  Tris, EDTA 
TF  transcription factor 
TGFβ  transforming growth factor β 
Tris  Tris(hydroxymethyl)-
aminomethane 
tRNA  transfer RNA 
Ub, ub  ubiquitin 
ub-HS  ubiquitin hotspot 
UBA  ubiquitin-associated domain 
Ubc  ubiquitin conjugating 
UBD  ubiquitin-binding domain 
UBL  ubiquitin-like 
UBX  ubiquitin regulatory X 
UBZ  ubiquitin-binding zing finger 
UCH  ubiquitin C-terminal hydrolase 
Ufd  ubiquitin-fusion degradation 
UIM  ubiquitin-interacting motif 
ULP  ubiquitin-like protease 
UPS  ubiquitin–proteasome system 
us  upstream 
USP  ubiquitin-specific protease 
UTR  untranslated region 
UV  ultraviolet 
V  Volt 
v/v  volume per volume 
VBM  VCP binding motif 
VCP  valosine-containing protein 
VIM  VCP-interacting motif 
vs.  versus 
WB  western blot 
WCE  whole cell extract 
WGA  Whole Genome Amplification 
WT  wild-type 
w/v  weight per volume 
Y1H  yeast one-hybrid 
Y2H  yeast two-hybrid 
YPD  yeast extract, peptone, dextrose 
ZnF  zinc finger 
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